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ABSTRACT

Dietary advice to individuals in Medical Nutrition Therapy for the prevention and
treatment of disease should be based on the best available evidence. A review of
the evidence identifies appropriate nutrients on which to base advice. However,
evidence to support the application of advice for the achievement of nutrient
targets in free-living individuals has not been adequately determined. In this
doctoral program the hypothesis tested was that structured advice based on the
pattern of intake from food group sources of required nutrients will result in better
achievement of dietary targets and thereby clinical outcomes than advice based on
existing core food guides.
In developing a more comprehens ive food guidance system, nutritional therapy for
diabetes treatment provides an appropriate example in which individual
macronutrients and the type of fat are targets of advice. A cross-sectional survey of
the food habits of a sample of women with Gestati onal Diabetes Mellitus was
conducted to confirm the relevance of food patterns to specific clinical outcomes, in
this case, glucose tolerance. Secondly, foods commonly consumed by these
women enabled the identification of food groups likely to impact on macronutrient
and fat profiles within the diet. Subsequent determination of a total diet model
demonstrated that a structured approach to dietary advice relating to nine food
groups (vegetables, starch, fruit, milk, soymilk, meat, oily fish/soybeans,
monounsaturated and polyunsaturated fats) for the identification of sources of
saturated and unsaturated fats would achieve nutritional adequacy and targets for
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energy and individual macronutrients with minimal variation. This then formed the
basis of individualised advice in dietary intervention trials.
Applying the newly developed advice system in an intervention trial demonstrated
its feasibility in women with Gestational Diabetes Mellitus. Compared with a similar
group receiving standardised low fat advice, 80% achieved saturated and
polyunsaturated fat targets compared with nil in the standard intervention group,
without detrimental changes to the overall macronutrient profile.
The clinical effectiveness of the advice system was again demonstrated in a
second trial. In this study men and women with Type 2 Diabetes Mellitus followed
two alternative patterns of advice based on the newly developed food guidance
system for six months. In these two groups respectively, 79% and 100% of
subjects, achieved targeted proportions of total polyunsaturated fat compared to
25% in a control group (p<0.05). In addition, greater improvements were achieved
for HDL-cholesterol (+18% and +21% compared to +13% control, p<0.05) and
triglyceride levels (-12% and -11% compared to -2% control).
In summary, this thesis has outlined the development and evaluation of an advice
system to support nutrition intervention in people with diabetes. Individualised
advice based on a structured food pattern identifying food group sources of target
nutrients was both feasible to implement and effective in practice. The application
of this knowledge will help support nutrition intervention research as well as
provide an evidence-based approach to Medical Nutrition Therapy.
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CHAPTER 1 INTRODUCTION

1.1 Evidence -based practice in nutrition intervention
This thesis, by detailing the development and evaluation of an advice system for
nutrition intervention, supports current philosophical concepts relating to evidencebased medicine. Evidence-based medicine involves the s pecific use of the best
evidence currently available to guide decision-making with regard to individual
patient care 1. In practice, this means integrating clinical expertise with evidence
from clinically relevant and systematic research. It is generally accepted that the
principles of evidence-based medicine apply to all areas of clinical practice,
including the field of nutrition and dietetics 2. Thus, the specific application of
clinical and nutrition knowledge in the treatment of disease is known as Medical
Nutrition Therapy (MNT) 3.
This knowledge refers to a hierarchy of research evidence in both animals and
humans demonstrating direct causal relationships and indirect effects between
specific nutrients and disease and/or disease factors 4. The randomised controlled
trial (RCT), the highest level of research evidence, confirms the specific application
of this knowledge for achievement of nutrient targets and substantiation of benefit
in terms of health-related clinical outcomes.
A systematic review of the research literature and other clinically relevant sources
provides a set of evidence-based recommendations, defining a framework that
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supports the quality of clinical judgments and facilitates individualised patient care
rather than a single treatment for all 5 .
Whilst individualised advice is fundamental to the principles of evidence-based
practice, delivery i n a scientific and effective manner with measured outcomes is
also required 3. The quality and specific blend of nutritional evidence from a
mixture of scientific knowledge, clinical experience and expert consensus,
however, has not always been certain. Consequently, the application of the
principles of evidence-based nutrition has necessitated changes in clinical
approaches and the need for RCTs to provide evidence to support practice.
Nutrition therapy for diabetes, for example, has long been considered the
‘cornerstone’ of treatment. However, the ‘ideal’ nutrition prescription that previously
applied to all diabetes patients has been replaced with an emphasis on health care
provider and individual patient goals 3. The change is largely due to the position of
diabetes in the research literature as one of a cluster of metabolic abnormalities
collectively known as the Metabolic Syndrome 6, 7. Hence, the traditional focus on
glycaemic control has shifted to a broader focus on metabolic control 8 , where
improvements in overweight, blood pressure, blood glucose and lipid levels, and
lipoprotein profile are all aimed at the prevention or reduction in risk of diabetesand vascular disease-related complications.
For the prevention and management of diabetes and its complications, the
American Diabetes Association (ADA) incorporates into its guidelines 8 dietary
recommendations from relevant US organizations, such as US Department of
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Agriculture (Dietary Guidelines for Americans), American Heart Association (AHA),
and National Cholesterol Education Program, and suggests that advice based on
food patterns provides a practical approach for the achievement of health benefits.
A total diet approach is recommended, where all foods fit into a healthy diet 8, 9 .
However, the bulk of research evidence on metabolic control supports attention to
specific proportions of different types of dietary fat 10. Where reduction in the
amount of saturated fat (SFA) is required, replacement with dietary
polyunsaturated fat (PUFA) is indicated, with the greatest benefits from increased
omega-3 (n-3) and reduced omega-6 (n-6): n3 ratio. The guidelines reflect this
evidence, recommending saturated and polyunsaturated fat in the diet as specific
percentages of total energy intake 8 and specific PUFA: SFA (P:S) and n-6: n-3
ratios 11. However, the application of advice for the achievement of recommended
fat proportions has not been well documented in intervention trials to support this
evolution in practice. Furthermore, few definitive RCTs have been conducted in
people with diabetes to confirm the effects of specific dietary interventions 10.
To assist the specific application of nutrition advice under free-living conditions,
food guidance systems enable the conversion of theoretical nutrient targets into
practical advice on foods under free-living conditions. Current advice for diabetes
treatment draws on a variety of advice systems, ranging from carbohydrate (CHO)counting systems 12, which focus almost exclusively on CHO -rich foods, to core
food guide classifications 13, 14 and exchange lists for meal planning 15, which
emphasize CHO-rich foods and high CHO diets as the preferred pattern of intake
16

. Few, however, have reported their methodological basis 17 or evaluated their
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effectiveness in producing desired outcomes 18 . Their adequacy for the
achievement of individual fat proportions and subsequent clinical benefit, therefore,
is presently unknown.
To substantiate the benefits of dietary intervention, structured methods and proven
assessments apply. A systematic framework for advice would support the practical
evaluation of nutrition interventions in terms of specific health outcomes and
enable individual nutrients and foods to be tested as part of the overall diet, while
changes in biomarkers of dietary intake would confirm the results.
For strategies to control/change dietary intakes, reference is made to previous
research. Large-scale lifestyle intervention trials demonstrating the effectiveness of
nutritional advice based on specific targets for total energy, fat and saturated fat
intakes in order to reduce the incidence of diabetes and related complications 19-21.
In terms of existing low fat strategies, however, achievement of relative amounts of
polyunsaturated fat appears to be problematic 22. For example, where reductions in
total fat intake in respons e to general low fat advice may unintentionally reduce all
types of dietary fat 23 . Alternatively, adjunct advice for increasing unsaturated fat
intakes mainly focuses on exchangeable edible fat portions 24, with limited impact
on individual fat ratios within the overall diet, but may instead result in higher
energy and n-6 PUFA intakes with subsequent loss of benefit 25. Incorporation of
all dietary fat sources has greater potential for achievement of overall fat
proportions and is more consistent with guideline recommendations for a total diet
food pattern approach to advice 8.
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To effectively guide advice for the achievement of specific nutrient targets, food
group development and construction of an overall pattern of intake to incorporate
sources of the required nutrients provides a framework on which to base
individualised advice. In the Dietary Approaches to Stop Hypertension (DASH) trial,
foods from 13 individual food groups were provided as sources of specific nutrients
to hypertensive patients to demonstrate the effectiveness of food pattern advice for
the achievement of focused clinical outcomes 26. In this case, targeting a broarder
range of nutrients for specific clinical outcomes required reference to a greater
number of food groups than currently available from core food groupings aimed at
general nutritional adequacy. In the case of diabetes, individual fat types are the
specific nutrients targeted. Food pattern analyses demonstrate the way in which
specific proportions of individual fats are achieved in practice, through major shifts
in intakes across several food groups 23. The application of this knowledge to the
development of an advice system and its implementation in free-living individuals in
an intervention trial to test achievement of specific nutrient variables and
subsequent clinical benefit would provide a methodology for nutrient intervention
and evidence for practice.
The aim of this research, therefore, was to develop a set of macronutrient-based
food groups and to evaluate the effectiveness of advice based on their specific
pattern of intake for the achievement of theoretical nutrient targets and thereby
health benefits. Specifically, the thesis considers the application of advice in RCTs
to free-living individuals with diabetes mellitus, targeting specific relative
proportions of different types of dietary fat and subsequent improvements in
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overweight, blood glucose and blood lipid levels. This would support evidencebased practice for nutrition intervention in MNT for diabetes and related conditions.
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CHAPTER 2 LITERATURE REVIEW

This chapter reviews current research evidence and practices supporting nutrition
intervention in the treatment of diabetes. It is divided into seven sections. The first
(Section 2.1) describes diabetes and clinical features related to the Metabolic
Syndrome as indicators of altered metabolism. The second (Section 2.2) is a
systematic review of the literature in the context of a hierarchy of research
evidence that supports specific macronutrients, in particular the type of fat in the
diet, as targets for nutrition intervention and subsequent improvements in
metabolism. A critical review follows (Section 2.3) in which current applications to
direct nutrition intervention are assessed in terms of their support for the evidencebase. This includes an assessment of nutritional guidelines and food guidance
systems for diabetes treatment. A look at previous approaches to nutrition
intervention research (Section 2.4) assesses the feasibility of advice approaches in
practice and reveals specific inadequacies for the achievement of macronutrient
targets, particularly for the type of fat, and the relevance to assessments in
substantiation research. Finally (Section 2.5), the inadequacies or gaps in the
research and requirements for the adequate achievement of specific nutrient
intakes are summarized, resulting in an hypothesis (Section 2.6) and subs equent
aims (Section 2.7) for the provision of evidence to support practice that anchors
this thesis.
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2.1 Diabetes and Related Complications
2.1.1 Type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is one of a cluster of metabolic abnormalities
(abdominal obesity, atherogenic dyslipidemia, hypertension, and glucose
intolerance) referred to as the Metabolic Syndrome 6, 7. Although the etiology of the
Metabolic Syndrome is largely unknown, insulin resistance involving reduced
glucose uptake and increased glucose and lipid outputs, has been identified as a
common underlying pathophysiological defect
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. T2DM is characterized by

glucose intolerance (fasting plasma glucose (FPG) >7.0 mmol/l or 2-h post glucose
load (2-h) >11.1 mmol/l and confirmed on another day) 28 and appears to be
indicative of the state of insulin resistance rather than an absolute deficiency in
insulin. Consequently, us ual treatment does not require insulin and the condition is
most often managed with dietary and general lifestyle modification alone or in
combination with oral therapy 8, 28. If alternative therapies become ineffective at
maintaining blood glucose levels within an acceptable range, insulin therapy may
then be required 28.
In Australia, the total prevalence of known and newly diagnosed T2DM among
adults 25 years and over is 7.4%, half of whom are unaware they have the
condition 29, 30 . These findings represent a more than doubling of the incidence of
diabetes in Australia since a previous survey conducted in 1981 31. Similar surveys
undertaken in the US reflect the Australian findings 32, 33. The dramatic increase in
diabetes over the past 20 years, estimated to be up from 300 000 to almost 1
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million Australians in 2001 34 represents a massive increase in the total health
burden on Australians. Parallel rises in overweight and obesity 29 indicate a serious
public health problem and present a major challenge for health professionals. The
annual total costs of diabetes in Australia have been calculated at $1 billion and
rising 35. Diagnosed diabetes was the 7th leading cause of burden of disease
(5.4%) in Australia in 1996 36 . Considering the high prevalence of undiagnosed
diabetes and subsequent failure to recognize diabetes as the underlying cause in
many cases of cardiovascular disease (CVD) mortality and morbidity, these figures
are likely to be huge underestimations of the true situation. International studies
estimate a similar health burden where 4% of the population with diabetes can
account for 12% of total health care costs 37.
In keeping with known associations with the Metabolic Syndrome, T2DM is
considered both a disease and a risk factor for other diseases 28 . Glucose
intolerance (diagnosed and undiagnosed) is a major independent risk factor for
CVD 38-41, regardless of blood lipid levels, while elevated blood lipid levels are
associated with increased risk of coronary heart disease (CHD) beyond that
conferred by diabetes 42 . Macro-vascular disease is, therefore, a major cause of
premature death and morbidity among people with glucose intolerance due to
myocardial infarction, stroke and large vessel occlusive disease 43-46. Major,
irreversible, long-term micro-vascular disease complications include retinopathy
and blindness, neuropathy and renal failure (dialysis/transplantation), foot ulcers
and lower limb amputation, and erectile dysfunction 28, 47 .

33
Approximately one third of people with Impaired Glucose Tolerance (IGT) (FPG
<7.0 mmol/l and 2-h <11.1 mmol/l) 28 will go on to develop T2DM in their lifetime 48.
People with Impaired Fasting Glucose (IFG) (FPG >6.1 and <7.0 mmol/l or 2-h
<7.8 mmol/l) 28 are also at increased risk 49, as are women first diagnosed with any
degree of glucose intolerance during pregnancy, that is, with Gestational Diabetes
Mellitus (GDM) 50. Genetic influences are strong 51-53: Aboriginal and Torres Strait
Islanders 54, 55 ; people with non-English speaking backgrounds 56, 57; and those with
a first degree relative with T2DM

58

are also at increased risk. There are also close

associations between obesity and insulin resistance 59-61: obesity in adult life 62, 63;
weight gain 64, 65 ; duration of obesity

66-68

; and other clinical features of the

Metabolic Syndrome (elevated lipid levels, CVD and hypertension) 69, 70feature
prominently and suggest environmental (behavioural) influences play a major role
71, 72

. Long term diet 25, 73 and physical inactivity are heavily implicated74. While

physical activity is known to have a strong influence on insulin sensitivity

75, 76

,

dietary influences are much more complex with individual nutrients possibly
exerting combined and separate effects, directly and indirectly via obesity 77 .
2.1.2 Gestational diabetes mellitus
GDM identifies a subgroup of the diabetes population with demonstrated glucose
intolerance first identified during pregnancy 78. Normal pregnancy is associated
with a reduced insulin sensitivity and increased insulin secretion 79 . While the
former redirects nutrients to the fetus, the latter is thought to be an homeostatic
response for maintaining relatively good blood glucose control despite the rising
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insulin resistance of pregnancy. Whether greater insulin resistance 80 or reduced
insulin secretary capacity or both 81 is common in all or some of these women is
unclear, however, multiple defects in insulin action and impaired compensation for
insulin resistance have both been reported and may represent the early detection
of both chronic insulin resistance and beta cell dysfunction in pregnant women 82.
In the Illawarra region of Australia, the incidence of GDM has been reported at
7.2% of pregnant women 83 , and may range from 1%-14% throughout the world 84,
85 86

, with the highest prevalence in ethnic groups 87, making GDM one of the most

common medical complications of pregnancy and hence a major medical concern.
Adverse perinatal outcomes include intra uterine death, maternal hypertensive
disorders, fetal macrosomia (large-for-gestational age baby), premature delivery,
caesarian section, and special care of the newborn 86. Pregnant women have a
continuum of perinatal risk related to rising maternal blood glucose levels 88.
Hence, primary management strategies are the prevention of adverse perinatal
outcomes based on maintaining glycaemic control and nutrition therapy is
considered the cornerstone of treatment. While post-partum glucose metabolism
generally returns to normal, women with GDM are at increased risk of recurring
GDM in a future pregnancy (35%) 89, and of developing T2DM in the following 5-10
years (up to 70%) 90, as well as obesity and T2DM in the offspring 86. CVD and
CHD risks are high in these women 91, 92, with endothelial dysfunction (an early
marker of macro-vascular disease) and lipid abnormalities observed as early as the
index pregnancy 93-95. Women who develop T2DM have a four to five-fold increase
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in CHD mortality rate compared with non-diabetic women, canceling any hormonal
advantage over men 96, 97 . Hence, the diagnosis of GDM identifies women with a
disturbed metabolism and is therefore a risk factor for T2DM and related
complications.
While those at risk of GDM are readily identifiable (older, shorter, obese, multiparous, of specific ethnicity, with a family history of diabetes and/or history of
previous GDM) 98, 99, pregnant women without conventional risk factors also
develop GDM. Although GDM is a little studied area of diabetes research, close
associations with features of the Metabolic Syndrome suggest diet and physical
activity are important 99.
In summary, Diabetes Mellitus clinically defines glucose abnormalities associated
with insulin resistance and the Metabolic Syndrome. Total prevalence of diabetes
and related conditions is increasing worldwide, adding substanti ally to the overall
health burden. Diagnosis of diabetes is a risk factor for CVD and micro-vascular
disease complications. Close associations with weight gain and obesity as well as
parallel increases over the past 20 years indicate strong environmental
(behavioural) influences, implicating dietary factors and reduced physical activity.
2.2 Evidence supporting macronutrient targets in nutrition intervention
Evidence for a relationship between diet and diabetes and associated features of
the Metabolic Syndrome draws on a hierarchy of nutrition research 4 involving both
animals and humans. To begin, the mechanistic relationships between nutrition
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factors and IR have been well documented in feeding trials using animal models (in
vitro and in vivo). Human studies involving dietary macr onutrient manipulations,
although relying on less direct observations of insulin sensitivity, for example
measures of glucose and lipid metabolism, nevertheless support the findings in
animal studies. Epidemiological studies, while not able to show direct causal
relationships, provide valuable support for animal and human feeding trials by
demonstrating possible associations between nutrient intakes and the development
of disease and risk factors for disease, such as overweight and body fatness and
glucose and insulin levels in free -living populations. The strongest level of
evidence, however, comes from the RCT, where manipulations of nutrients in
humans confirm the conclusions drawn from mechanistic and observational
studies. This systematic hierarchical approach enables discrimination between
different forms of research and allows a broad assessment of the available
evidence and the identification of gaps in the research 4. Further, the methods
used in RCTs involving free-living individuals provide evidence for the application
of research knowledge.
2.2.1 Dietary fat
Mechanistic Studies
Storlien et al report that the strongest evidence for a relationship between diet and
clinical markers of insulin action relates to dietary fat intake 100. Early in vitro and in
vivo studies, mainly in rodents, demonstrated that high fat feeding results in
impaired insulin action in both fat and muscle tissue 101, 102, the latter being the
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major site of insulin stimulated glucose uptake. Compared to tissue from rats fed
an equi-caloric high CHO diet, insulin resistant rats also show major increases in
muscle triglyceride stores 103 and impaired glucose transport systems 104, 105,
suggesting impaired glucose utilization, a relative reduction in metabolic rate and
subsequent accumulation of body fat 106. In vivo studies, involving chronic high fat
versus high CHO feeding, also report a rapid deterioration in whole body insulin
action in rodents consuming the high fat diets 107, 108.
Although these studies suggest a clear relationship between high fat feeding and
insulin resistance, more recent research manipulating fat sub-types has provided
further evidence that distinctions in the pattern of fatty acid consumption may be
just as important 109, 110 . SFA intakes are associated with detrimental effects. While
substitution with PUFA appears to have a neutral or protective effect against the
processes that lead to obesity and insulin resistance 111, these effects appear via
multiple control points 74 , where PUFAs are more readily mobilized from adipose
tissue, preferentially incorporated into lipid membranes, and more readily oxidized
112

compared to SFAs. PUFAs also appear to inhibit insulin-stimulated hepatic

triglyceride secretion 113, 114, a major determinant of skeletal muscle fatty acid
uptake, and a regulatory effect on gene expression, suppressing both lipid
synthesis 115 and adipocyte differentiation 116. Increased n-3 PUFA consumption
has been shown to prevent insulin resistance 110 through a reduction in lipid stores
and a relative increase in the percentage of n-3 fatty acids in muscle membrane
lipids 117, resulting in improved insulin stimulated glucose disposal in both liver and
skeletal muscle. While the benefits of PUFA appear to be clear, in vitro studies
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demonstrating increased susceptibility to oxidation suggest high PUFA diets may
be more atherogenic 118 . A high n6:n-3 PUFA ratio in high fat diets also appears
detrimental due to excess accumulation of adipose tissue and changes in skeletal
muscle lipid stores and membrane lipid composition 117, 119. Further, the effect of fat
type may be mediated by glucose concentrations, where pancreatic beta-cell
capacity to respond to increased glucose concentrations has been shown to be
dramatically reduced in the presence of SFA 120, 121, possibly due to a number of
mechanisms including inhibition of cell proliferation and insulin mRNA expression,
increased apoptosis (cell death) and fatty acid synthesis resulting in fat
accumulation and ultimately beta-cell dysfunction. Under euglycaemic conditions
fatty acids switch from synthesis to oxidation, while the addition of MUFA promotes
beta-cell proliferation, even at low glucose concentrations 120. These mechanistic
studies highlight the complexities of metabolic nutrient interactions and affirm the
role of fatty acids in determining gene expression and cell function with the
potential for impairments in both insulin sensitivity and insulin secretory capacity.
Furthermore, saturated fats have been shown to increase neuronal activity in areas
of brain hypothalamus associated with feeding, and suppressing activity in areas
associated with satiety 122.
Indirect effects in humans
The association between dietary fat and insulin resistance in humans has been
substantially reviewed 123. Research in humans largely supports the evidence from
animal studies but mainly through results from epidemiological studies. Few
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studies have been conducted using in vivo techniques to assess insulin action in
humans following high fat/low fat diets 124, and for those that have been conducted,
results have not been clear 125-127. Relying on less direct associations, high fat diets
in humans again appear deleterious, independent of fatty acid profile
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. In terms

of blood lipid levels, saturated fats appear more detrimental than unsaturated fats.
In a review, Grundy concluded that compared to oleic acid (MUFA), considered to
have a neutral effect on blood lipids, dietary SFAs (palmitic, myristic, lauric) raises
serum cholesterol concentrations, while stearic acid (SFA), does not 129. These
effects appear due to influences on gene regulation, the major effect likely due to
suppression of LDL-C receptor expression, with little or no effect on high density
lipoprotein cholesterol (HDL-C) or very low density lipoprotein cholesterol (VLDL-C)
concentrations. In contrast, n-6 linoleic acid (the most predominant dietary PUFA)
lowers total cholesterol (total-C) relative to oleic acid, and possibly lowers all
lipoprotein fractions. Wardlaw et al demonstrated that the addition of either PUFA
or MUFA to high SFA diets resulted in significantly lower serum total and low
density lipoprotein cholesterol (LDL-C) levels and a dramatic lowering of serum
triglyceride concentrations 130 . Furthermore, these changes were accompanied by
an overall replacement of palmitic acid by unsaturated fatty acids in serum
phospholipids with specific replacement matching those fatty acids present in the
diet. By comparing human muscle samples from male patients undergoing
coronary surgery with normal men, reduced concentrations of PUFAs in skeletal
muscle phospholipids were associated with reduced insulin sensitivity 131 . A
number of studies support this close relationship between the fatty acid
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composition of the phospholipids of skeletal muscle cell membranes and insulin
sensitivity 123. Similar results have been observed for high MUFA compared to high
CHO diets. Replacing MUFA with CHO in T2DM patients, however, has resulted in
significant increases in plasma triglyceride, VLDL-C, glucose and insulin values 132.
Substitution of MUFA with PUFA (from 3-14% PUFA) may be more beneficial,
resulting in greater reductions in total and LDL -C and triglyceride levels 133, 134 .
However, compared with a high MUFA diet, T2DM subjects on a high PUFA diet
reported higher plasma total and LDL-C, fasting glucose and insulin levels 135.
More specifically, increasing n-3 PUFA intakes in humans has been shown to
reduce serum cholesterol 136 and plasma triglyceride levels 137, especially in those
with elevated levels, improve thrombogenic properties such as platelet aggregation
138, 139

, arrhythmias and heart disease risk 140, and competitive pathways for

essential fatty acid production has been linked to alterations in eicosanoid
production 141, 142. In addition, changes in the food supply over evolutionary time
periods have promoted a change in n-6:n-3 ratio from an original 1:1 to around
15:1 in Western diets 143. While the benefits of lowering the ratio in humans are
plausible, further research is required.
Epidemiological Research
Cross-sectional studies rely on associations with measured clinical outcomes.
Marshall et al conducted a cross sectional study in which the diets of 1076 subjects
living in the San Luis Valley in Colorado were assessed using 24-hr diet recalls 144 .
Subjects diagnosed with IGT or diabetes reported greater total fat intakes as a
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percentage of energy (%E) than subjects with normal glucose tolerance. When 134
of these subjects with IGT were followed for 1-3 years, increased fat consumption
preceded the development of T2DM after controlling for obesity (Marshall et al
1994).
Twin studies are useful for standardizing genetic predispositions. Mayer et al
looked at the usual dietary intake and insulin concentrations of 544 non-diabetic
female twins 145 . A 20g/day increase in total dietary fat was associated with a
higher fasting insulin level before and after adjustment for obesity (Mayer et al
1993), but was significantly attenuated by physical activity. Within identical twin
pairs, total dietary fat was positively related to fasting insulin levels before, but not
after adjustment for obesity.
The Seven Countries Study also followed a large cohort of non-diabetic men over
30 years and found that both total and saturated fat were associated with the
development of diabetes.
In the Zutphen Study the diets of non-diabetic men were assessed using a diet
history (DH) interview and found not only detrimental associations between total,
SFA and monounsaturated fatty acids (MUFA) and glucose tolerance, but an
inverse association between PUFA (vegetable fat) and insulin levels 146. Colditz et
al also observed an inverse association for vegetable fat (as well as calcium and
magnesium) and the risk of diabetes amongst 84,360 US women over a six year
period 147. This association was again attenuated by obesity.
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While higher fat intake is associated with increased body weight and fatness 148
and in particular central adiposity 149 (the major risk factor for the Metabolic
Syndrome) 150, evidence from epidemiological studies are considered to be
inconclusive with regard to total dietary fat intake and the promotion of obesity
independent of total energy intake 151. Hence, it is argued that energy density may
be the crucial dietary factor. However, there is considerable evidence to suggest
that the increase in obesity may depend more on fat profile than on total fat intake,
where relationships between diabetes, central adiposity and total fat, SFA and
even MUFA intakes have also been observed, but not for dietary PUFA, which may
provide protection 74, 111, 149.
Observational studies have also identified links between the quantity and quality of
dietary fat and the development of GDM. For example, Moses et al examined the
diets of women with a recurrence of GDM using DH interviews and food records
(FR), and found that more of their total energy intake was consumed as fat when
compared with the dietary intakes of women with no recurrence 152. Increased
weight between pregnancies was also associated with a recurrence of the
condition, again providing parallels for increasing dietary fat and overweight.
However, there was also a proportionate reduction in CHO and fibre intakes, which
need to be considered when interpreting such observations. More specifically, Bo
et al reported an independent association between SFA and the development of
gestational glucose abnormalities, especially in the absence of conventional risk
factors 153 . In a study of maternal plasma phospholipids, SFA concentrations were
significantly higher and PUFA (n-3 and n6) and MUFA concentrations significantly
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lower in women with GDM than in healthy, pregnant women 154, indicating possible
links between higher SFA consumption, cell membrane composition, and insulin
resistance. Wang et al conducted a study on nulliparous pregnant Chinese women
diagnosed with GDM and compared them with age -, gestational age-, height- and
parity-matched women with normal glucose tolerance and IGT using a 24-hour
recall dietary assessment method 155. Increased PUFA intakes and an increased
P:S ratio were associated with a reduced incidence of glucose intolerance in
pregnancy (independent of body weight and body mass index (BMI)), hence linking
inadequate PUFA intakes with the clinical expression of insulin resistance. While
GDM is a relatively little studied area of nutrition research, studies indicate that
women who develop GDM have prior metabolic abnormalities, possibly a reduced
sensitivity to insulin and/or beta-cell dysfunction which need to be addressed
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Where diet composition may accentuate the hormonal influences that induce
insulin resistance in late pregnancy, high PUFA intakes and a high P:S ratio may
have a protective effect. There is currently a serious lack of randomised c ontrolled
dietary intervention trials in free-living GDM subjects to fully assess the role of
dietary fat in the diet.
Foods as Sources of Unsaturated Fat Intake
Studies referring to foods as sources of PUFA support the benefits and
demonstrate practical approaches for increasing PUFA in the diet. Most studies
have favoured fish (whole fish and oils) and nuts. The benefits of fish oils have long
been expounded, particularly as a source of n-3 PUFA. However, in terms of
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insulin sensitivity, modest improvements have been reported 157, 158. While their
triglyceride lowering effects have been duly noted, their use in diabetes patients
has been questioned due to possible impact on glycaemic control and detrimental
effects on LDL-C concentrations 8 . More recent research, however, has allayed
concerns of adverse effects on glucose metabolism 159, 160. Accordingly, Friedberg
et al conducted a review of the effects of fish oil on glycaemic control in diabetes
161

. All studies reviewed showed a reduction in mean triglyceride concentrations in

association with fish oil and a slight but significant increase in serum LDL-C
concentrations with no adverse effects on diabetic control. Durrington et al
observed no adverse effects on glycaemic control or LDL-C levels, in diabetic
patients treated with n-3 PUFA supplements 162. The supplement was found to be
an effective means for lowering serum triglycerides in patients with CHD and
hyperlipidaemia, including those with diabetes whose triglycerides had previously
remained elevated despite lipid lowering drug treatment. Evidence from the general
population has indicated that food containing n-3 fatty acids (specifically
eiocosahexenoic acid (EPA) and docosahexenoic acid (DHA) in fish) offers cardioprotection 163-165. Further, researchers involved in the Oslo diet study 166 in which
subjects were supplied with oily fish in addition to dietary advice, reported diabetic
improvements independently from alterations in other dietary factors or cholesterol
lowering. The Seven Countries Study also made a food-based observation for the
possible protective effects of fish consumption in terms of diabetes risk 70 . Data
from the Nurses’ Health Study indicated women who consume fish regularly may
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reduce their risk of CVD. This was the first long-term study (conducted since 1980)
confirming the health benefits of fish oils in women 167.
Epidemiological studies consistently show an inverse relationship between nut
consumption and CHD 168-170, predominantly through lipid lowering effects 171.
Although nuts are a rich source of unsaturated fat, they also contain significant
amounts of vitamin E (antioxidant properties), fibre, magnesium, potassium and
arginine 169 . Thus, the protective effects appear to be mediated through several
mechanisms that may be specific to consumption of the whole nut. Unsaturated
fatty acids and fibre may bring about improvements through reductions in
triglyceride and cholesterol concentrations 133, 172 and improvements in antithrombogenic pathways, as previously noted. Magnesium and potassium may
improve blood pressure 173, and arginine may lower blood pressure through
vasodilatory mechanisms 174.
Epidemiological evidence also reveals a negative association between nut
consumption and body weight 168, 170 . Again, several mechanisms appear to be
involved. Nuts (legumes) are rich sources of fibre and protein, both of which
enhance satiety 175, 176. Whole nuts are inefficiently absorbed 177. When subjects
were fed whole peanuts, 17-18% of dietary fat was excreted in the stool. Although
energy dense, nuts have a high satiety value and chronic ingestion of nuts evokes
strong dietary compensation 176 and little change in energy balance 171. Therefore,
(pea)nuts may promote increased energy expenditure (EE) due to their highly
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unsaturated fat composition 178, being preferentially oxidized 112, and their protein
content 179.
One chronic feeding study reported significant weight loss in a group consuming
nuts despite participants being asked to maintain body weight and activity levels
180

and their energy intakes being comparable with a control group

. Where several

experimental human feeding trials involving a variety of nuts have shown either no
change or a reduction in body weight among nut consumers, poor absorption may
be an explanation 133, 181, 182.
Unfortunately, epidemiological reviews do not differentiate between intakes of the
various types of nut 169, 183, while their fat profiles vary considerably. For example,
almonds, hazelnuts, macadamia nuts and peanuts are composed mostly of MUFA,
while pine nuts, brazil nuts and walnuts are highest in PUFA
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. Walnuts are

unique in that they are a rich source of both n-6 and n-3 PUFA 185. The n-3 PUFA
is the form alpha-linolenic acid (ALA) (18:3n-3), which can be elongated and
desaturated in the human body as the essential precursor of the n-3 PUFA in fish
oils (EPA 20:5n-3 and DHA (22:6n-3) 186 with similar benefits 187. Conceivably,
therefore, the consumption of walnuts can lower both plasma triglyceride and
cholesterol concentrations 188 .
In a randomised cross-over intervention trial, Almario et al found that walnut
supplementation did not increase body weight despite increased energy intake188.
A low fat diet + walnuts caused weight loss (1.3+0.5kg) and a reduction in plasma
total and LDL-C concentrations compared with habitual diet and a low fat diet
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without walnuts. However, HDL-C was also reduced when walnuts were added to
habitual diet but not on the low fat diet + walnuts.
Lifestyle Intervention Trials
Intervention trials in which dietary advice is provided to free-living individuals
provide evidence for the benefits of the application of nutritional theory. A number
of large-scale lifestyle intervention trials have demonstrated reductions in diabetes
risk and related complications by targeting changes in dietary fat intake and
physical activity levels. The Diabetes Prevention Program, a large multi-centre trial
involving 3243 non-diabetic at-risk men and women (overweight with elevated
blood glucose levels) showed that intensive treatment, including individualised
advice for low caloric, low fat (<25%E), low SFA diets and increased physical
activity significantly reduced the incidence of diabetes (58% reduction) compared
with standardised general advice over 3.5 -5 years. The result was also significant
compared with a general advice group receiving oral therapy, which achieved a
31% reduction in risk compared with the control group.
Similarly, the Finnish Diabetes Prevention Study, involving 523 high risk individuals
(first degree relatives with T2DM, overweight (BMI>25), or IGT) provided an
intensive treatment group with specific advice aimed at achieving <10%E SFA and
20-25%E MUFA/PUFA

189-191

. Over five years, subjects from this group significantly

lowered plasma glucose concentrations, blood pressure, serum lipids, and body
weight and significantly increased HDL-C levels compared to standardised general
advice.
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The KANWU study went a step further to determine whether a change in dietary fat
quality could alter insulin action in 162 free-living men and women with IGT 25.
Advice aimed at provide an iso-energetic diet, containing either a high proportion of
SFA (17%E SFA, 14%E MUFA) or MUFA (8%E SFA, 23%E MUFA) plus a random
assignment of fish oil supplement (containing 3.6g n-3, two taken three times/day)
or placebo. After three months advice, insulin sensitivity was significantly impaired
and LDL-C increased on the high SFA diet. In contrast, the high MUFA diet di d not
alter insulin sensitivity and LDL-C was reduced. The addition of a fish oil
supplement had no influence on insulin sensitivity or insulin secretion. The
favourable effects of substituting MUFA for SFA were, however, limited to low to
moderate fat intakes (<37%E).
Hence, results from lifestyle intervention trials support the bank of current research
evidence suggesting advice strategies aimed at total diet modification, in particular
manipulation of the fat profile (low total and SFA and high MUFA) wi thin the
context of a low to moderate fat diet, improves clinical measures associated with
increased risk of diabetes and related complications. Similar large-scale studies
increasing PUFA intakes have not been undertaken.
In summary, high fat and high saturated fat diets promote clinical abnormalities
associated with aspects of the Metabolic Syndrome and hence IR. Increasing
PUFA, in particular n-3 fatty acids, demonstrates largely protective effects.
However, due to the competitive nature of fatty acids an increased P: S ratio and
reduced n-6: n-3 ratio offer the greatest benefits. Notwithstanding, energy cannot
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be disregarded in terms of the promotion of obesity and related effects.
Observations in GDM women offer similar but limited evidence for differential
effects of relative amounts of SFA and PUFA in the diet. Evidence for specific
individual foods as sources of PUFA/ n-3 PUFA largely involve fish oil
supplementation with concerns for increased LDL-C concentrations. The
consumption of whole food sources, such as fish and nuts, provide similar benefits
to oils in the diet, as well as other synergistic components that may also provide
benefit. Lifestyle intervention trials demonstrate that advice targeting the theory on
dietary fat profile can be applied in practice to reduce the risk of T2DM and related
complications in free-living at-risk groups. Clinical intervention trials demonstrating
specific approaches to increasing relative proportions of dietary PUFA and
subsequent effects in diabetes groups are required.
2.2.2 Dietary carbohydrate
Mechanistic Studies
Like fat, both the amount and type of CHO have been shown to have differential
effects on insulin sensitivity in animals. These studies, again mainly in rats, have
shown detrimental effects of diets very high in sucrose and fructose on insulin
action 77 and insulin sensitivity 192 . These effects appear to be due to the fructose
component of sucrose 193, probably via a stimulatory effect on hepatic lipogenesis
194

and subsequent hepatic triglyceride secretion 195, not seen with high glucose

feeding. Raised serum triglyceride concentrations during high sucrose (fructose)
feeding have been shown to have a direct correlation with insulin resistance 196, 197
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(via increased skeletal muscle uptake and storage). Furthermore, pregnant rats fed
a high sucrose diet have been observed to have an enhanced ability to secrete
triglycerides from the liver, to avoid triglyceride accumulation (fatty liver), and
reached the threshold for adipose fat accumulation earlier relative to non-pregnant
rats 198. While replacing sugar in the diet with starch reduced plasma triglycerides
in both pregnant and non-pregnant rats, chronic hyperinsulinemia (elevated basal
insulin levels) has also been observed (in vitro) to promote insulin-stimulated
triglyceride secretion in the liver. Normo-insulinemia (fasted or food deprived state),
on the other hand, favours an inhibitory response to acute insulin stimulation 199.
Therefore, it is possible that any pattern of intake that raises basal insulin levels
has the potential to stimulate chronic hepatic triglyceride secretion and subsequent
insulin resistance.
Indirect Effects in Animals
While improvements to metabolic indices have been reported from the use of
complex CHOs, or starchy foods, study results are by no means uniform. However,
in vitro and animal studies have demonstrated that different metabolic responses
can be accounted for by varying degrees of processing. Plasma glucose and
insulin responses (in vivo) correlate closely to the rate of starch hydrolysis (in vitro)
200

, which in turn is dependent upon the degree of processing of the starch prior to

consumption 201, providing an explanation for the beneficial effects attributed to
some starches but not others.
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Some studies have attempted to manipulate both CHO and total fat in combination.
Fernandez et al experimented with guinea pigs (physiologic ally more similar to
humans than rats) and showed that both the type of CHO and the amount of fat
affected plasma lipid concentrations 202. Dietary composition was either high or low
fat with the CHO component made up of either starch or sugar, providing four
experimental diets in all. The combination of high fat and sugar was the most
detrimental, resulting in elevated plasma LDL-C and high levels of plasma
triglycerides compared with the other diets. Substitution of starch in the high fat
group subsequently reduced LDL-C and triglyceride concentrations.
While high CHO/low fat diets have been shown to lower HDL-C and raise
triglyceride levels and generally produce higher post-prandial glucose response 203,
the type of CHO in combination with the type of fat may also be important204. Rats
fed sucrose had higher plasma cholesterol concentrations than rats fed cornstarch.
However, this difference disappeared after the rats were treated with fish oil
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Although reductions were reported for both diets, the fish oil treatment had the
greatest impact on the highest cholesterol concentrations, that is, the sucrose diet.
These studies demonstrate fuel partitioning under different metabolic conditions
and the differential roles of fat sub types as well as a dietary fat: CHO ratio for
possibly both insulin secretion and insulin sensitivity. However, mechanistic
evidence is still at an early stage.
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Indirect Effects in Humans
High CHO diets have been implicated in the development of obesity, which in turn
has strong associations with insulin resistance 77. Aarsland et al reported a marked
net whole body fat synthesis during acute (1-4 days) CHO overfeeding (2.5 times
energy requirement) in humans, confirming the body’s ability to convert excess
CHO to fat 206. While hepatic secretion of de-novo fat increased 35 times, the
investigators concluded this was not the major site of fat synthesis during CHO
overfeeding, proposing that the most likely site is adipose tissue.
The effect of sucrose intake at the liver, however, is similar to rats, resulting in
elevated plasma triglycerides and fasting insulin concentrations, again mainly due
to the fructose component 207-209. Previous hyperinsulinemia and/or
hypertriglyceridemia magnified this effect, in some cases dramatically, suggesting
an increased sensitivity to sucrose (fructose) in some people 210 and may be
insulinogenic in humans (but not glucogenic) 211 . These studies lend support for
Zammit’s hypothesis that dietary patterns that elevate basal insulin levels
determine acute effects of diet on hepatic triglyceride secretion and subsequent
insulin insensitivity 195.
Epidemiological Research
Observational studies have generally found no correlation between total CHO
intakes and the incidence or risk of IGT or T2DM

147, 212-214

. However, the total

CHO content of the diet does not take into account fibre content and/or the
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glycaemic or ins ulinaemic effect of the food consumed. In human clinical trials it
has been found that foods that are more slowly digested stimulate reduced glucose
and insulin responses 215 . Factors known to reduce the rate of digestion include
dietary fibre (soluble and insoluble), the nature of the starch (amylose versus
amylopectin), food form (degree of processing) and increased frequency. For
example, controlled feeding studies have shown benefits of whole grains on
glucose and insulin responses compared with refined gains 216, 217. In addition,
whole grains (along with fruits and vegetables) have been consistently associated
with reduced risk of CHD 218 . Data from the Health Professionals Follow-up Study
(a national longitudinal survey of 51,529 male US health professionals) found no
differences for total CHO intakes, but diets with low cereal fibre content and high
glycaemic load increased the risk of T2DM in men 214. A large survey of women
(Nurses Health Study - 121,700 women aged 30-55 years) found similar results 219.
The Framingham Offspring Study, involving a cohort of 2834 subjects, found an
inverse association between whole-grain intake and insulin resistance and a lower
prevalence of the Metabolic Syndrome, largely due to cereal fibre content. While
glycaemic load and glycaemic index (GI) were positively associated with insulin
resistance, only GI was associated with prevalence of the Metabolic Syndrome 220 .
Feeding Trials in Humans
The glycaemic response to foods has been noted to reflect many differences in
food form and hence the GI, a ranking of foods according to post-prandial glucose
response compared to 50g glucose or white bread, is an attempt to quantify these
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effects 221. Low GI foods extend the absorption time and slow the rate of nutrient
delivery, thus lowering the postprandial response and have been used in clinical
feeding trials in diabetic and non-diabetic subjects to successfully predict acute
postprandial glyc aemia following the consumption of individual foods and mixed
meals 222, 223. Chronic feeding studies focusing on the GI, however, have produced
some inconsistent results. In a review by Miller it was reported that lowering the GI
of the average diabetic diet (by exchanging >50% of the CHO from high to low GI
foods) resulted in improvements in CHO or lipid metabolism or both

224

. Dietary

interventions however have found difficulties controlling for fat and fibre levels
because many low GI foods tend to be fibre-rich and low in fat. For example,
Jenkins et al reported that in a low versus high GI dietary intervention trial, the
highest fibre intakes resulted in the greatest fall in total -C and the higher the P:S
ratio the greater the fall in LDL-C

223

. Low GI interventions that controlled for fibre

(moderate intake) and fat (moderate intake with no specific attention given to fatty
acid ratios) may have enhanced the possible benefits of low GI diets by
manipulating these other dietary factors. However, increasing meal frequency and
reducing the size of each feed seems to provide the same metabolic advantages
225

. This leads to the concept of GI load, which captures both quality and quantity

of CHO in the diet, and has been positively associated with obesity 226, insulin
resistance, especially in overweight individuals 218. The GI concept itself, however,
is controversial. While many low GI foods are minimally processed and high in fibre
others are high in fat and sugar, both of which effectively lower the GI

221

. This

seeming anomaly has prompted criticism of the GI for its exclusive focus on
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postprandial glucose whilst ignoring the macronutrient mix and the insulinemic
effect of foods 8. Proponents of the GI, for example, suggest there are no
detrimental effects of sugar intake based on its effect on postprandial glycemia 224.
However, other metabolic consequences of sugar ingestion such as effects at the
liver may be more clinically significant in the etiology of insulin resistance 227. While
the GI is a useful tool for predicting the postprandial glycaemic response to a
particular food, background insulin insensitivity may modify this response, which
cannot be predicted using the GI.
In GDM women, where the influence of energy and macronutrient intake has been
assessed, a relationship has been found between higher CHO (55-60%) intakes
and lower incidence of macrosomia (large-for-gestational-age infants) 228 . Indeed,
no women consuming diets containing more than 210g CHO/day had large-for-age
infants, suggesting the imprudence of very low CHO or high fat diets.
In summary, while optimal types and amounts of CHO in the diet remain the
subject of future research, there is evidence from animal, human and
epidemiological studies to suggest fibre, cereal fibre and GI load may be protective
dietary components. Although the GI concept is controversial, the weight of current
evidence indicates it to be a useful tool for characterizing the quality of CHO
beyond dietary fibre content. Therefore, t otal diet approaches aimed at lowering
the glycaemic load through the redistribution of wholegrain cereals and fibre-rich,
low glycaemic-effect foods may provide dietary protection against risk.
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2.2.3 Dietary protein
Mechanistic Studies
The mechanistic action of protein on insulin resistance is little known. However,
different types of proteins may also induce different metabolic effects. A review by
Anderson et al concluded that consumption of soy protein rather than animal
protein significantly reduced serum concentrations of total-C, LDL-C and
triglycerides 229. Although few studies have directly assessed the role of dietary
proteins in the regulation of insulin sensitivity and glucose homeostasis, rats fed
soy protein were shown to have lower plasma insulin concentrations than those fed
casein 230. While cod protein feeding fully prevented the development of obesityinduced insulin resistance in high-fat fed rats through a direct action of amino acids
on insulin-stimulated glucose uptake in skeletal muscle cells 231.
The CHO:protein ratio may also be of importance. Lavigne et al again
demonstrated that in rats fed a high-sucrose diet, cod and soy proteins reduced
FPG concentrations compared with casein 232. Dietary cod and soy proteins were
found to improve glucose tolerance and whole body insulin action on glucose
disposal. Similarly, rats consuming low fat diets were given either casein or
soybean protein isolate in combination with sucrose or starch 233. Plasma
cholesterol concentrations and rates of VLDL-C and triglyceride secretion were
higher on the casein diet, but only in combination with sucrose. These proteininduced differences were not seen with the starch diets. Such studies once again
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highlight the metabolic effects of nutrients in combination and underscore the need
to address all dietary components in studies of diet and disease.

Indirect Effects in Humans
Human feeding studies of protein intake are very few. It is understood that this is
due to technical difficulties in isolating proteins in the laboratory context. However,
Hubbard and Sanchez have reported that a soy protein meal induced lower postprandial blood insulin concentrations in human subjects than a casein meal 234. In
untreated T2DM subjects, the insulin response curve was lower after ingestion of a
meal containing fish or soy proteins compared with casein 235. Furthermore, studies
of insulin responses to a variety of foods have found that protein is an important
predictor of postprandial insulin response and can induce as much insulin secretion
as some CHO-rich foods 236. These results are somewhat out of proportion with the
relatively small blood glucose responses to these foods, with beef protein found to
be the most discrepant and suggest the insulinemic effect of foods, independent of
glycemia, may have considerable clinical significance.
In summary, there is currently less evidence for the optimal amount of protein in
the diet or its effects on insulin sensitivity and blood glucose levels than for other
macronutrient variables. Nevertheless, in terms of dietary induced metabolic
effects, there is some evidence to indicate that the type of protein may also be
important. Therefore, advice for the inclusion of whole foods such as fish and nuts
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for the type of fat they contain may provide added benefits due to their specific
protein content.
2.2.4 Summary of evidence on macronutrient targets
Our current understanding of the diet-disease relationship, drawn from mechanistic
studies, is that high fat feeding and the pattern of consumption of individual fat
types affects insulin action at multiple control points. PUFAs, in many cases, have
opposite or beneficial effects compared with the detrimental effects observed for
SFAs (on the metabolic events leading to obesity and insulin resistance).
Additionally, the type of fat, in company with hyperglycaemia, may have
detrimental effects on cell function. High sucrose feeding also reduces insulin
sensitivity, probably due to the stimulatory effect of the fructose component of
sucrose on hepatic triglyceride secretion. Interestingly, minimally processed
starchy foods, soy and fish proteins may have a protective effect on insulin
sensitivity.
Human studies, drawing on less direct measures of insulin sensitivity offer support
for these findings, with high fat diets resulting in reduced insulin sensitivity in
humans. Compared with high SFA or high CHO diets, diets high in MUFA and
PUFA lower most lipid sub-fractions, with the greatest reductions occurring on high
PUFA diets. Earlier concerns for detrimental effects on glucose homeostasis in
diabetes subjects have been allayed by more recent studies. Serum and skeletal
muscle phospholipid fatty acid contents reflect dietary fatty acid ratios, with
reduced phospholipid PUFA concentrations associated with reduced insulin
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sensitivity. Increasing n -3 intakes demonstrates cardio-protective effects mainly
through fish oil (whole fish and supplements) and nuts. Increased sucrose
(fructose) in the diet raises triglyceride concentrations in humans. While
background hyperinsulinemia enhances this effect, substitution with dietary starch
reverses it. Research on dietary starc h suggests the inclusion of whole grains,
increased fibre intakes, reductions in the GI and increased meal frequency all
contribute to reductions in post prandial glycaemic response to CHO-rich foods.
The effects of protein on insulin resistance in humans are not clear at this time, but
studies of insulin response suggest differential influences between soy, fish and
animal proteins.
Epidemiological research adds another layer of support to these findings, where
both total and saturated fat consumption are positively associated with increased
fasting insulin levels, IGT and development of T2DM. In contrast, vegetable fat has
a negative association with insulinemia and risk of diabetes. Obesity, however,
appears to be a potent modifier of these effects, with energy density an
independent risk factor in the development of obesity and related changes in
metabolism, requiring additional attention. In terms of dietary CHO, the effects are
less clear. Where epidemiological data has failed to demonstrate a relationship
between total CHO and T2DM, low cereal fibre content together with increased
glycaemic load is associated with increased risk.
Hence, the hierarchy of research evidence provides support for macronutrient
targets in nutrition intervention in terms of diabetes and related conditions. At each
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level of the hierarchy there is strongest support for a reduction in total fat intake
and discrimination between types of fat in the diet. A reduction in saturated fat and
replacement with PUFA, particularly n-3 PUFA, might provide benefit at multiple
stages of metabolism and, therefore, may impact on disease risk. While the
evidence-base is strong, the actual achievement of these dietary targets and
subsequent benefit in free-living diabetes groups is still to be confirmed in RCTs.
Associations with other macronutrient variables also require further research, but
indicate that the amount and type of CHO (due to effects on glycaemia and risk of
diabetes) are also important.
2.3 Applications of the Evidence Base in Nutrition Intervention
The previous section outlined current research evidence in order to determine
appropriate targets for nutrition intervention in the treatment of diabetes. This next
section reviews the clinical applications that support the theory on nutrition.
Translation of the evidence-base requires a number of systems formulated to direct
advice to free-living individuals to enable a change in dietary intake in order to gain
a benefit in terms of related clinical markers of health and disease. In order to
comprehensively assess the appropriateness of existing nutrition applications, the
following is a review conducted in three parts. First, current nutrition guidelines for
diabetes, including those for GDM management and CVD risk, are assessed in
terms of how closely they correspond to the macronutrient targets established in
the previous section. Second, current food guidance systems are examined to
assess how well they correspond to the guidelines and/or macronutrient targets in
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order to estimate their capacity for the achievement of theoretical dietary intakes.
Finally, the relevance of these systems for assessments in substantiation research
to provide evidence for specific health-related outcomes in terms of specific dietary
intakes is also discussed. Thus, this section provides an evaluation of the capacity
of current nutrition applications for the conversion of theoretical macronutrient
targets into practical advice on foods for people with diabetes.
2.3.1 Nutritional guidelines
Based on the extensive body of research, current guidelines in nutrition for the
prevention and treatment of diabetes and related complications largely reflect the
evidence-base with the emphasis on limiting intakes of both energy and fat intakes.
ADA guidelines for diabetes provide recommendations in terms of macronutrients
as proportions of total energy intake 8. Where the recommendation for protein is
based on a lack of research evidence to support a change in usual intakes (1520%), the most specific recommendations relate to the area of most substantial
research evidence, the fat fraction of the diet. Even so, due to a lack of trials
conducted specifically in diabetes populations, the recommendations on fat are
largely borrowed from general population guidelines, that is, less than 10% of
energy from SFA (for persons with elevated LDL-C levels it is less than 7% of
energy)(A-Level evidence). Approximately 10% of energy should be from PUFA
(C-Level evidence). The latter recommendation has a lower level of support due to
a lack of studies in persons with diabetes to allay concerns for a possible
accompanying rise in plasma LDL-C levels, mostly in response to n-3 (fish oil)
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suppl ementation. Research supporting the cardio-protective effects of foods
containing n-3 fatty acids has prompted the recommendation for “Two to three
servings of fish per week” (B-Level evidence). However, neither a target amount for
n-3 PUFA nor the amount consumed from the two servings of fish is provided by
ADA. For this, this review refers to the International Society for the Study of Fatty
Acids and Lipids (ISSFAL) recommendations, which list specific intakes from within
the fat profile

11

by considering both the beneficial effects of n-3 fatty acids and the

detrimental effects of SFA and n-6 PUFA in the overall diet. In the case of the
latter, adverse effects are considered to result from competition with n-3 fatty acids
for eicosanoid pathways. Hence, for a healthy diet, two interdependent dietary
changes are recommended, that is, increasing n-3 PUFA intakes and
simultaneously reducing the proportion of SFA and n-6 fatty acids in the diet. For a
2000kcal diet, recommended minimum daily intakes for n-3 fatty acids (0.65g
EPA+DHA and 2.22g ALA) are accompanied by upper limits for saturated fats
(<8%E) and n-6 PUFA (3%E). Hence, providing a P:S ratio of at least one and an
n-6:n-3 ratio under 10 is recommended.
While the total proportion of fat in the diet is not specified by ADA, the remaining
60-70% of energy intake from CHO and MUFA must account for individual
metabolic profile and weight management goals. Where moderate caloric
restriction is recommended, due to the high energy density of fat, similar restriction
is expected to result in low to moderate fat diets.
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With reference to CHO intake, food-based recommendations are provided in terms
of the type (whole grains, fruits, vegetables, and low-fat milk) and total amount to
be included in the diet (A-level evidence). While the latter is considered more
important, the high level of support for specific CHO-rich foods suggests that the
type of CHO is indeed important. Further, while there is insufficient evidence of
long-term benefit of low-glycaemic-index diets (B-Level evidence), epidemiological
evidence for reducing glycaemic load and knowledge of the food factors that
extend absorption time and slow the rate of nutrient delivery (fibre, degree of
processing, fat and protein content) suggests those foods recommended in the first
instance (whole grains, fruits, vegetables and low-fat milk) can readily be classified
as low-GI and fibre-rich. The consumption of dietary fibre is recommended to a
level equivalent to, but not greater than, ‘other Americans’ (B-Level evidence). In
order to achieve recommended levels for fibre intake, specific types of CHO-rich
foods may need to be targeted. Attention to the spacing of meals is also
recommended.
Despite concerns that fructose may adversely affect plasma lipid levels (added
fructose is not recommended as a sweetening agent) sucrose (50% fructose) and
sucrose-containing foods are given no restriction (A-Level evidence). This appears
to be based on an assumption that the resultant level of glycemia in response to
‘sugar’ is moderate compared to isocaloric amounts of starch and that this is the
most relevant consequence of sugar consumption (albeit a measurement
previously questioned in terms of low GI diets and a lack of evidence for long-term
effect). Studies looking at the influences of sucrose support detrimental effects of
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the fructose component on triglyceride synthesis at the liver with consequent IR
and glucose intolerance 193, 211, 227, 237, 238.
ADA guidelines are relatively non-specific for GDM women 8. An appropriate
individualised nutrition prescription and meal plan is recommended based on
nutritional assessment, glycaemic control, energy balance and appetite, without
ketosis, making appropriate adjustments throughout pregnancy. For overweight
pregnant women, primary treatment is moderate caloric restriction (30% of
estimated energy needs) in an attempt to lower glycemia and reduce macrosomia.
Caloric restriction in pregnant women, however, must be viewed with caution.
Although effects on the fetus are still unclear 239 , controlling maternal blood glucose
levels in obese and/or severely insulin resistant women may impede fetal growth
240

. Therefore, to improve pregnancy outcomes, nutritional therapy for GDM is as it

often is in practice for T2DM, the combination of dietary restriction, CHO counting
and intensive monitoring of blood glucose levels. While these approaches directly
address post prandial glycemia the research literature suggests this may not be the
most important factor in the etiology of GDM and future risk. Where screening for
GDM was initially developed to identify women at risk of T2DM, current
approaches to risk management in these women need to look beyond birth
outcomes 156. Dietary management that addresses metabolic control may be more
beneficial for both short- and long-term risks as well as avoid the risks associated
with low CHO diets. However, the influence of dietary modification on metabolic
abnormalities and perinatal outcomes has not been adequately assessed with few
controlled dietary intervention trials to suggest optimal nutritional therapy for
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women with GDM and provide evidence-based statements regarding specific
dietary approaches to GDM management 241.
Where ADA suggest a total diet food pattern approach 242 may provide the greatest
benefit, the provision of advice that takes into account the overall diet requires
reference to a variety of foods. With the exception of fish as a source of n-3 PUFA,
food-based recommendations are limited to CHO-containing foods.
In contrast, AHA guidelines 243 emphasize healthy eating habits and behaviours,
acknowledging the various metabolic contributions made to CVD by the growing
rates of obesity, hypertension and diabetes for the general population.
Consumption of a varied diet of foods from each of the major core food groups is
recommended, with specific advice to eat at least two servings of fish/week; five or
more servings of vegetables and fruits/day; and six or more servings of grain
products/day, preferably whole grain. For controlling energy, monitoring portions
(size and number) is also suggested, as well as limiting foods with a high sugar
content/caloric density and foods high in saturated fat, trans -fats and dietary
cholesterol. Sodium and alcohol intakes are also limited. More specific
recommendations are provided for those with or at increased risk of established
dislipidemia, diabetes and insulin resistance for whom it is suggested unsaturated
fats replace saturated fats, with CHO intake, especially sugars and refined foods,
should be limited and replaced with high-fibre CHO foods instead.
Thus, dietary guidelines for diabetes and other clinical abnormalities related to the
Metabolic Syndrome provide specific recommendations for individual fat types.
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Provided as relative proportions of total energy intake, advice for the achievement
of the recommendations in free-living individuals need to be set in the context of
the total diet and personal and preferences incorporated. While this is
acknowledged in the guidelines, how this is achieved in practice requires further
evidence-based support. Whilst a broad theory base supports the
recommendations, the specific application of individual fat targets and subsequent
effectiveness has not been adequately assessed in free-living diabetes groups.
2.3.2 Food guidance systems
The specific application of nutrition intervention is supported by food guidance
systems, which aid the conversion of nutrient targets into food-based advice. In
order to develop appropriate intakes, a suitable database of estimates for the
nutrient composition of all foods normally consumed is required. The general
concept is that foods are categorised by lists or groupings, and mean estimates of
the nutrient and energy content for each list are similar to individual food
compositions. In general, food guidance systems provide a selection of food
choices or food groups in a recommended or suggested daily intake pattern that
delivers nutrients for the optimal health of the general population 16. In this way
using common food groups and standard serving sizes, a total diet approach to
nutrition communication can be achieved 242.
It is generally recognized that for individual countries different systems are needed
to account for differences in culture, overall nutrition, and the food supply 244, 245.
However, each applies to the general population and not to those with specific
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dietary needs. As such, most food guides are primarily concerned with the
maintenance of general physical health and account for the usual daily
consumption patterns of that country. It is considered, therefore, that specific
groups with distinct and/or varying dietary needs 246, for example vegetarians, or a
dietary pattern determined to have a specific health benefit, such as the
Mediterranean diet 247, require tailored food guidance systems.
However, to be effective, food guides for a specific purpose must incorporate the
unique dietary components for the specific population and/or pattern of intake 247.
For this, prior research is required regarding food availability, food consumption
patterns, and nutritional needs and standards 16. Dietary targets for a specific
health benefit or outcome are also required, as well as an understanding of food
consumption patterns and how they can impact on results. For example, current
trends in food sources of fat have identified shifts in intakes away from dairy foods,
red meat and edible fats to grain based mixed dishes, high fat snack foods and fat
enriched potatoes 248. Hence, specific food groups and individual foods and their
pattern of intake may need to be targeted for achievement of specific dietary and
clinical outcomes. The criteria used for food group classification will, therefore
,differ between systems depending on the specific purpose. For most, however, the
focus is on foods as sources of energy, protein and essential minerals, vitamins
and fibre for general health maintenance.
A comparison of 12 official international food guide pictorial representations found
that the fundamental classifications for foods into basic food groups are
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surprisingly similar between countries 16 , many having been adapted from the
USDA food guide pyramid 14, and included grains, vegetables, fruits, milk and dairy
products, meat, fats and sugar. For individual foods, the categorization of potatoes
and root vegetables (either with other vegetables or with grain foods), beans and
legumes (mostly valued for their protein content and/or placed with vegetables for
their high vitamin, mineral and dietary fibre content), and nuts (mainly grouped for
protein content but also with fats and oils) were found to be the most varied. Most
guides were inconsistent in terms of the CHO content of foods, making it difficult to
evenly distribute CHO over a day. Any observable differences in categories were
for vegetable and fruit groups (some guides categorized them as a single group),
the milk and dairy product group (either listed separately for mineral content or with
protein foods) and, despite widely varying nutritional differences, fat and sugar
groups (mostly grouped together, but some guides omitted them altogether). This
was due to perceptions that they were ‘ingredients’ rather than ‘foods’ and hence,
of no nutritional value (Australia 13 and Canada 249), and/or the belief that their
inclusion as part of a healthy diet would be perceived as advocating increased
energy intakes. Hence, intakes of fat and high fat foods (when included) were
generally limited in a blanket approach, with sources of different types of fat not
well defined, even in the simplest terms such as saturated and unsaturated fat
sources. Furthermore, no country identified fish, legumes, soy foods, or nuts as
rich sources of unsaturated fats, with only one country, Korea, placing nuts in the
fats and oils group. These findings are not in keeping with current research
knowledge of the roles of ‘essential’ fats in the diet and are not supportive of the
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need to increase intakes of unsaturated fat. In order to meet intakes of different
types of fat in the proportions recommended, the identification of food sources of
unsaturated fats may be of importance.
In addition, portion size appeared particularly problematic in that consumers likely
have their own personal perceptions of size 250 . In the review of international food
guides 16, some countries were found to avoid quantitative recommendations
altogether, but most recommended specific quantities or emphasized suggested
portion size. This appears to be important in order to alleviate confusion for the
consumer 251.
With regard to the overall pattern of dietary intake, most countries reviewed
consistently recommended a greater consumption of grains, vegetables, and fruit
groups with lower intakes of meat, milk and dairy groups 16. In terms of
macronutrient delivery, the emphasis placed on CHO-rich foods translated to a
high CHO diet as the preferred pattern of intake for health by all countries 16. This
is largely without a clear distinction between whole and refined grains. Again, these
findings appear to be out of step with current research evidence and existing
recommendations that refined CHO and sugar should be replaced with either
minimally processed whole grain products and/or healthy sources of fats and
protein. This begs the question of whether general population guides can
adequately meet the needs of alternative dietary patterns, such as those high in
protein or modified fat, and whether they should form the basis of advice to high
risk groups, for example overweight individuals with a history of diabetes and/or
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heart disease, which accounts for a large cross-section of the general population.
Most importantly in substantiation research (considered in more detail in the next
section of this thesis), food guidance systems need to be flexible to support new
aspects of the diet that need to be tested. Therefore, whether a food guide
established 50 years ago 14 , which now forms the basis of most food guidance
systems, can support current research evidence and changes in perceptions of
what constitutes a healthy diet is a significant research question.
The ADA Exchange Lists, established for the treatment of diabetes and weight
management, differ from core food guides in that sources of dietary starch (breads,
cereals, starchy vegetables, and legumes) are listed together, enabling their
distribution throughout the day to assist blood glucose control, and not with low
CHO vegetables and other foods, such as modified ‘fats’, sugar-free sweets and
‘sweeteners’ and fat-free/sugar free drinks, condiments and seasonings, that have
little impact on blood glucose levels. Similarly, to assist achievement of a healthy
fat profile, a ‘fat list’ is provided into three sub-lists based on the main type of fat
they contain: SFA, MUFA and PUFA. The SFA list contains butter, cream and lard,
as well as high fat foods highest in saturated fat such as bacon, chitterlings, salt
pork and coconut milk. The MUFA list includes avocado, oils, olives, nuts, peanut
butter and sesame seeds, while the PUFA list includes margarine, mayonnaise,
walnuts, oils, dressings and seeds. Therefore, ADA exchange lists are more
supportive of overall metabolic control than core food groups. However, they stop
short of a total diet approach inclusive of all foods in the diet. For example,
individual foods in which fat is the secondary nutrient, such as soy products
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(soymilk, soy yoghurt, tofu, etc) and fish, are not readily distinguished (categorized)
from s imilar foods rich in dietary SFA (dairy products and meat). Whether advice
that refers only to the edible fat portion of the diet can adequately address overall
fat modification is questionable and such applications used in RCTs are reviewed
in detail later in Section 2.4.2 Trial applications to dietary fat modification.
Whilst food guidance systems are commonly used for education and meal
planning, their application in intervention trials for the adequate achievement of
dietary change and subsequent outcomes has not yet been sufficiently tested 17.
First, the methodology behind individual food guidance systems needs to be
considered. Unfortunately, the methodological basis of food guidance systems has
not been well documented and little research has been conducted in terms of how
closely the macronutrient composition of individual foods matches mean estimates
for energy and macronutrients 17, 252. A rationale for the 1995 ADA exchange lists
has been provided as verification of published estimates for mean energy and
macronutrients 17 . However, calculations of the variation and range for each
exchange list were found to be relatively large and agree with assessments of
earlier versions of the exchange lists that indicated actual energy intakes might be
higher than estimated.
Hence, from this review of food guidance systems it can be concluded that, at least
in theory, no existing food guidance system groups foods in a way that is
conducive to the adequate achievement of overall changes in the proportions of
different types of fat in the diet. Therefore, no system is considered suitable to
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guide advice for the treatment of diabetes and associated aspects of the Metabolic
Syndrome.
2.3.3 Summary of applications of the evidence base
Current nutritional guidelines for the treatment of diabetes are the result of a shift in
focus that largely supports the research evidence for macronutrient targets and
proportional intakes of individual fat types to address the clinical features of the
Metabolic Syndrome. Recommendations for the type of fat are provided as
percentages of total energy to acknowledge the relationship between total energy
intake and overweight and obesity as risk factors for disease. Current clinical
practice strategies for both T2DM and GDM, however, often focus on glycaemic
control and the direct effects of CHO intake on post prandial blood glucose levels.
Whilst the evidence for this approach is not clear, it can result in a narrow focus on
a single nutrient (CHO intake). Where the guidelines emphasise controlling the
total amount of CHO in the diet, in practice food-based advice refers to both
amount and type with preferences that correspond to whole grains, high fibre and
lower glycaemic responses (milk, fruit). More research, however, is required if
recommendations are to adequately define the total diet and measurable clinical
outcomes.
To support the guidelines, food guidance systems enable a total diet approach to
advice to assure nutritional adequacy. Whilst existing food guides may also be
useful for reducing the total amount of fat in the diet, again the common focus is on
CHO-rich foods and high-CHO diets as the preferred pattern of intake, but mainly
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without distinguishing the type of CHO, such as wholegrain and high fibre choices.
Unique dietary components need to be incorporated into the advice system to
ensure adequate achievement of specific dietary targets 16. Therefore, current
systems may be inadequate for the achievement of specific proportions of different
types of fat and CHO. Although ADA exchange lists group starchy CHO foods
together and edible fat portions by fat profile, there is no system currently that
distinguishes all foods by fat profile and positions them in a manner that supports
advice for proportional shifts in the type of fat in the diet.
2.4 Approaches to Nutrition Intervention Research
While the apparent inadequacies of existing applications to nutrition intervention
have been described, practical approaches to nutrition intervention in RCTs also
need to be reviewed. In this way, the capacity of existing applications for the
achievement of specific nutrient modifications and expected clinical outcomes can
be more adequately assessed.
2.4.1 Lifestyle approaches to nutrition intervention
Results from lifestyle intervention trials, reported earlier in Section 2.2.1,
demonstrate the significance of intensive individualised advice targeting
macronutrient variables as risk factors for the prevention and treatment of disease
20, 21, 191

. The Diabetes Prevention Program 20 and the Finnish Diabetes Prevention

Study 19, 189 each assessed the efficacy of intensive lifestyle intervention strategies
in preventing or delaying T2DM in free-living ‘at-risk’ overweight individuals. Both
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studies referred to established food guidance systems and specific individualised
lifestyle goals targeting changes in diet (<30% of energy as fat and <25% of energy
as SFA) and physical activity levels to demonstrate the effects of lifestyle
modification on weight loss and consequent diabetes risk. In the Diabetes
Prevention Program the intensive treatment was significantly more effective in
preventing the development of T2DM in high-risk individuals over an average 2.8
years than a control group receiving standardised general dietary advice with
limited follow-up. Similarly, subjects in the intensive treatment group in the Finnish
Diabetes Prevention Study were more likely to attain lifestyle goals and hence
achieved a significantly greater reduction in risk compared with a general advice
group.
In China, the Da Qing IGT and Diabetes Study 21 randomised high risk individuals
into four parallel treatment groups, control (standardised advice) versus three
active treatments: diet only, exercise only or diet and exercise combined. Those in
the exercise groups were given individualised advice for the type and rate of
increase in leisure activity, while the diet groups were provided with individualised
advice referring to total calories and exchange lists for common food groups,
including a separate ‘fats’ group. Overweight subjects were encouraged to reduce
energy to lose 0.5-1kg/month. After six years of bi -annual follow-up, all diet and
exercise groups achieved significant reductions in the incidence of diabetes
compared with the control group. Nutrient analyses found no significant differences
between groups for macronutrient intakes. However, differences in diet quality
and/or proportions of the different types of fat in the diet were not assessed, and it
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may be reasonable to suggest that differences in diet quality may have resulted
from specific food-based advice without impacting on the macronutrient profile.
While the benefits from lifestyle interventions are clear, strategies for the
achievement of dietary targets and the effects of individual nutrient manipulations
in these trials are not necess arily transparent enough for transfer to practice.
Methods used in intervention trials need to be adequately reported to enable the
generalisation of results to similar groups under similar conditions. These studies
targeted weight loss as a modifiable ris k factor for diabetes and related
complications. Whilst the appropriateness of reductions in total energy, fat and
SFA for the achievement of weight loss and subsequent risk reduction have been
confirmed, evidence for a reduction in risk independent of weight loss is not as
clear. The methods from these trials do not provide transparent processes for the
achievement of dietary targets nor do they provide unequivocal evidence for
specific intakes of individual nutrients or foods. Furthermore, increases in PUFA
intakes and subsequent benefit in free living diabetes subjects has not been
adequately assessed.
2.4.2 Trial applications to dietary fat modification
This section reviews clinical intervention trials that provide more specific detail of
the practical applic ation of existing food guidance systems and strategies for
manipulating dietary fat. These studies highlight the difficulties faced by
researchers and clinicians alike in achieving specific proportions of the different
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types of fat in the diet and appear particularly problematic for adequate increases
in the proportion of dietary PUFA.
For example, a weight loss intervention trial conducted over 32 weeks
demonstrated the practical application of the ADA Food Exchange System and
USDA Food Guide Pyramid for maintaining adequate intakes of most vitamins and
minerals in energy-restricted diets of 219 healthy, overweight and obese premenopausal women 22. In terms of the fat content of the diet, mean total fat intake
was reduced by about 6% of energy intake (from 33.2% of energy pre-study to
26.9% of energy at 32 weeks). This change, however, resulted largely from
reductions in both SFA (11.3% to 8.3% of energy) and MUFA (10.1% to 8.3% of
energy), with little change to PUFA intakes (5.2% to 4.8% of energy). The latter
were low compared to the levels recommended for dietary PUFA and resulted in a
mean P:S ratio of 0.57, which was also well below the ratio of >1 recommended for
the general population.
Nydahl et al reported on an experimental study design and the problems
associated with manipulation of fat type 24. Conducted among healthy college
students, the study consisted of three experimental diets: a reference diet (high
SFA) and two fat modified diets (moderate and high MUFA). The study
endeavoured to achieve these differences in dietary fat proportions via
exchangeable edible fat portions (margarine and other fats used in cooking and
spreading) in week day meals without changes to the total fat content. However, it
was determined that these dietary sources accounted for <30% of total daily fat
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intake reported by the student population. Therefore, target fatty acid compositions
were unable to be achieved through exchangeable fat portions in week day meals
alone. At least one weekend meal and snack foods had to be included in order to
enable desired increases in unsaturated fat proportions. Additionally, margarines
especially manufactured for this purpose were more similar in SFA and MUFA
content than anticipated due to issues with taste and mouth-feel acceptability. This
resulted in intakes that were also more similar than intended for the test diets, with
higher than expected n6:n-3 ratios in both modified fat dietary intakes.
The KANWU study demons trated under relative free living conditions how changes
in fat profile (high MUFA versus high SFA) can be achieved to improve insulin
action in humans 25 . Again, advice targeted the edible fat portion of the diet
(supplied) to achieve the required fatty acid proportions over three months. While
substituting MUFA for SFA resulted in favourable alterations in clinical markers of
insulin action, increases in total fat consumption were also reported, with a number
of individuals reporting high fat intakes (>37% of energy), at which level favourable
effects were no longer seen.
The Nydahl et al and KANWU studies demonstrate the underlying difficulties
related to manipulations within the dietary fat profile. Both studies approached the
challenge of fatty acid manipulation using exchangeable edible fat portions as
delivery agents for increasing the proportion of unsaturated fat in the diet. The
problem with this strategy was the assumption that most fat intake is derived from
this fraction of the diet. As Nydahl et al found, exchanging saturated for

78
unsaturated edible fat portions alone may have inadequate impact on overall
proportional intakes of dietary fat. This may be particularly so for intervention
groups already following a low fat diet, such as those previously exposed to dietary
advice, for example patients with established diabetes. The temptation here is to
simply increase the amount of exchangeable edible fat, predominantly as
unsaturated fat. As demonstrated in the KANWU study, this strategy runs the risk
of increasing overall dietary fat intakes. An additional consideration is that those
groups already indoctrinated into a ‘low fat’ regime may be resistant to increasing
the amount of edible fat in the diet. While the KANWU study was successful in
substituting MUFA for SFA in the diets of free-living subjects using exchangeable
fats alone, some individuals increased their fat intake to a level where the clinical
benefits of improving the fat profile were not observed, suggesting the impact of
improvements in fat quality is limited to low to moderate fat intakes.
Hence, results from clinical intervention trials demonstrating applications to modify
the fat profile confirm the need for a total diet approach for controlling total energy
intake and the amount and type of fat in the overall diet and suggest that attention
to all fractions of the fat profile provides benefits beyond those relating to total fat
reduction. Considering secondary sources of fat intake and individual food sources
to ensure desirable P:S and n6: n-3 ratios might be a better approach to advice for
improvements in health/disease outcomes.
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2.4.3 Food pattern applications to nutrition intervention
In the formulation of advice, food patterns offer information on how a ‘healthy diet’
can be achieved. This section outlines specific information on foods as sources of
nutrients and required shifts in intakes for particular dietary outcomes. Such
information forms the basis of advice in terms of intakes from specific foods and/or
food groups within the overall diet. In terms of fat intake, the benefit of food pattern
advice stems from its inclusiveness of all foods in the diet and, therefore, the ability
of advice to address all sources of dietary fat, not just added fat. Where the
literature indicates controlling energy intake should underpin all dietary intervention
strategies, the high energy density of high fat foods also requires attention. The
development of advice based on food patterns offers the opportunity to adequately
meet these challenges in a truly total diet approach to nutrition intervention.
Firstly, in order to determine how to bring about changes to the dietary fat profile,
analyses of population consumption patterns offer direct information on food
sources of fat intake and resultant clinical outcome measures. For example, over
the period of dramatic parallel increases in the prevalence of obesity and T2DM
(1981-2000) 30, fat consumption as a percentage of overall calories has been
falling 248. Observations of the food patterns of the general population over similar
time periods describe shifts in both the quality and quantity of dietary fat. In the US,
trends in energy and macronutrient consumption, monitored over the past 40
years, show reductions in reported mean energy intakes for all age groups 253 .
These reductions in energy have paralleled reductions in reported total fat intake
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(9-10% of energy), but not all from saturated fat (2% of energy). In general, the
average adult consuming a low fat diet consumed less energy than high fat
consumers and fewer grams of total fat 253. Foods with modified-fat content also
contributed a greater percentage of total calories in low fat diets. Fruit and grain
consumption was also higher, with low fat milk contributing a greater portion of total
milk intake, which in terms of absolute amounts, was similar or greater than in high
fat diets 253. Popkin et al showed that between 1965 and 1996 there has been a
population shift from animal-based sources of fat toward fast foods, fried foods and
grain based mixed dishes 248. More specifically, sources of fat in the diet have
shifted from dairy, red meat and edible fats, to grains (mixed dishes), high fat
snacks and potatoes (with added fat) 248, suggesting that the ratio of visible to
invisible fats has been reduced, and that beneficial visible fats, such as
unsaturated oils, have been the preferred target of ‘low fat’ messages rather than
invisible fats such as those used in processed and fast foods.
The effectiveness of dietary change is considered contingent on the transfer from
high total/saturated fat diets to low fat, nutrient dense diets 253. For this, explicit
rather than broad behaviour changes are required targeting key food sources in the
diet, for example, switching food choices from full- fat to low-fat milk and from high
fat snacks to fruit 253 . This strategy introduces the idea of incorporating individual
foods as sources of specific nutrients in order to achieve nutrient targets. For
example, where PUFA intakes need to be increased, sources of PUFA and in
particular n-3 PUFA are quite specific. Walnuts and fish have been used
successfully in previous studies (outlined in Section 2.2.1 in a review of food
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sources of PUFA) to deliver this type of fat for the achievement of health benefits,
How this information can be incorporated into advice for free-living individuals
without increasing fat and energy intakes requires reference again to RCTs. The
following studies report on food intake patterns for specific manipulations to the
dietary fat profile.
During a 12 month intervention trial aimed at alterations to individual fat intakes
under free living conditions, 63 adults with existing T2DM reported specific patterns
of dietary change 23 . At baseline, subjects already reporting low fat intakes (<30%)
did not report low SFA intakes as might be expected compared to existing
guidelines. This suggests total fat reduction had likely resulted in reductions to all
fat types and mainly to the unsaturated fat content of the diet. In order to achieve
differential proportions for individual fat types in low fat (27% of energy) and
modified fat (37% of energy) diets, this study reported that changes in food
patterns and particular cuisine choices were required. The dietary change process
reported by Tapsell et al involved complex shifts in both the quality and quantity of
fat intake using a systematic approach to individual dietary modeling. This involved
shifts in the intake of fat from SFA-rich foods (meat, dairy products, fast foods and
cakes) to unsaturated fat-rich food sources (spreads, oils and nuts) regardless of
the amount of fat consumed. More specifically, those achieving the target fat
proportions changed their intakes to low fat dairy products and leaner cuts of meat,
more oils, spreads and nuts, and consumed fast foods less than twice a w eek. In
terms of cuisine choices, the low fat and modified fat groups consumed South East
Asian and Mediterranean cuisines, respectively. This study further demonstrates
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the complexities of the dietary change process and implicates the lack of guidance
that may be experienced by people receiving general dietary advice. Analyses of
this type, however, help explain how dietary change can be achieved and therefore
are important to inform both intervention trials and clinical dietary management.
From this anal ysis it is apparent that categories of foods and individual food
sources from across the overall diet are important for the achievement of dietary
change for the achievement of specific nutrient intakes. The concept of an
appropriate food group intake pattern for the achievement of dietary goals and
consequent clinical benefit has been tested in the DASH dietary intervention trial.
The DASH trial was a randomised multi-centre feeding trial that compared clinical
responses to parallel patterns of food intake 254. Subjects were 459 adults with
untreated systolic blood pressure less than 160mm Hg and diastolic blood
pressure 80-95mm Hg. All foods were provided over three eight week feeding
periods – a control diet (typical American diet), a diet rich in fruits and vegetables,
or the DASH diet (a combination diet rich in fruits vegetables, low-fat dairy foods,
reduced in total fat, saturated fat, and cholesterol. The primary clinical outcome
was systolic blood pressure response. The DASH diet, without sodium reduction or
weight loss, significantly lowered blood pressure in virtually all sub groups
examined (race, sex, age, BMI, years of education, income, physical activity,
alcohol intake and hypertension status), and was particularly effective in African
Americans and those with established hypertension 255 . The fruits-and-vegetables
diet also reduced blood pressure in the same subgroups, but to a lesser extent. As
a result, it was concluded that the DASH dietary pattern may be an effective
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strategy for preventing and treating hypertension in a broad cross section of the US
population, including those at highest risk of blood pressure-related CVD. It is
acknowledged, however, that additional research is required to confirm these
results in free-living individuals 255.
Unlike nutrient focused dietary intervention trials, the DASH trial was designed to
test eating patterns rather than individual nutrients in an effort to identify practical,
palatable dietary approaches that might impact on blood pressure related morbidity
and mortality in the general population 254. DASH diets were compared to control
diets by analysing dietary sources of nutrients using 13 food groups in total 26.
Major energy sources were refined and whole grains (23% DASH and 35%
control). Whole grains also contributed markedly to protein, fibre, calcium,
magnesium, potassium, zinc, and folate intakes (11-46%). Vegetables made major
contributions to fibre, vitamins A, C, E and folate as well as an average 15% of
magnesium, potassium and calcium intakes. These results highlight the importance
of staple foods as sources of multiple nutrients, the balance of which need to be
considered when providing advice for changes in a single nutrient. Improvements
in the nutrient content of the DASH dietary pattern compared with the control or
‘western’ diet were accomplished by varying the selection of food items (for
example, from refined to wholegrain) and quantities of certain food groups (red
meat intake was reduced to increase fruit and vegetable intakes). The DASH diet
provides a model for a food based pattern of intake to deliver an equivalent of
2000kcal/day: 4-5 fruits, 4-5 vegetables, 2-3 low fat dairy products, 7-8 grain
products (preferably wholegrain), <2 meats, poultry, fish, 4-5 nuts, seeds and

84
legumes/week with emphasis given to all food groups 256. The greater number of
food groups (compared with core food groups), acknowledges the importance of
individual foods as sources of nutrients enabling advice to meet specific nutrient
targets. For example, a separate food group for nuts, seeds and legumes as
sources of unsaturated fatty acids enabled their inclusion in the DASH food
pattern, effectively contributing to the overall reduction in the proportion of
saturated fat in the diet. This also suggests that a representative food from this
category could be incorporated into the overall pattern of intake to test its ability to
ensure adequate amounts of unsaturated fat and associated health outcomes.
More specifically, walnuts and fish as individual food sources of PUFA could be
tested in diabetes groups for substantiation of the effectiveness of recommended
nutrient intakes and related health outcomes.
2.4.4 Relevance to substantiation research
To support health-related claims on individual foods nutrients and bio-active
ingredients, substantiation research is aimed at the establishment of evidence,
requiring measurable dietary differences 257. This requires an appropriate study
design and proven approaches to advice, validated in practice, in order to achieve
specific effects on clinical outcomes in intervention trials.
Measurement of the diet, however, is difficult especially under free-living conditions
258

. Evidence confirming dietary intakes and achievement of subsequent health

benefits require similar valid methods for the collection and assessment of data.
For example, data from a validated Diet History (DH) can be confirmed by
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comparison with Food Records (FR), described in detail in Section 3.4 as sources
of bias in intervention trials.
The identification of relevant and valid clinical markers of disease can provide
measurable clinical outcomes for the substantiation of health-related claims on
individual food and nutrient variables 257 . In terms of diet-related CVD risk,
accepted clinical reference points are LDL-C and HDL-C, fasting triglycerides, and
blood pressure levels

259-262

. Since accumulation of body fat represents the most

important risk factor for T2DM, and its distribution predicts the development of IR
and related clinical abnormalities, markers of overweight and body fat
accumulation are considered relevant markers of nutrient effects

119, 123, 257

. Hence,

potential claims for health effects of dietary intakes can be made either directly in
relation to body weight, body fat and abdominal fat, or indirectly based on
energy/food intake and associated measures of appetite and satiety 257.
Finally, valid biomarkers are required to confirm dietary intakes 257 . The fatty acid
composition of lipids in body tissues can correspond to dietary fat intakes

263

. This

is particularly marked in plasma or serum (or erythrocyte membranes) and is a
convenient and reliable biomarker to confirm assessments of diet and dietary
change and, hence, support health-related claims 25.
Thus, the guidelines for assessments in substantiation research have been
established. However, in terms of the application of advice, structured sys tems
need also to be developed and validated in practice for the establishment of advice
methodologies to ensure dietary change and consistent outcomes in free-living
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groups. In this way, a structured approach to advice would provide a framework
into which single food/nutrient variables to be tested can be identified and
incorporated within the overall diet without change to confounding dietary
variables.
2.4.5 Summary of approaches to nutrition intervention
A number of approaches to nutrition intervention have been reviewed. Lifestyle
intervention trials have demonstrated that regular advice based on specific goals
for controlling energy and fat in the diet reduces the incidence of clinical markers of
disease in those at risk of diabetes. Nutritional adequacy and reductions in the total
amount of dietary fat, and to a limited extent the amount of saturated fat, have also
been demonstrated in these trials. However, in clinical trials demonstrating more
specific modifications to the dietary fat profile, the impact of existing advice
systems on the proportions of different types of fat, in particular P: S and n6: n-3
ratios, appears limited. Indeed, general low fat diet advice strategies may
unintentionally result in reductions in all fractions of total fat intake. Adjunct advice
strategies aimed at concomitantly increasing unsaturated fat intakes have focused
on exchangeable edible fat portions. A limiting factor in this approach may be the
small contribution of edible fats to the total fat content of the diet, particularly in low
fat diets.
An examination of food patterns exposes that a major portion of dietary fat is from
SFA-rich staple foods such as meat and dairy. Advice to increase the edible fat
fraction, therefore, may have little impact on overall fat ratios , but instead may
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increase total fat and energy intake with subsequent loss of benefit. Alternatively,
reference to secondary fat sources and, therefore, all foods in the diet has greater
potential to impact on overall individual fat proportions. Food pattern analyses
demonstrate the way in which specific individual fat proportions are achieved,
largely through shifts in fat intakes from SFA-rich staple foods to unsaturated fatrich sources across several food groups (fish, oils, nuts) within the total diet.
Hence, advice referring to a food group pattern of intake might be effective for the
achievement of target nutrients. For example, the DASH dietary trial demonstrated
how incorporation of appropriate food groups supported advice for a beneficial
pattern of intake with focused clinical outcomes. In this way, a greater number of
food groups enabled advice to target a wider range of nutrients, suggesting
individual food sources of nutrients are appropriate for the achievement of specific
nutrient intakes. In substantiation research, where changes in specific nutrient
variables need to be identified, a structured approach would enable manipulation of
some nutrients whilst controlling others. In terms of identifying the benefits of
individual food sources of nutrients a standardised methodology is required in
which individual foods and nutrients to be tested can be incorporated into the
overall diet for consistent outcomes within the free-living context.
2.5 Requirements for Further Nutrition Intervention Research
The application of the principles of evidence-based practice in MNT requires
knowledge of the best available evidence for the relationship between risk factors
of disease and possible dietary exposures. In the case of diabetes, traditional
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practices focus on blood glucose control and CHO-rich foods. Therefore, strategies
to redistribute CHO, increase fibre intakes and reduce the glycaemic effect of the
dietary pattern are fairly well established. However, targets for differential
proportions of fat within a total diet framework are also recommended 8. Therefore,
dietary advice that focuses almost entirely on CHO content, for example CHO
counting systems, are inappropriate on their own. While measures of glycaemia
may be useful in diagnosis, a narrow focus on this clinical marker alone may have
limited value in the dietary treatment of patients with diabetes 204. In view of
research evidence in relation to underlying IR and CVD risk, current diabetes
guidelines advocate a shift in focus to individualised advice for improvements in
overall metabolic control as distinct from a singular focus on glycaemic control.
Therefore, targeting overweight, blood pressure, blood glucose and blood lipid
levels is required to satisfy this broader interpretation of the evidence-base and
evolution in practice. Translating the guidelines into advice practices for consistent
clinical outcomes, however, requires further research in order to explore the
content, feasibility and impact of a dietary treatment based on current research
knowledge.
In a review of the evidence to support macronutrient targets in nutrition intervention
(Section 2.2), both animal and human studies are reasonably consistent in
implicating the role of high fat and high saturated fat intakes in the development of
IR and related clinical features such as overweight and obesity, hypertension, and
dyslipidaemia, as well as overall diabetes and CVD risk. There is also support for
consumption of unsaturated fats from natural sources, such as vegetable oils, fish
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and nuts, particularly as sources of n-3 PUFA in the treatment of IR-related
conditions rather than a reduction in total fat intake alone. Furthermore, the
combination of high amounts of fat (SFA), sucrose (or refined CHO), and excess
animal protein, all common components of a Western dietary pattern, may have
the most detrimental effects of all on insulin sensitivity and associated clinical
markers of disease 253. Hence, the long-term benefits of advice based on specific
dietary targets, in particular those for reducing total and saturated fat intakes have
been confirmed worthy in lifestyle intervention trials.
Implementation of the evidence-base requires referent to existing applications to
nutrition intervention (Section 2.3). Current dietary guidelines largely support the
research evidence. The most specific recommendation is for individual fat types
(<10% E SFA and approximately 10% E PUFA), and fish as an individual food
source of n-3 PUFA. A total diet approach, however, is recommended in which
CHO-rich foods (whole grains, fruits, vegetables, and low-fat milk) and their
distribution over a day is emphasized as part of a healthy dietary pattern. Food
guidance systems are then used in dietary counseling to guide advice. However,
existing systems may be inadequate for addressing specific proportions of
individual fat types in the overall diet. In order to effecti vely guide advice, food
guidance systems need to incorporate the unique dietary components targeted. To
date there is no system that distinguishes all food sources by the type of fat they
contain and none that provides a pattern of intake that targets different proportions
of fat in the diet.
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Approaches used in intervention trials (Section 2.4) confirm the appropriateness of
advice in terms of achievement of a dietary targets and consequent clinical benefit.
Existing approaches seeking to modify the dietary fat profile have been shown to
achieve nutritional adequacy and appropriate reductions in total fat, and to a lesser
extent the proportion of SFA in the diet. However, inadequate amounts of
unsaturated fat in the diet, especially PUFA content, have also been observed. A
reliance on exchangeable edible fat portions to reach unsaturated fat targets is
problematic, particularly in low fat diets, and may result in higher fat and energy
intakes, compromising potential benefits.
Studies reporting food pattern applications to nutrition intervention demonstrate the
way in which the overall fat profile reflects intakes across several food groups
within the total diet and how changes in individual fat proportions require shifts in
intakes from specific food sources delivering significant amounts of SFA and PUFA
to overall intakes. Therefore, effective strategies for achievement of specific
nutrient intakes may include targeted advice on key food sources. A structured
food pattern approach to advice would support the incorporation of individual food
sources of unsaturated fat into the total diet whilst controlling other dietary
variables for consistent outcomes and the substantiation of benefit.
2.5.1 In conclusion
The philosophy underscoring MNT demands evidence-based practices to support
it. For the treatment of diabetes, the shift in focus from CHO intake and glycaemic
control alone to individual advice addressing a range of clinical outcomes aimed at
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overall metabolic control demonstrates that research evidence is a dynamic
process. Nutrition applications need to support the evolution in practice. Dietary
guidelines draw on the evidence base and recommend specific macronutrient
targets for the treatment of diabetes. Where existing food guidanc e systems are
not adequately structured to support these targets, development of an advice
system based on research evidence and tested in RCTs provides evidence-based
support for the application of advice and a methodology for subsequent research
and its transfer to practice.
The evidence provided in the conduct of this thesis reveals that a structured total
diet approach to advice in which individual foods are identified by the types of
macronutrients they contain supports advice for the achievement of macronutrient
targets. This in turn has provided a framework in which key foods can be identified
as sources of required nutrients and linked to related health outcomes for the
substantiation of benefit in RCTs. Where diabetes treatment has provided the basis
for this research, the identification of key sources of PUFA and the development of
a pattern of intake for controlling total fat and energy were determined and tested
in diabetes groups under free-living conditions. The methods described, however,
would apply to other nutrition therapies and intervention groups and serves to
provide an outline for nutrition intervention and the gathering of evidence for
practice.
The studies conducted as part of this thesis describe the theoretical development
of a structured food guidance system for the achievement of target macronutrient
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proportions and controlled energy intakes and its implementation and practical
assessment in RCTs. In this way, the following hypotheses have been adequately
tested.
2.6 Hypothesis
Structured advice referring to a food pattern linking macronutrients to individual
food sources will result in better achievement of dietary targets and improvements
in clinical outcomes than general dietary advice.
2.6.1 Sub hypotheses
1.

In the context of clinical practice, total diet advice based on food group
sources of macronutrients and individual fat types will result in better
achievement of target energy, macronutrients and individual fat proportions
than general dietary advice under free-living conditions.

2.

Advice based on the food group intake pattern being tested in (1) will result
in greater improvements in health-related clinical outcomes than general
dietary advice, thus substantiating a benefit under free-living conditions.
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2.7 Aims
The four studies described in subsequent chapters outline the theoretical
development of an advice system (Studies 1 and 2) and its practical application in
the clinical setting for free-living individuals (Studies 3 and 4). The following aims
relate to each of these studies in turn.
1.

To establish a link between specific food patterns and the clinical expression
of disease.

2.

To develop an advice system that links theoretical nutrient targets to
common food sources of macronutrients and individual fat types.

3.

To test that the advice system developed in (2) is feasible to implement in
clinical practice and will result in better achievement of target energy and
macronutrient proportions by free living subjects than general dietary advice.

4.

To test that the advice system tested in (3) is effective in practice and will
result in greater improvements in relevant clinical outcomes in free-living
subjects than general dietary advice.
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CHAPTER 3 METHODOLOGY

This chapter details the methodological principles underpinning the studies
undertaken as part of this thesis in support of nutrition intervention practices, and
described in subsequent chapters. It is divided into four sections. The first (Section
3.1) gives a brief outline of the studies conducted and the role of each in the
establishment of evidence for practice. Different types of evidence are defined and
the RCT described within the research evidence hierarchy. The second (Section
3.2) provides the rationale for study design and the development of methods for
nutrition application in RCTs. The third (Section 3.3) outlines background research
undertaken to support the development of methods for nutrition intervention, and
the fourth (Section 3.4) provides a summary of the sources of bias, inherent in
intervention trials, that need to be addressed if evidence for practice is to be
established.
3.1 Establishment of Evidence for practice
The four studies conducted as part of this thesis are in effect layers of evidence for
nutritional and research intervention. First, typical food patterns conducive to better
glucose tolerance were extracted from observations within an appropriate study
sample. These were then developed into a food guidance system to direct
intervention for diabetes treatment. Finally, the feasibility and effectiveness of
these methodologies and underlying evidence-based nutrition principles were
tested by application in two RCTs. Each layer involved the collection of evidence to
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put into research practice and can be mapped to Studies 1 to 4, described in detail
in Chapters 4-7, respectively. In this way, gathering the best evidence is in
essence the endpoint of this thesis, where it provides the rationale for developing
the methodologies outlined in the sections following.
3.1.1 Hierarchy of research evidence
As stated at the beginning of this thesis, evidence-based practice is the specific
application of knowledge on nutrition and clinical data in the treatment and
prevention of disease 3. To this end, dietary studies are defined according to a
hierarchy of research evidence on which to base conclusions regarding dietdisease relationships and the establishment of evidence for practice 4. Two broad
categories of nutrition research exist: feeding trials (animal and human), where
intakes of one or more dietary components are manipulated and responses
compared; and epidemiological studies where diet and disease components in free
living individuals are linked in both an observational (cross sectional and cohort)
and experimental sense (RCT). The former provide mechanistic evidence for direct
relationships between a particular nutrient or proportions of nutrients and clinical
abnormalities. The latter, while not able to demonstrate direct causal relationships,
provide valuable support for mechanistic studies by demonstrating possible
associations between nutrient intakes and clinical markers of disease.
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3.1.2 Randomised controlled trials
The RCT represents the highest level of research evidence within the research
evidence hierarchy for diet-disease relationships and, therefore, is the most
appropriate study design for the establishment of evidence-based practices for
nutrition intervention 3 and the substantiation of benefit 258 . The RCT differs from
the observational or cohort study in that it allows the investigator to allocate
random treatments and, therefore, has the potential to produce high quality results
similar to a controlled experiment. In this way, comparisons between treatments
provide measurable outcomes in terms of both the achievement of the nutrients
targeted and consequent clinical benefit. To support the application of research
knowledge, studies need to be conducted in a sample of the treatment population
in the clinic al practice context under free conditions in order that results may be
transferred to the broader context. The RCT was chosen as the best design for the
intervention studies conducted as part of this thesis. In this way, different advice
approaches were able to be compared in free-living diabetes groups. Evidence for
practice was attained by assessing achievement of dietary targets and changes in
clinical outcomes in response to each approach.
3.2 Methods development
3.2.1 Rationale
In this thesis, Section 2.1 provided an overview of diabetes and its associations
with the Metabolic Syndrome. Section 2.2 provided a review of the literature on IR-
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related nutrition research to establish evidence to support relationships between
macronutrient variables and variations in clinical markers of IR such as overweight,
blood glucose levels and blood lipid profile. The weight of research evidence
supports changes in the proportions of individual fat types for the dietary treatment
of IR-related abnormalities such as diabetes. The amount, type and frequency of
CHO in the diet are also important. Importantly, these findings are supported by
guidelines for the MNT of diabetes and related complications, reviewed in Section
2.3.1, which recommend individual types of fat as specific percentages of total
energy intake as part of total diet advice based on food patterns. Attention to the
CHO fraction is also recommended in terms of amount, type and distribution
throughout the diet. Reviews of current food guidance systems, Section 2.3.2, and
nutrition applications, Section 2.4, outline the inadequacies of existing approaches
to advice and indicate that to adequately address the research evidence and
guidelines required the development of an appropriate food guidance system and
its application in RCTs to substantiate dietary and clinical outcomes that, in turn,
validate the intervention framework. The guidelines, therefore, provide reference
points on which to base study design and methods. Specific proportions of
macronutrients thus become dietary targets for the development of advice.
3.2.2 Methods from previous dietary intervention trials
Lifestyle RCTs dem onstrate nutrition interventions conducted under free-living
conditions and provide methods and guidance for the practical application of
strategies for dietary change 19-21, 264 . Previously reviewed for providing evidence to
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support dietary fat targets in nutrition intervention (Section 2.2.1) and again looking
at the methodologies used in lifestyle approaches to nutrition intervention (Section
2.4.1) these trials focused on modifiable risk factors in the prevention of diabetes
and its related complications. They have demonstrated that structured
individualised programs improve compliance to advice, resulting in better
adherence to dietary targets and, therefore, greater likelihood of achieving
improvements in clinical outcomes than control groups receiving standardised
general advice with flexible follow-up. Features of the intensive approaches were
structured programs with regular contact, programmed follow -up and individualised
goals for specific changes in diet ary intakes and physical activity levels. The
Finnish DPS also found that individuals achieving a greater number of lifestyle
goals achieved a greater reduction in risk, regardless of the treatment approach.
Clinical trials demonstrating modification of the fat profile, outlined in Section 2.4.2,
have identified the difficulties for achieving adequate PUFA/n-3 PUFA whilst
reducing SFA and controlling energy intakes using existing advice systems.
Targeting amounts from the ‘added fat’ portion of the diet was also ineffective
particularly within low fat/modified fat diets. Therefore, the development of a total
dietary approach in which all foods are targeted is indicated.
Food pattern analyses, reviewed in Section 2.4.3, exposed traditional sources of
fat in the diet as staple sources of SFA. Sources of PUFA were from a broader
range of food groups, but more likely to be the target of fat restriction in low fat
advice, for example oils and nuts. Targeting these foods as sources of fat to
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include in the diet, whilst applying traditional low fat advice strategies to staple
foods , might improve the ratio of fat types in the diet.
In keeping with the DASH study, which demonstrated the way in which a greater
number of food groups (than core food groups) addressed a broader range of
nutrients, reference to a greater number of food groups might also be required to
address different types of fat in the diet. Hence, a food pattern inclusive of all foods
in the diet but grouped to identify key sources of different types of fat would
enhance advice to modify the fat profile and allow the control of overall fat and
energy intakes. Therefore, with reference to previous research, an outline for an
appropriate advice system and protocols for dietary intervention have been
established.
3.2.3 Construction of a model food pattern
While the structure and context in which advice is given is important, the subject of
this thesis is ensuring dietary advice matches the theoretical aims of the
intervention, in this case macronutrient recommendations. This requires knowledge
of the macronutrient content of individual foods and an understanding of
consumption patterns and the variability that might be encountered due to
individual food choices. Such knowledge and understanding supports the
conversion of macronutrient targets into practical advice on individual foods and
food groups in order to provide understandable and achievable information to freeliving individuals. In this way, the exercise of developing an overall dietary intake
from component foods/food groups supports advice for intervention by enabling
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transparent processes and an appreciation of the impact of food groups and
individual foods on nutrient variables. Accuracy of the process is critical for both
adherence and outcomes and is dependent upon development/selection of an
appropriate nutrient database, relevance of foods/food groups to dietary targets,
and the ease with which resultant dietary patterns can be implemented as
simplified advice. Large, computerized nutrient databases are, on the whole,
inappropriate for this exercise 252 . They are cumbersome, time consuming and not
useful for assessing nutrient intakes in terms of food groups and varying portion
sizes. Exchange list systems offer a convenient alternative method for constructing
individual diets 17 . Many current systems, however, are based on a compilation of
(referenced and unreferenced) food databases, with few analyses for accuracy and
variance 17. Assessment of the ADA exchange lists for meal planning reported
large within-group variations and application of the system to an overall dietary
pattern was not reported 17. To date, an assessment of Australian food guidance
systems has not been reported.
The need for a simplified format for the calculation of overall nutritional intake is
met through development of a ‘ready reckoner’ system to expedite the dietary
modeling process 265. The ready reckoner is a convenient and simplified reference
for food composition data and provides a framework for assessing and modeling
food consumption patterns for the achievement of dietary change. In conjunction
with exchange lists of foods of similar nutrient compositions, the ready reckoner is
an important facilitator for individualizing advice and assuring it matches both
nutrient and food-based targets. Based on food groups appropriate to nutritional
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goals, the number of food groupings is minimized to enable speed and
convenience for the clinical situation. While simplification may reduce the accuracy
of the instrument, its relevance to dietary goals should not be compromised.
Therefore, theoretical assessment of the accuracy and degree of variability within a
dietary modeling system is required. Practical application in RCTs can then be
carried out to assess the utility of the advice system in clinical practice and to
confirm the theory in terms of achievement of dietary goals and related clinical
outcomes.
3.3 Background Research
In order to develop an advice framework for application in a RCT for diabetes
treatment, background research was conducted. Although nutrient
recommendations for diabetes are specific in terms of proportional individual fat
intakes, nutrition interventions require an understanding of the eating habits, food
preferences and patterns of intake demonstrated by the study population to ensure
advice is appropriate for changes in clinical outcomes. Where advice based on
food patterns is recommended 8, the impact of food factors and food patterns on
clinical outcomes is not as well studied as that for nutrient intakes. Similarly, as
reviewed in Section 2.2, evidence to support advice on the pattern of CHO intake is
not as strong as that for dietary fat intake. Therefore, in order to develop
appropriate food-based advice for the overall pattern of intake, the examination of
food patterns of a sample diabetes group was necessary to further elucidate the
diet-disease relationship. This was done by establishing a link between specific
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food patterns and clinical outcomes, in this case between CHO intake and glucose
abnormalities (Study 1 CHAPTER 4).
Such relationships do not exist in isolation, however, and development of an advice
framework for the total diet needed to account for multiple dietary factors and their
metabolic effects. Hence, foods and food patterns needed to incorporate the
findings from Study 1 and to be theoretically linked to guideline variables
(macronutrient recommendations 8 ) for the construction of a model food pattern to
meet predetermined targets for energy, macronutrients and individual fat types for
the treatment of diabetes (Study 2 CHAPTER 5). The following outlines the
methods used in Studies 1 and 2, respectively, conducted as part of background
research for the development of an advice framework targeting specific nutritional
and clinical outcomes in intervention trials.
3.3.1 Food pattern analyses
Study 1: To establish the link between food patterns and blood glucose
abnormalities
This study was conducted to establish a link between specific food patterns and
glucose intolerance as the clinical expression of insulin resistance and clinical
marker for diabetes treatment. The DASH feeding trial demonstrated the clinical
benefits of food patterns designed to effect a change in blood pressure levels as
the clinical expression of CVD 266. In order to further elucidate relationships
between food patterns and blood glucose tolerance, a cross sectional survey of the
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food habits of a sample of women with demonstrated glucose intolerance
(presenting with GDM at the beginning of the third trimester of pregnancy) was
compared with that taken from a sample of glucose tolerant pregnant women. Food
pattern analyses were used as an alternative to traditional nutrient analyses to
enable a better understanding of the relationship between diet and clinically
diagnosed glucose intolerance by providing specific information on foods for
inclusion in an advice system for the treatment of diabetes.
The analysis of food patterns involves the study of individual food factors rather
than broader aspects of the total diet in order to examine diet-disease relationships
and related concepts 267. Analyses of food choice patterns are less dependent
upon the inadequacies of nutrient databases and allow the diet of a study
population to be described in a manner that is useful in the clinical setting, both for
the researcher/practitioner and the consumer 268. To perform food pattern
analyses, individual foods and food ingredients reported by individual members of
the study population are first combined into groups. Criteria for the formation of
food groups may vary dependent upon the objectives of the particular analysis, for
example food components, culinary use, metabolic responses, and so on 269.
Analysis of food groups may, in turn, be conducted based on various criteria such
as absolute weight in grams, number of servings, or %E intake 267. This type of
analysis can establish links between specific food factors and clinical markers of
disease, either cross-sectionally 270 or prospectively 267, determine whether current
nutrient guidelines can actually be met; provide guidance for healthy eating
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patter ns and information on how dietary change might be achieved in practice for a
specific health benefit 271 .
Limitations of food pattern analyses
Limitations of food pattern analyses stem from three main sources of bias:
differences between populations, method/s of data collection, and criteria for
interpretation.
Firstly, the outcomes of food pattern analyses can be directly affected by potential
differences between populations according to age, sex, religion, and ethnicity 269.
Therefore, in terms of application, it is important that the data-set is taken from an
appropriate study sample clinically similar to the target group 270. Thus, in order to
ensure the relevance of information drawn from the analyses conducted in this first
study, the study sample was chosen to match the sample targeted for the
subsequent intervention trial (Study 3 CHAPTER 6). That is, a convenience sample
of well defined glucose intolerant patients (women diagnosed with GDM using an
OGTT 272 drawn from a local clinic). GDM women also represent individuals who
have a demonstrated increased risk of T2DM

273-275

and CVD 276, 277 compared with

other members of the general population, making current eating habits relevant to
primary prevention strategies for future risk management. The representativeness
of the study sample is an important aspect of intervention research, and is
discussed in detail later in Sec tion 3.4 as a source of bias in intervention trials.
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Secondly, the type of method used to collect dietary data can also impact on
results from food pattern analyses 267, 268. Therefore, it is again important that the
chosen data collection method has unique requirements for this type of analysis.
For example, rather than provide total intakes alone, the method should be
representative of habitual intakes and sensitive to significant individual foods,
cuisine choices and patterns of food intake over an average day. The DH captures
a detailed history of recent past dietary intake 278 and performs well in clinical trials
279

, and so was the data collection method of choice for all studies conducted as

part of this thesis. The FR is commonly used to cross-validate dietary data
collected via another method 279, 280, and was used for this purpose here. Both
methods are discussed in detail in Section 3.4 as sources of bias in intervention
trials.
Finally, the greatest limitation for food pattern analyses stems from several
application specific decisions that investigators must make. Based on prior
knowledge, interpretive assessments are made according to predetermined
objectives and/or anticipated outcomes. The investigator determines the factors
used for the aggregation of foods into groups, the number and type of food factors
to be analysed as well as how to treat food group variables, for example as
absolute weight, %E intake, or number of servings 267 . The decisions made shape
the outcomes of the analyses according to study-specific objectives.
To address the limitations of the food categorization process for this study, several
criteria were developed to define food groups and to identify specific patterns of
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intake that may impact on the glucose tolerance of GDM women. Previous
research points to the impact of the total amount of CHO on blood glucose levels 8,
whilst evidence for the effect of source or type of CHO in the diet is less clear. In
order to clarify the effect of source or type of CHO in the diabetes diet, this study
focused on CHO-rich food sources categorised in two ways: according to food
groups (cereals, fruit, milk, etc) and diet GI scores (low, intermediate and high, GI
load and meal GI).
These criteria were chosen to identify foods of similar components and metabolic
effect and represent classifications used in previous dietary analyses 214, 281. Diet
GI scores obtained from free-living subjects demonstrate a normal distribution, and
are considered valid for use in common statistical procedures 281. However, GI
scores expressed as percent energy may be biased by the possibility of
underreporting by the study group. Furthermore, in terms of variations in individual
responses and the impact of other meal components, GI scores of individual foods
have been found to have limited use in evaluations of glycaemic response.
Consequently, individual foods organized into groups related to a more rounded
estimate of the body’s response (high, intermediate and low GI) may eliminate
some of the error related to assigning individual foods exact GI values, discussed
elsewhere 282, 283.
Such analyses may add insight to the limited research in this area, particularly from
a clinical practice perspective, where findings may be applied directly to practice.
The information from this study, while particularly relevant to GDM where there is
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scant research on which to base clinical practice/research methods, is also
relevant to other diabetes groups for whom information on foods and food patterns
is of similar value.
3.3.2 Food Guidance Systems
Study 2: To model an advice framework based on food patterns for the
achievement of macronutrient targets
This study was conducted to link food patterns to specific proportions of
macronutrient variables including different types of fat in order to guide advice for
the achievement of dietary targets for the treatment of diabetes in an intervention
trial.
Where nutrient guidelines need to be converted into advice on foods, food
guidance systems provide a set of food values for estimating the nutrient and
energy content of the diet, as well as lists of foods of similar values to enable an
outline of flexible food choices to meet estimated intakes 17, discussed in detail in
Section 2.3.2. Food guidance systems, therefore, represent a us eful dietary tool for
the application of advice to match theoretical aims in a range of clinical and
research settings. However, to be effective a food guidance system must
incorporate unique dietary factors/components and targeted information on specific
foods 16, 246. Therefore, the particular purpose of the intervention and its specific
dietary targets need to be addressed. Where the purpose of this thesis is to
provide evidence for the application of nutritional guidelines for diabetes
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management and thus establish an appropriate advice system, the focus therefore
is on weight management and control of blood glucose and lipid levels. Dietary
targets are drawn from research evidence, outlined in Section 2.2, and treatment
guidelines, outlined in Section 2.3.1, and refer to specific proportions of
macronutrients and indi vidual fat types as well as controlling energy intake and the
amount and type of CHO in the diet. A further layer that might be added would be
to target an individual food source as delivery agent for increasing a specific
nutrient, such as PUFA, and to model intakes into the overall diet as part of
substantiation research.
In order to assess the appropriateness of an advice system for a specific purpose,
an awareness of the assumptions and limitations inherent in food guidance
systems is essential. First of all, the target population is an important consideration.
Current systems have been developed largely for the maintenance of physical
health and well-being of the general population 16. There is an assumption here
that one system based on criteria for nutritional adequacy is appropriate for the
specific nutritional requirements of all populations. Achievement of adequate
nutrition, however, may not address the particular need of a s ub-population, and
has been discussed in Section 2.3.2. Therefore, the development of advice and
subsequent testing should be based on study samples with similar characteristics
to those for whom advice is required.
Secondly, an appropriate advice framework is dependent upon the database of
specific foods used in its development and the criteria used to aggregate individual
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foods into food groups of similar values. Different criteria are required for different
systems depending upon the purpose and specific dietary targets 16. The links
between specific food factors/components and clinical markers of disease
established by food pattern analysis need to be confirmed in the application of
advice developed from them. Nutrient values within each food group need to be
similar. However, increased variation may occur for nutrient values not used as
criteria in food group development. For example, where food groups are based on
the particular goals for nutritional adequacy, as discussed in Section 2.3.2, the
system becomes very specific for that purpose and not for others 16. In the case of
adequate nutrition, the emphasis is on foods as sources of energy, protein and
vitamins and minerals 13 . While it is important to acknowledge these dietary
variables in any food guidance system, the limitations imposed by these criteria on
food group development need to be addressed in a system with additional goals in
mind. This is particularly so for energy intakes if all foods are not grouped
according to estimates of macronutrient and/or energy content. Where CHO
distribution is required 8, portion size for CHO-rich foods needs to be standardised
and differences in quality (wholegrain, fibre-rich, low GI) identified. Likewise, where
specific changes in fat proportions are required, individual f ood sources need to be
identified 23, 24, 284. For example, foods grouped to enable similar values for total
dietary fat content alone may limit the achievement of targets within the fat fraction,
discussed in detail in Section 2.4.4. Indeed, there are a number of assumptions
that limit the achievement of specific proportions of different dietary fat types using
existing systems. Foods are often grouped according to total fat content with the
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assumption that a reduction in overall fat intake will result in a reduction in the
proportion of saturated fat in the diet and, therefore, will improve the ratios of other
fat types. However, while current systems appear conducive to reducing total fat
intake by sub-categorizing low fat options and limiting the amount of edible fat in
the diet, they do not adequately define foods as sources of different types of fat
and, therefore, are unable to support specific manipulations, discussed in Section
2.3.3. For diabetes treatment, the need to discriminate individual fat types has
been recognized, but is largely confined to exchangeable edible fat portions. The
assumption being that edible fat is the main source of dietary fat and that targeting
this fraction of the diet will impact on overall intakes without changes to other
dietary variables. However, edible fat sources may contribute only 30% of total fat
intake, and staple food sources, such as meat, milk and cheese, largely define total
and saturated fat intakes. Therefore, secondary sources of individual fats need to
be adequately defined to enable an effective exchange of saturated for unsaturated
fat-rich foods. Hence, as concluded in 2.3.2 no current advice system identifies
sources of individual fat types in this way and, therefore, none are considered
suitable to address nutrient targets in the treatment of diabetes and ultimately
benefits in free-living diabetes subjects, discussed in Section 2.3.3.
With the limitations of current systems in mind, development of a food advice
framework for the application of specific treatment advice for diabetes required not
just a working knowledge of the nutrient composition of foods, but an
understanding of food intake patterns and how they may impact on results. In this
way, background research was conducted to identify foods and patterns of intake
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for inclusion in the system. To this end, the following steps were taken: i) to identify
common food sources of the nutrients under study; ii) to apply appropriate criteria
for the development of food groups as sources of the nutrients under study, as well
as unique sources of specific nutrients; iii) to model a sample food group intake
pattern that would provide targeted proportions of the nutrients under study; and iv)
to conduct statistical analyses of the resultant food groups and sample food group
intake pattern to confirm the appropriateness of advice in terms of potential
variation in intakes compared with nutrient targets.
The identification of foods and food patterns drawn from a local sample of glucose
intolerant women from Study 1, resulted in an appropriate food data base providing
a reference for common food sources of macronutrients, culturally appropriate and
locally available. Subsequent food group development based on criteria drawn
from the treatment guidelines (macronutrients and fat types) enabled identification
of a set of food groups and individual foods for inclusion in an appropriate intake
pattern modeled to achieve guideline targets.
Accuracy of the modeling process is critical for achievement of dietary goals. While
accuracy of the food database also has an impact, so too does simplific ation of the
database into food groups and average rounded nutrient values to expedite the
process of dietary modeling. Therefore, in this study assessment of the accuracy of
the system was undertaken, where the application of statistical analyses estimated
potential variation in intakes due to individual food choices to meet the equivalent
intake pattern.
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Hence, constructing a total food intake pattern to match dietary targets supports
the theory for their application in dietary intervention, but required a different set of
constructs to those used in food group development. Here nutrient goals and food
group sources were merged for the development of a model food intake pattern to
ensure the nutrient proportions under study in the intervention trials. Reference to
the model would provide advice in terms of the amount and frequency of major
food groups as sources of macronutrients and different types of fat for the
achievement of macronutrient targets, estimated energy requirements, and overall
nutritional adequacy.
3.3.3 Dietary Intervention trials
In terms of effective practice, the methods used in dietary intervention trials to bring
about changes in diet and clinical markers of disease in free living populations
provide information for the clinical application of research evidence. The
implementation of an advice system under free-living conditions provides evidence
for its transfer to clinical practice and its use in future trials for the substantiation of
benefit. For the purposes of providing evidence for nutrition intervention, a dietary
advice framework was applied in the clinical practice context in RCTs, conducted
as part of this thesis, in women with GDM Study 3 CHAPTER 6 and in men and
women with T2DM Study 4 CHAPTER 7.
Study 3: To test the feasibility and applicability of an advice framework based on
food patterns for achievement of the fat profile recommended for diabetes

113
This study was a RCT conducted to test the clinical feasibility and applicability of a
dietary advice framework that identifies food sources of macronutrients and
individual fat types for nutrition intervention in a free-living sample of women with
GDM.
Study 4: To substantiate the clinical effectiveness of an advice framework based
on food patterns and the incorporation of an individual food source for increasing
the proportion of PUFA in the diet
The second trial was a longer term randomised controlled dietary intervention trial
in free living adult men and women with T2DM conducted in the clinical practice
setting, to test the transfer of the advice framework to other diabetes groups, to
assess the incorporation of a single food source, walnuts, of a specific nutrient,
PUFA/n-3 PUFA, into the advice framework, and to confirm the clinical
effectiveness of advice based on food patterns to ensure specific intakes for
macronutrients and individual fat types.
It is rare however for a RCT in free-living samples to provide data for a pure
nutrient-disease relationship due to the greater likelihood for confounding variables
and bias. Unless these limitations are adequately addressed it may be difficult to
extrapolate to fee-living populations 258, 285. The following outlines confounding
factors and sources of bias in dietary intervention trials and the methods used to
address them.
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3.4 Sources of bias in intervention trials
Representativeness of the study sample
For the purposes of developing evidence-based methods and practices, dietary
intervention trials need to be conducted under the conditions for which results are
to be generalized. For this thesis, two intervention trials were conducted in samples
of local free-living glucose intolerant individuals (women with GDM, and men and
women with T2DM, respectively) identified clinically by their level of glucose
intolerance as determined by oral glucose tolerance test (OGTT) 28, 78, and seen
under clinical conditions. As outlined previously, study design was developed from
information gained in background research in a representative sample (Study 1
CHAPTER 4).
Sample size
Estimation of an appropriate sample size for an intervention trial uses data already
available form other trials. For example, the standard deviation of the mean of a
similar population can be used to calculate the expected standard error of the
mean of a new population 285. The ability to detect significant differences between
comparison groups is heavily dependent on the power of significance tests. The
power relates to the proposed difference and the standard error of the difference,
which is dependent on sample size, and the significance level set for the probability
of detecting a difference, usually set at P=0.05.
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Published data for estimates of sample size and standard deviation to determine
an effect in humans, however, are limited. In a previous dietary intervention trial
with a similar sample size to the T2DM study sample outlined in this thesis,
changes in proportions of individual dietary fat intakes were determined but did not
demonstrate a difference in clinical outcomes between low fat and modified fat diet
groups 23. Although there are some differences in dietary strategies (for example,
significant reductions in dietary SFAs were not anticipated in the control group),
attention to study design will demonstrate achievement of dietary targets and
feasibility of the specific intervention approach. This is likely to represent
conservative estimates because specific aspects of study design would be
expected to substantially increase the power of achieving a significant difference
between groups 286 , that is, repeated measures at baseline and over specified time
points and structured dietary advice are likely to reduce the between-subject
variance and strengthen results. A high level of dietary compliance in the study
groups (pregnancy and diabetes diagnosis are motivations for adherence to dietary
advice to achieve good clinical outcomes) has a similar effect. Adjusting for sex is
also likely to reduce the variation and increase the power 285. Nutrition trials that
recruit high-risk individuals, however, require relatively small numbers because the
spread (variance) of end points is minimized 286. In this thesis, trial groups were
highly defined with homogenous characteristics between individuals. Therefore,
large numbers were not required and results could still be readily extrapolated to
the wider diabetes community.
Duration of the intervention
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An insufficient trial period to adequately accumulate quality end points can reduce
statistical power 286 . For this thesis, studies were conducted with standard clinical
practice conventions in mind. Because Study 3 involved GDM women, the period
of intervention was limited to the third trimester of pregnancy (from diagnosis at
around 28-30 weeks to delivery at 36-40 weeks gestation). For this reason, this
intervention was conducted as a pilot study to assess feasibility of the dietary
strategy in free-living subjects under clinical conditions. Study 4, involving T2DM
patients, however, was conducted over a six-month period to enable the
assessment of long-term compliance and changes in clinical outcomes. This was
considered sufficient time to test adherence to dietary advice and chronic nut
consumption over the longer term, and for incorporation of biological biomarkers
and changes in relevant clinical outcomes in order to substantiate a benefit 257.
Dietary adherence and compliance
Compliance to dietary advice and adherenc e to specific intakes and targets for
nutrients and energy is essential in dietary intervention trials for two reasons: firstly,
to allow confidence in conclusions drawn from relationships between dietary
change and changes in relevant clinical outcomes; and secondly, to confirm
feasibility for extrapolation to the clinical setting and free-living individuals. Factors
that impact on dietary compliance include study design, length of the intervention
period and the utility of advice and palatability of the diet being tested. Compliance
was enhanced through attention to study design where individualised advice,
specific dietary targets, and regular support played a role. Study lengths were
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consistent with clinical practice timeframes and were considered reasonable. In
Study 4, long-term adherence was assessed over six months, a period that may be
expected in clinical practice following diagnosis of diabetes and/or when seeking a
change/s in clinical outcomes, such as blood lipids, and/or blood glucose control.
Dietary intervention involving free-living populations need to be structured and
supportive of dietary change so that the quality of dietary data in terms of
over/under reporting and unintended changes to background dietary variables are
minimally affected. The studies outlined in this thesis offered support for the
achievement of dietary change by referring to foods commonly consumed and
locally available, and exchange lists to support individual food choices.
Dietary monitoring
Dietary monitoring is an important aspect of dietary intervention trials as it confirms
compliance to the foods/nutrients under study and ensures reliability and
repeatability of results and transfer to the treatment population for whom
conclusions are made 258. For interventions seeking to estimate clinical practice
methodologies, some of the methods used to monitor dietary compliance should be
feasible to implement in the clinical practice setting. In the interventions reported in
this thesis, monitoring dietary compliance was undertaken in two ways, as part of
normal clinical practice with regular visits between subject and dietitian. On these
occasions the dietitian, in checklist fashion, readily assessed adherence to dietary
advice by referring to the individualised food group intake pattern provided initially
to each subject. In addition, a dietitian telephoned subjects in Study 4 on one
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occasion between each clinic visit. At specific time points at the beginning and end
of each study more formal dietary assessments were undertaken in the form of DH
interviews and weighed FR, described later in this Section.
Dietary variables
The c ooperative, synergistic, additive and confounding effects of various food
components need to be acknowledged 258. The ability to control non-intervention
dietary intake (reference diet) in accordance with nutrition intervention goals
assists dietary adherence and allows a more accurate assessment of the
intervention. In this thesis, changes in dietary fat proportions were required without
alterations to intakes of energy and other nutrients. Therefore, advice needed to
address the total diet with the required changes incorporated. Therefore, each
group was provided with similar advice except for that relating to specific fat
intakes/individual food source (walnuts). The complexities inherent in dietary
change to effect intakes of specific fat types have been discussed previously in
Section 2.4. As demonstrated by Tapsell et al shifts in food group sources of fat
intake encompass several food groups 23. Appropriate food group classifications,
therefore, are important in order to retrieve food based data relevant to the
manipulation if dietary fat under study. In this case, food groups needed to reflect
individual fats in order to inform practice on specific food intakes for the adequate
achievement of fat targets.
Capturing food habits
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Dietary intake is highly complex, where there are thousands of distinct food items
available for consumption and most people eat a variety of food items every day.
Collecting complete and accurate data on the varied diets consumed by free-living
study participants poses several challenges. The appropriateness of the
methodology to the research question and an understanding of the limitations that
exist can reduce the degree of error and provide a realistic estimate (Margetts).
Although the error inherent in dietary data collection is acknowledged, any data
tested statistically should be recorded as precisely as possible 286. This is
dependent, to a great extent upon matching the method of data collection to the
purpose for which the data will be used. For the purposes of individualising dietary
advice in the clinical context, an accurate assessment of background or ‘reference’
diet is also important 258 , taking into consideration usual intake patterns, variations
and personal preferences. Hence, a tool that is sensitive to the distribution of
foods, cuisine type, food and meal patterns would be a good fit for a dietary
intervention trial seeking to provide food pattern advice. An outline of the
appropriateness and limitations of the two methods used in this thesis for the
collection of dietary data follows.
Diet History
The DH is a retrospective meal- based dietary measurement that enables a
reasonable level of reproducibility and validity for intake of individual foods and
food groups as well as meal patterns 287. An interviewer administered
questionnaire, the DH aims to cover a lengthy time period in order to capture
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habitual diet. Its strength lies in being able to assess frequency of intake of
individual foods and content and frequency of meals, resulting in a detailed
assessment of usual meal patterns and overall consumption patterns. Heavy
reliance on memory and inaccuracies in estimating the frequency of consumption
and portion size can be overcome to a large extent through the ability of the
interviewer and adequacy of interview design. Including adequate ins truction,
open-ended questions and other various tactics, such as visual aids and recording
information on food preparation methods, food types, recipe ingredients, as well as
including a ‘food frequency checklist’ of common/relevant foods can reduce
participant burden whilst building a reasonable picture of overall intake. A
questionnaire of this type has been developed in the Illawarra region and validated
within local diabetes populations 278, 279, 288. This format was adapted and provided
the primary data from studies reported as part of this thesis.
Food records
The weighed FR is an alternative data collection method, usually providing a few
days worth of intake. In contrast to the DH, this is a prospective method in which
the subject is required to record all foods and drink and the amount consumed
daily. Its strength is in its ability to capture quantitative data. For this reason, the
weighed FR is often used as the standard for comparison with another method 289,
and was used for this purpose in the studies presented as part of this thesis.
Although based on weighed portions and household measures, this may not be the
most precise estimate of the person’s ‘usual’ dietary intake. Foods that were eaten
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infrequently may be missed, portion size may be inaccurately measured. A further
limitation is the ‘training effect’ 280, where participants are aware of study aims or at
least well aware of the aims of the dietary advice provided and consume foods
accordingly but only for the recording period. The ‘instrument effect’ also has an
impact, where the effort required to weigh and record foods disrupts normal eating
patterns 290 .
Comparison between two data sets
A second data set provided from an alternative data collection method can be used
to create a standard for statistical comparison

286

. To assess the relative validity of

data from the DH used in this thesis, a comparison was made with data from the
FR to estimate the degree of error and acceptability of the data obtained. Where
data collection methods are either retrospective or prospective in their evaluation of
dietary intake, the DH and FR are as examples of each, respectively, and
therefore, as they display different sources of error, are useful in comparison
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.

As previously discussed, the DH is subject to random error due to poor memory
and systematic error due to underreporting. In contrast, the FR is subject to
reporting bias, where recording intake influences food choices and results in
altered intakes during the recording period 292 .
In the intervention studies reported in this thesis, the DH and FR were compared
using Bland Altman plots 286 in which the difference between the two methods is
plotted against the sum or average. The two methods agree if the difference
between the data (measuring the same intakes) is small enough to use either

122
method interchangeably. Plotting the differences provides visual evidence of a
relationship between the difference and the mean, but this can also be assessed
for significance using the correlation coefficient. A mean difference close to zero,
however, shows little overall bias. Whether the difference (distance of the mean
from zero and the width of the 95% limits of agreement) is acceptable, however,
depends on subjective judgment based on the size of the measurement and its
purpose for which a difference is considered acceptable. For the purposes of the
studies conducted as part of this thesis, the decision needed to be clinically
relevant and related to what was c onsidered reasonable variation from expected
nutrient targets.
Nutrient analysis
Computerised nutrient databases assist the process of nutrient analysis. Accuracy
of the selected nutrient database/s, therefore, is an important consideration.
Databases have been shown to vary significantly in their mean deviations from
chemical analyses values for some nutrients. While differences between individual
foods are known to vary by up to 45%, food databases demonstrating relatively
good accuracy report mean macronutrient values within 15% of reference values
252

. Further, the nutrient content of the whole diet, based on random variations

across food items (which tend to cancel each other out) has been estimated to vary
by as little as 5% 293.
Accuracy of the database is dependent on the quality of available food composition
data and therefore the technology used to obtain it. It is also dependent on the
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range of foods included in the database. In reality, specific food values in the
primary database are also based on means. Inadequacies stem from missing
foods or recipes and food combinations for which individual components have to
be used to assemble the consumed food. The computer software used for the
primary nutrient analyses reported in this thesis was the latest version of a program
providing updated national food composition data from 11 databases and
approximately 4500 foods. Individual foods, commercial brand name items, generic
foods items and whole meals were included as well as variations in nutrient content
according to cooking methods. Where a food or meal was not found, substitutions
were made with similar foods and equivalent recipes entered. Due to the
extensiveness of the database this occurred in a minority of cases. Estimates for
long-chain fatty acid intakes, however, were not possible using the same database.
For this, fat containing foods were re-entered into a separate database for analysis
of individual fatty acids. The limitation here was that this database contained fewer
food choices so that substitutions with foods of similar fat proportions (total fat
content was matched first) occurred more often and therefore had a greater impact
on results.
Dietary validation
Procedures that validate dietary data are an important aspect of dietary studies to
provide confidence in conclusions drawn from relationships between dietary intake
data and clinical outcome measures. Having acknowledged measurement error,
the principal behind the validity of dietary data requires a set of replicate readings
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from each member of a sample

286

. However, the measurement of dietary data is

indirect and represents an unknown quantity from the truth. Further, comparison
can usually only be made with another similarly indirect method. Hence, there is no
gold standard reference methodology against which dietary data can be compared.
Therefore, validation of reported dietary data in this thesis has been provided using
several methods: comparison with another data collection method (FR), how well
reported energy intake relates to basal metabolic rate (BMR), biochemical markers
of fatty acid consumption (the lipid composition of RBCs), repeated measures, as
well as assessment of changes in associated clinical markers of metabolic
abnormality (weight, glucose control) 257.
Underreporting
Since there is no gold standard for the comparison undertaken above, it is
important to attempt to confirm validity, if any, using a further assessment method.
Biomarker measures of EE such as urinary Nitrogen excretion and doubly labeled
water have confirmed the frequent under-estimation of food intake 294. Individuals
reporting low energy intake can alter results and subsequent conclusions
depending on whether their data has been included or excluded

295

. Therefore,

methods of validation most often refer to energy intakes. Because primary outcome
variables for this thesis were energy and macronutrients as a %E intake, the
potential bias in reported energy intake needed to be estimated. One method
employed to identify underreporting and/or to examine effects under-reporters may
have on the data, is the Goldberg cut off

294

, based on the assumption that energy
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(EI) intake=energy expenditure (EE) under stable weight conditions 296. However,
EI:BMR=physical activity level (PAL) is used 294 in the absence of a measure of
actual EE,, where the energy requirements of individuals are dependent on
variations in basil metabolic rate (BMR) according to age, sex and body size and,
therefore, can be expressed as PAL to represent daily metabolic rate and, in turn,
can be compared to mean reported energy intake (EIrep : BMR) for the study
population. Assuming a sedentary lifestyle, agreement is dependent on a
calculation of the confidence limit below which energy intake is unlikely to be valid.
If mean activity level for the population is known, an upper limit can also be
determined. In Study 4, a lower limit only was used based on estimated activity
levels defined by the World Health Organisation 297. Alternatively, a direct
comparison between reported EIrep and estimated EE (EEest) can be made for each
individual. In Study 4 these were calculated using the Schofield Equation 298 and
again WHO defined activity levels 297.
Repeated measures
By obtaining data from each member in a sample more than once, the data can be
evaluated in terms of replicate readings at each time point and/or over time to
investigate the differences between groups at each time point 286. For assessment
of these differences, the use of the t-test has its limitations. Firstly, the more tests
there are, the more likely it is that two sets of data at any given time point will
produce a significant difference. This is especially relvant when there is more than
two groups and more than two time points. Secondly, small groups make it difficult
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to estimate the variance, or measurement error, on which such analyses depend
(Bland). Alternatively, the analysis of variance (ANOVA) compares the variation
between groups to the variation within the groups and uses all the data to estimate
the variance, and thereby provides a more powerful comparison between groups
and over time and was used for statistical assessments in this thesis.
Biomarkers
Due to a relationship between dietary fat composition and the fatty acid
composition of body tissues, individual fatty acids in body tissues can potentially be
used as markers for intakes of different types of dietary fat and dietary change 257.
However, the relationship can vary between individual fatty acids and for different
tissues 117 . The fatty acid composition of tissues such as serum lipids and
phospholipids in erythrocyte membranes reflect changes in dietary fat composition
during the preceding weeks 117 299-302 and is the most reliable and only readily
accessible lipid fraction available for biomarker analysis 257. The relationship
between long-chain essential fatty acids (EPA and DHA) in the diet and in tissues
is strong, whereas the relationship between SFA in the habitual diet and in tissues
is much weaker. As changes in intakes of individual fat types were the primary
outcome for studies conducted as part of this thesis, changes in PUFA
concentrations in blood samples were biomarkers of PUFA intake 257.
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Clinical markers
While clinical outcome variables are considered secondary for this research, they
are standard reference points for practice and in substantiation research, and this
type of data from the studies conducted as part of this thesis will contribute
considerable information for future studies focusing on these variables. Hence, an
important clinical outcome measure for T2DM patients is the effect of nutrition
intervention on relevant clinical indices. Due to associations between IR, body fat
accumulation, and blood glucose and lipid levels, changes in weight, body fat and
glucose tolerance were assessed as relevant markers of dietary change. For
example, the HbA1c tested a change in long-term blood glucose control while, BMI
due to its strong correlation with total body fat 257 was a useful assessment of
weight management. Blood lipid levels identified changes to dietary fat intake
related to the Metabolic Syndrome.
Ethical issues
Unique ethical issues arise relating to working with humans, including the
individual’s right to be fed, disruption of food/cultural traditions, and the impact of
the intervention on disease prevention 258. Volunteers must be fully informed of all
requirements of the research and of their rights to ask questions, complain or
discontinue at any time. Separate avenues of complaint must be provided. The
researcher and all members of the research team have a duty to protect the
privacy of all participants involved in their research. Every endeavour must be
taken to ensure that all participant information is treated with confidentiality.
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Specific permission must be sought from each participant for subsequent use of
this information. Results should be reported as group data or anonymously without
revealing the personal details of any individual. Confidentiality and privacy issues
relating to the publication of research findings or reporting in a public forum should
be adhered to and participants informed of the intent. Ensuring the research meets
specific regulations and standards is met by a system of ethical approval from
appropriate legal bodies/committees. The research reported in this thesis obtained
prior approval and followed all ethical guidelines and requirements by the Human
Research Ethics Committee of the University of Wollongong and Illawarra Area
Health Service of New South Wales.
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CHAPTER 4 PILOT STUDY LINKING FOOD PATTERNS WITH CLINICAL
OUTCOMES

A significant portion of this chapter has been published in the peer-reviewed article:
Gillen L, Tapsell LC, Martin GS, Daniels S, Knight S, Moses RG. The type and frequency of
consumption of carbohydrate-rich foods may play a role in the clinical expression of insulin
resistance during pregnancy. Nutr Diet 2002;59(2):135-143
LG was responsible for study design, data collection and assessment, preparation of the
manuscript and involved in critical discussions of study design and outcomes. LT was responsible
for critical discussions of study design, analyses and preparation of the manuscript. GM and SD
were involved in dietary assessment design and data collection. SK and RM were involved in
coordination of the study.

4.1 Introduction
For the purposes of this thesis, a pilot s tudy was conducted in order to assess the
significance of food patterns and relevance to known clinical outcomes in a clinic
sample of the treatment population. A cross sectional observational study
examined the food habits of a convenience sample of women with GDM, a group
with demonstrated glucose intolerance and at-risk of pregnancy complications and
T2DM and CVD in the longer term. While dietary studies have traditionally focused
on the impact of macronutrient variables on clinical outcomes, this study aimed to
examine habitual food patterns likely to influence glucose intolerance and hence
related outcomes. Based on clinical and research knowledge, data obtained from
this type of analysis would likely be informative and relevant to the practical
application of research knowledge for improvements in blood glucose-related
clinical outcomes.
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GDM, or glucose intolerance during pregnancy, has an incidence of 7.2% in the
Illawarra region of New South Wales 83. Associated adverse outcomes of GDM can
include assisted delivery, caesarian section and admission of the newborn to
special care 303, 304 . The risk of subsequent development of T2DM, in both mother
and child, is also greatly enhanced 305-307. Those most at risk tend to be older,
overweight, multiparous, have specific ethnic origins, a family history of diabetes 99,
308

and/or history of GDM

98

. However, even women with no identifiable risk factors

can display clinical symptoms of insulin resistance at an appreciable rate (3%) 99,
suggesting other factors may play a role.
An increased insulin resistance is characteristic of pregnancy and women become
glucose intolerant if they are unable to increase endogenous insulin secretion to
overcome this physiological resistance 80, 309, 310. Controlling blood glucose levels
may help preserve both optimal beta-cell function and maximise insulin sensitivity.
Hence, a diet that assists glycaemic control 311, 312 might be beneficial in
ameliorating the features of insulin resistance for all women during pregnancy.
While clinical trials have shown that managing the consumption of the type and
frequency of CHO-rich foods can benefit glycaemic control and reduce insulin
demand 225, 313, 314, few studies have assessed patterns of intake in the diets of
free-living pregnant women and those who develop GDM. We have previously
reported that women who develop a recurrence of GDM report higher fat intakes
than those who do not

152

,

but were unable to detect a significant difference in total

CHO intake. Large prospective studies have also been unable to detect a
relationship between total CHO intake and diabetes risk 147, 212, 315. This type of
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assessment however does not account for the glycaemic effect of CHO-rich foods
or the ability of foods to increase demands for insulin. Consequently, a qualitative
assessment of the consumption of both the type and frequency of CHO-rich foods
may uncover patterns of intake during pregnancy likely to play a role in the clinical
expression of insulin resistance.
In this study, we compared the patterns of consumption of CHO-rich foods reported
by a group of free-living women newly diagnosed with GDM and a group of healthy
glucose tolerant pregnant controls.
4.2 Methods
4.2.1 Participants and Study Design
All pregnant women attending the Prenatal Clinic at The Wollongong Hospital are
offered an oral glucose tolerance test (OGTT) at the beginning of the third trimester
of pregnancy to determine GDM status. Diagnosis is based on the
recommendations of the Australasian Diabetes In Pregnancy Society (ADIPS) 272.
It is conventional practice for any women diagnosed with GDM to be referred to the
Illawarra Area Health Service, Diabetes Centre for medical management. These
women are usually seen within two working days. Between August 1999 and
January 2000 a convenience sample of 16 pregnant women newly diagnosed with
GDM and 24 healthy pregnant controls (as determined by OGTT), and matched for
age and pre-pregnancy weight, were recruited on request on first attendance at the
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Diabetes Centre (prior to any dietary intervention) and at the Prenatal Clinic,
respectively.
All women were of similar gestational age (28-33 weeks). Data on age, prepregnancy weight, parity, and incidence of GDM in a previous pregnancy and
family history of diabetes (yes/no), were collected by self-report. Height and current
weight were measured at the time of interview. BMI (weight (kg)/ height (m2) was
calculated for both pre-pregnancy and current weight, while weight gain during
pregnancy was assessed as the difference between the two weights. The Human
Research Ethics Committee of the University of Wollongong and the Illawarra Area
Health Service provided ethical approval for this research.
Four dietitians administered an open-ended DH questionnaire developed
specifically for the study of diet in pregnant women screened for GDM in the
Wollongong area of the Illawarra region, Australia

279, 316

.

The women were asked

to describe their ‘usual’ intake (‘usual’ meaning for the previous two- to threemonth period). All women were asked if they had changed their ‘usual’ diet
(yes/no) on first becoming pregnant and/or over the period of the pregnancy and,
for those with GDM, since being diagnosed. Dietary data were entered into
FoodWorks Nutrition Software, (Version 2.03, 1999, Xyris Software, Qld, Australia)
for nutrient analysis. This software used the NUTTAB 95 Australian food
composition database 317.
Food intake data were analysed for energy and macronutrient composition,
expressed as kilojoules (kJ) and grams (g) respectively, and reported as means ±
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standard deviation (SD). CHO-rich foods were classified according to five broad
food groups: cereal/grains, fruits, vegetables, milk and sugar-rich foods, then
divided into 15 sub -groups in order to identify, more specifically, the food sources
of CHO intake (Table 4-1). For each subject, the total energy (kJ) and CHO (g)
provided by each food group and sub-group were calculated, and a mean intake
value was established. In addition, the frequency of cons umption of CHO-rich food
groups (defined as the number of times the food group was reported in a meal or
mid-meal regardless of serving size) was assessed.

Table 4-1 Carbohydrate-rich food groups and subgroups used for analysis of food intake patterns
Cereals/grains
Bakery goods

Fruits
Whole
(fresh/frozen/canned)

Vegetables
Total
(fresh/frozen/canned)

Biscuits

Juice

High carbohydrate

Breads

b

Low carbohydrate

a

Milk

Sugar-rich

Milk/Yoghurt

Foods

Other milk
products

Beverages

c

Breakfast
cereals
Pasta
Rice
a
Where carbohydrate content is > 50g/100g and sugar contributes > 50% of total carbohydrate
b
c
content, Where carbohydrate content is ≥ 10g/100g, Where carbohydrate cont ent is <10g/100g

A GI value was assigned to each food within the broad food groups, according to
published values 221. If the GI of a food was unknown and a suitably similar food
could not be substituted, the food was excluded from the analysis. Appendices A
and B outline food substitutions and exclusions, respectively.
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The assignment of GI values enabled foods to be classified into sub-groups
according to GI (high, intermediate or low), which were similarly assessed for
amount and frequency of consumption. An ‘average’ diet GI score for each
subject’s overall diet was also calculated, as follows:
Diet GI = Sum of GI value of individual foods X CHO content (g)
__________________________________________________
Total CHO content for the day – excluded CHO

318

Individual meal GI scores were obtained using the method described for mixed
meals 319. A glycaemic load score was obtained for overall diet and individual
meals from the sum of the [GI value of the individual foods X the CHO content] (g)
214

.

To control for total energy intake, all nutrients as well as the scores for diet GI

and glycaemic load, were expressed as percent energy (32) using the calculation
[mean nutrient intake (diet score) / energy intake] X 100.
Differences between the two study groups were assessed using independent twotailed t-tests and results expressed as means ± standard deviation (SD), with the
level of significance reported at P<0.05. Such comparisons were made for:
demographic data defining age, gestation, weight and weight gain; dietary data
comparing total intakes for energy (kJ), macronutrients and fatty acid sub-fractions
(percent energy), total intakes from CHO and CHO sub-fractions (g); energy (kJ)
and CHO (g) from the CHO-rich food groups and sub-groups, as well as the
frequency of consumption of these foods (a simple count of the number of times a
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food was reported); average diet GI and meal GI scores and GI load scores,
respectively.
4.3 Results
Characteristics of the GDM and control groups are presented in Table 4-2. No
significant differences were found between groups for matched variables (age and
pre-pregnancy weight), or for other measures of weight and weight gain during
pregnancy, or stage of gestation at the time of the survey. The GDM women,
however, were shorter and had a greater parity compared to women in the control
group (P<0.05). Data on incidence of previous GDM and family history of diabetes
were compared and not found to be different. Four of 16 women with GDM and
one of 24 control women had a previous pregnancy in which GDM was diagnosed,
while six women with GDM and three from the control group reported a family
history of diabetes. Fourteen of 16 women with GDM were born in Australia or the
UK, hence, ethnicity was not considered to influence the results of this dietary
study.
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Table 4-2 Maternal characteristics of women with GDM and healthy pregnant controls

Characteristics
Age (yrs)
Gestation (wks)
Parity
Pre pregnancy weight (kg)
2
Pre pregnancy BMI (kg/m )
Weight (kg)
2
BMI (kg/m )
Pregnancy weight gain (kg)
Height (cm)
a

a

GDM

Control

n=16
31.4±4.8
29.4±1.7
1.9±1.5
63.1±14.7
24.3±5.6
73.4±14.8
28.3±5.5
11.5±4.4
161.2±4.3

n=24
29.2±5.6
29.4±1.2
0.6±0.7*
67.0±18.5
24.2±5.5
76.6±9.9
27.4±2.5
10.6±5.2
167.8±6.0*

Mean ± standard deviation.

* P<0.05 by two tailed t-tests.

Similarly, no differences were found between groups for reported dietary change
during the current pregnancy. Eight of 16 women with GDM and 16 of 24 control
women reported a dietary change on first becoming pregnant, while 7 GDM women
and 16 controls reported a dietary change over the period of the pregnancy. For
the GDM group, seven of 16 women reported a dietary change since diagnosis (in
most cases 2-3 days prior to the survey). Only three GDM and two control women
reported no dietary change at all during the current pregnancy. The dietary intakes
of energy and CHO were not significantly different between the two groups (Table
4-3).
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Table 4-3 Mean total dietary intakes for GDM and control groups

GDM

a

Control

(n=16)

(n=24)

Total Energy (kJ)
8814.0±2888.7
Carbohydrate (g)
263.1±96.2
Carbohydrate (% E)
48.0±7.3
Protein (% E)
18.4±4.7
Fat (% E)
31.0±8.9
MUFA (% E)
10.6±3.0
PUFA (% E)
6.6±5.1
SFA (% E)
12.6±4.4
Fibre (g)
25.1±7.9
Sugar (g)
128.2±78.8
Starch (g)
128.6±37.9
a
Mean ± standard deviation.
b
determined by t-tests for differences between groups.
% E = percent energy.

a

10384.1±2344.2
309.0±71.3
48.0±6.8
17.4±2.2
32.5±7.2
10.7±2.3
5.1±2.2
14.4±4.8
25.2±8.2
162.1±53.6
141.5±34.9

P-value

b

0.07
0.09
1.00
0.39
0.55
0.86
0.17
0.24
0.97
0.11
0.28

The GDM group consumed smaller amounts of CHO (g) from pasta, fruit juice, and
milk products (P<0.05) (Fig 4-1). There was also a non-significant trend by the
GDM group to consume less (g) milk/yoghurt (P=0.09).
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Mean carbohydrate intake
(grams/day)

Fig 1 Mean carbohydrate intakes from carbohydrate-rich
foods by GDM and control groupsa
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no differences were observed from further sub-divisions of these food groups.
* P<0.05 two-tailed t-test.
b

Figure 4-1 Mean carbohydrate intakes from carbohydrate-rich foods by GDM and control groups

The GDM group reported a lower frequency of consumption from high CHO
vegetables or foods and beverages from the sugar-rich group (P<0.05), despite
similar intakes in terms of total kJ and CHO (g) from these foods. A trend for less
frequent intakes was also demonstrated for the cereal/grains group (P=0.06).
The GDM group of women consumed significantly less total energy and CHO from
low GI foods, expressed in terms of kilojoules (2450.8±1255.9 kJ GDM vs
3592.0±1645.3 kJ control) (P=0.02) and CHO grams (P=0.01) (Fig 4-2). This
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observation was made also for dinner meals, (530.0±501.7 kJ GDM vs
920.0±564.6 kJ control) (P<0.05) and (15.9±14.8 g GDM vs 28.8±18.5 g control)
(P<0.05). The GDM women also reported consuming less low GI cereal/grains,
again, both in terms of kilojoules (2413.4±1322.8kJ GDM vs 3625.0±1717.0kJ
control) (P<0.05) and CHO grams (79.1±39.5g GDM vs 117.1±55.2g control)
(P<0.05).

Fig 2 Mean carbohydrate intake from foods of known GI
values by GDM and control groupsa
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Values are mean ± standard deviation. * P<0.05 two-tailed t-test.

Figure 4-2 Mean carbohydrate intakes from foods of known GI values by GDM and control groups

No differences were found for energy or CHO intakes from high or intermediate GI
foods, however, these foods were reported less frequently by the GDM women
over an average day (high GI foods: 5.9±2.4 GDM vs 8.3±4.1 control) (P<0.05);

140
(intermediate GI foods: 15.6±6.2 GDM vs 19.5±5.3 control) (P<0.05). In particular,
high GI vegetables were reported less often by the GDM group (2.9±1.5 GDM vs
4.7±2.9 control) (P<0.05).
The mean diet GI for each group was not significantly different (58.3±4.4 GDM vs
56.7±4.3 control). However, when adjusted for total energy intake the GDM group
had a significantly higher diet GI score than the control group (74.8±31.8 GDM vs
57.6±16.3 control) (P<0.05). No differences were found when comparing mean
glycaemic load scores (14130.5±6018.8 GDM vs 16234.8.1±4027.2 control) nor
when expressed as %E (159.5±24.0 GDM vs 157.9±26.1 control). The mean
dinner meals GI score for the GDM group was significantly higher than for the
control group (65.6±6.6 GDM vs 59.2±8.0 control) (P=0.01). Furthermore, the
average standard deviation across all meal GI scores was higher for the GDM
group (14.3 GDM vs 9.3 control), indicating greater variation in GI scores for meals
across the day, although no further differences for meal comparisons of GI were
found. Similar comparisons for meal glycaemic load scores were not significantly
different between the two groups.
Foods of unknown GI, excluded from the analyses, made up ≤ 10% of the CHO
intake for 15 of 16 women with GDM and 23 of 24 control women, with no
significant differences between the two groups for the amount of food excluded as
a percentage of either total energy (kJ) or total CHO (g).
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CONCLUSION

4.4

Summary

The limited evidence-base for dietary intervention in the management of GDM
comes from clinical trials using individual foods and set meals to modify blood
glucose levels 223, 320, 321. Far fewer studies have reported on the food choice
patterns of pregnant women under ‘free living’ conditions. In particular, the diets of
women with GDM are very much underreported 310. Those who have examined
populations at risk of diabetes have focused mainly on macronutrient intakes and
‘suspect’ foods and have failed to identify dietary differences that warrant specific
recommendations 152, 213, 322.
In this study differences were found in the pattern of CHO intake reported by
women diagnosed with GDM compared with glucose tolerant pregnant controls. By
controlling for other risk factors related to GDM (age and pre pregnancy weight),
and recruiting at similar stages of gestation, few significant non-dietary differences
were found between the two groups, except the GDM women were shorter and
had greater parity (P<0.05), two aspects found previously for GDM women 323.
While significant differences in energy and macronutrient intakes were not found in
this sample, the trend by the GDM group to consume less energy and CHO is a
phenomenon observed for other diabetic populations 152, 213 . Whether lower intakes
reflect actual dietary changes or recall bias in response to diagnosis is uncertain

142
and may represent a limitation of the study. The types of foods restricted by the
GDM group however were not those normally associated with underreporting

268

.

In this study, the GDM group reported consuming less CHO from low GI
cereal/grain foods, in particular pasta, and from fruit juice and milk groups. While
none of these foods have a high GI value, it could be speculated that these women
perceived these foods as worthy of restriction. Although we did not assess this, all
but three of the women in this group reported some type of dietary change during
the current pregnancy and, while the GDM women had not yet received any
specific dietary advice for diabetes management of the current pregnancy, four of
the 16 had a prior GDM pregnancy and may have been exposed to previous
dietary advice. Similarly, high CHO (starchy) vegetables were consumed less
frequently throughout the day by the GDM group, suggesting these women were
trying to limit their intakes of these foods. Hence, the food choice patterns
described diverge from those recommended for pregnant women, a nutritionally atrisk group with additional requirements for the nutrients contained in these food
groups, for example vitamin C and calcium from juice and milk, respectively.
Additionally, although the total amount consumed from foods with higher GI values
were similar for both groups, the GDM group reported selecting them on fewer
occasions during the day (P<0.05). Again, these behaviours are contrary to current
diabetes management strategies that focus on smaller portions and more frequent
intakes over the day.
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The patterns reported by the GDM women contributed to a significantly higher
average diet GI score, expressed as a percentage of total energy intakes, when
compared to the control group (P<0.05). The GDM group also reported significantly
lower intakes of low GI foods at dinner and subsequently higher GI meal scores for
that meal (P<0.05).
Even modest reductions in GI scores, within the range of values found in a freeliving diabetes population, have been shown to improve blood glucose control 281,
324

. Similarly, foods with comparatively higher GI values, consumed more regularly

over the day, have been shown to modify blood glucose levels by spreading the GI
load 212, 315. The lack of any significant difference in our study between the two
groups for total GI load scores further suggests partitioning the load may be more
important for controlling blood glucose levels than the load per se, although this
was not apparent from differences in meal glycaemic load scores. It should be
noted however that unless fluctuations in meal GI and load scores for each person
in the group coincide for different meal-times, mean representations may be unable
to detect any significant differences between groups. Arranging individual meal
scores from lowest to highest regardless of time frame may prove more
informative. Despite this, the evening meal, possibly the main meal of the day, was
significantly different for meal GI scores between the two study groups, and may
have been the only meal with consistent enough intakes between individuals to
detect a significant difference. How these meal scores impact on other meals such
as breakfast the next day is uncertain, but clinical evidence suggests an effect for
glucose and insulin responses to later meals 325, 326.
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4.5 Theoretical significance
Women who develop GDM fail to overcome insulin resistance in pregnancy due to
a variety of factors, the most alterable of which may be diet. Clinical trials using low
GI CHO-rich foods and increased frequency of intake to modify blood glucose
levels have shown the greatest potential benefit 223, 225, 313. This small crosssectional survey of the food habits of free-living pregnant women has identified
patterns of intake from CHO-rich foods that support this view. Compared to
glucose tolerant pregnant controls, women with GDM reported less CHO-rich foods
with low GI values, in particular, pasta, fruit juice and milk products, and a reduced
spread of consumption of foods with higher GI values. While both groups reported
dietary changes in response to pregnancy, reference to previous research
suggests the patterns of intake reported by the GDM group are likely to impact on
glucose tolerance.
4.6 Limitations and areas for further research
This study has focused on food patterns as a means for understanding dietary
relationships in GDM. Analyses of food choice patterns are less dependent on the
inadequacies of nutrient databases and allow the diet to be described in a manner
that is useful outside the research setting

327

. A limitation is that it is sensitive to the

way food consumption data are categorized 269. Accordingly, several criteria were
used to define food groups and identify patterns of intake. Food source and GI
identify foods of similar components and metabolic effect 214, 281, and are
considered valid criteria for statistical assessment 281.Possible bias due to
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underreporting, however, has been overcome by organizing foods into groups
based on a more rounded estimate (high, intermediate and low GI), eliminating
some of the error between individual responses and exact GI values 282, 283.
Appropriateness of the methodology too can reduce the degree of error for
estimating dietary intakes 328, 329 . The pattern of intake is dependent on the way
consumption is reported and, a meal-based DH that requires a sequential re-telling
of regular intakes, is sensitive to the daily spread of individual foods and food
groups
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. The modified version used for this study was validated in a local

diabetes population and is considered sufficiently valid and reliable for use in
studies of pregnant women in the Wollongong area 279. While a DH taken prior to
diagnosis and the exclusion of women with risk factors for diabetes during the
current pregnancy may have avoided the possible introduction of dietary and other
forms of bias, the omission of data obtained from women with a previous GDM
pregnancy did not significantly alter our results. Nonetheless, the results do
indicate that a qualitative assessment of the patterns of CHO intakes of a
convenience sample of women with and without GDM can uncover dietary
differences not readily identifiable using traditional macronutrient comparisons.
A larger prospective dietary intervention study is requir ed to confirm the role of
food patterns in the dietary management of GDM and to further assess the impact
of food patterns on the clinical expression of insulin resistance during pregnancy.
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4.7 Relevance to thesis and implications for practice
The results from this study of the food habits of glucose intolerant and normal
glucose tolerant pregnant women suggest qualitative differences in food choice
patterns that have the potential to provide physiological benefits during pregnancy.
While both groups reported dietary change during the course of the current
pregnancy, different perceptions about the relationship between diet, health and
disease, as well as previous exposure to dietary advice may account for dietary
differences between the two groups. While one might expect previous exposure to
dietary advice to result in beneficial patterns of intake, traditional ‘negative’ nutrition
messages can translate into food restrictions that impact on food variety and
frequency of consumption. Nutritional and metabolic susceptibility to disease has
been previously noted

327, 330

, and may therefore be an important consequence of

dietary change and has implications for the dietary management of pregnant
women who have an increased susceptibility to glucose intolerance at this time.
For this thesis, the pilot study results demonstrated the importance of food pattern
analyses for assessing aspects of the diet -disease relationship by providing dietary
information not obtainable using a nutrient-based approach. In this way, the
relevance of food patterns to the dietetic process, to inform practice and on which
to base advice was confirmed. In terms of advice for diabetes, this study
recognized the role of CHO in the diet and justified attention to this nutrient in
advice approaches using frequency of intake and different aspects of the food form
to influence glycaemic control.
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CHAPTER 5 DEVELOPING FOOD PATT ERNS TO GUIDE ADVICE TO
ACHIEVE MACRONUTRIENT TARGETS

A significant portion of this chapter has been reviewed for publication in the Journal
of Nutrition and Dietetics and revisions have been resubmitted to the Editorial
Board:
Gillen LJ, Tapsell LC. The development of food groupings to guide dietary advice for people with
diabetes. Nutr Diet: In review
LG was responsible for the implementation of study design, data collection and analyses, involved
in critical discussions of study design, analyses and study outcomes as well as preparation of the
manuscript. LT was responsible for critical discussions relating to study design, analyses and
preparation of the manuscript.

5.1 Introduction
A theoretical study was conducted to develop and statistically test a food advice
framework for the achievement of nut rient targets in an intervention trial. With
diabetes as the example, nutrient targets were macronutrients and fat types as
proportions of total energy intake. Developing a set of food groups and specific
intake pattern provided an outline and a methodology of the processes involved in
dietetic practice for the conversion of the theory on nutrients into practical advice
on foods.
Diet is often quoted as the cornerstone of treatment for diabetes, and there is
considerable evidence that advice targeting specific dietary change offers
substantial benefit 20, 21, 190, 331, 332. Current guidelines for the treatment of diabetes
and related complications provide nutrient intake recommendations, the most
specific of which target the proportions of different types of fat in the diet 8 . Where

148
dietary advice necessarily refers to foods, the system of advice generation,
however, needs to assure that nutrient targets can be met.
A number of food guidance systems are available with varying purposes. For
example, the carbohydrate counting system in diabetes management 333 focuses
on the distribution of carbohydrate-rich foods throughout meals to support
glycaemic control. General food guidance systems, such as the Australian Guide to
Healthy Eating (AGHE) 13 and the Food Guide Pyramid 14 , outline the number of
servings from core food groups required to meet nutritional requirements for the
general population. Exchange lists published by the American Dietetic Association
(ADA) 15 take a total diet approach, where ‘all foods can fit into a healthful eating
style’ 334, and provide some information on the type of fat contained in foods 335.
While certain food groups are generally recognised for contributing a particular
type of fat, for example meat and dairy for providing saturated fat, none of the
current guidance systems pr ovide adequate reference to food sources high in
monounsaturated or polyunsaturated fats. Hence, general low-fat advice strategies
based on these systems do not necessarily address specific relative amounts of
the different types of dietary fat 22 . While it is acknowledged that individualising
advice is fundamental to the treatment of diabetes, a structured food-based advice
strategy to guide the achievement of appropriate targets for each type of fat is also
required. This must satisfy both recommended and practical evaluations in order to
determine whether the resultant intake pattern does indeed achieve the nutrients
targeted.
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The aim of this paper, therefore, is to describe the development and characteristics
of a food categorisation system for the treatment of diabetes, resulting in a set of
food groups inclusive of the type of fat (vegetables, starch, fruits, milk/soymilk,
meat/oily fish/soybeans, and fat-MUFA/PUFA) and its application in terms of a
reference intake pattern to guide advice to meet energy and nutrient targets with
minimal potential variation.
5.2 Methods
5.2.1 Study design and theoretical evaluation
The process for the systematic development and evaluation of a specific food
group intake pattern to guide advice for the achievement of overall energy and
nutrient targets is summarised in Fig. 5-1 and outlined in detail below:

150

Foods consumed by treatment population
25% excluded
Foods providing 75% total macronutrient intake

Foods grouped by main macronutrient
content
Foods sub-grouped by secondary macronutrients including
fatty acid composition

Portion sizes manipulated to minimise variation

SD, range, CV and variance for
energy and macronutrient values of
food groups calculated
Food groups compared to
existing core food groups

Nutritional
adequacy
assessed
Food group pattern for 8000kJ/day to
meet specific macronutrient and fatty
acid targets

Variation in total energy and macronutrient
intakes estimated

Capacity of food pattern to guide advice to
meet energy and nutrient targets with
minimal variation established
Figure 5-1 The systematic development and evaluation of a good group pattern to guide advice to
ensure energy and nutrient target s

151
Development of food groups as sources of macronutrients and fat types
Identification of foods to include in the food groups
Foods to be included in a set of food groups for the achievement of specific
nutrient targets were identified from foods commonly consumed by 16 women with
gestational diabetes mellitus (GDM) from Wollongong, Australia. Characteristics of
the study sample have been previously described

336

. Individual foods reported in a

diet history 337 by each woman were analysed for energy and macronutrient
content using the nutrient analysis software program FoodWorks (Version 2.1,
2000, Xyris software, Brisbane, Australia) incorporating nutrient tables for use in
Australia (AUSNUT, Canberra, 2000). Mixed dishes and prepared foods were
analysed using individual ingredients where possible. Using pooled data, the
percentage contribution of common food groupings, such as cereal, meat, and
cheese, to total macronutrient consumption for carbohydrate, protein and fat was
determined. The groupings were then rank ordered under these macronutrient
variables to determine major food sources of each (Table 5-1). Food groupings
contributing to approximately 75% of total intake for each macronutrient were taken
as representative of foods commonly consumed by the study sample.
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Table 5-1 Rank order of the percentage (%) contribution of common food groupings to
approximately 75% of macronutrient content of the diets of 16 women with GDM
Food
Groupings

Protein
% total intake

Meat
Cereals/bread
Milk/yogurt
Fish
Vege/legumes

23.8
21.1
14.9
7.4
6.6

Total intake:

73.8

Food
Groupings
Cereals/bread
Fruit
Sugar-rich

Carbohydrate
% total intake
42.1
16.9
12.7

Food
Groupings
Oil/margarine
Meat
Cereals/bread
Milk/yogurt
Cheese
Fast food
Nuts

71.7

Fat
% total intake
18.0
11.7
11.3
11.1
9.9
7.8
4.5
74.3

Categorisation of the included foods base on macronutrient composition
Individual foods belonging to the common food groupings were then categorised by
the relative proportions of all macronutrients contained in a single serving. Thus,
with reference to existing standards 13, 14, mean energy (kJ) and macronutrient
content (grams) per serving were derived. Each macronutrient was considered in
turn, commencing with the main macronutrient (carbohydrate, protein or fat). A
fourth category accommodated foods which did not have the levels of
macronutrients identified in the other three lists, mainly vegetables, but never-theless needed to be included in terms of total energy and micronutrient intakes. Subcategories were developed based on secondary macronutrient compositions. For
example, in the case of fat content, the need to identify the type of fat required
SFA-rich versus PUFA-rich sub-categories in the milk and meat groups, but not
MUFA-rich as this type of fat largely mirrored SFA content. Fast foods, such as
ham/cheese burgers and fried chicken, had similar fat profiles to that of SFA-rich
high-fat meat and cheese and, therefore, were included in that group. Similarly, fat-
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rich foods (oils, spreads and nuts) were categorised as PUFA-rich or MUFA-rich,
according to the main type of fat they contained. This process would also have
necessitated a SFA-rich sub-category within the fat-rich group except the study
sample was already limiting fat-rich food sources of this type of fat, for example
butter.
To minimise variation between individual foods within each food group, the
following steps were followed:
i)

A reference food was identified within each main macronutrient category.
For example, bread was taken as the staple food for carbohydrate.

ii)

Portion sizes for individual foods in each list were modified to produce a
gram amount for the main macronutrient close to that of a standard serving
of the staple food. Thus, portion sizes for foods listed under carbohydrate
were modified to more closely match the 15 grams of carbohydrate taken for
one slice of bread.

iii)

Sub-categories were based on secondary macronutrients and also on other
nutritive components such as the presence of starch and sugar.

Thus, a set of reference food groups representing the mean macronutrient content
of common foods was determined (Fig 5-2).
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Figure 5-2 Categorisation of individual food portions based on equivalent macronutrient and fat compositions
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Estimation of food group variation
All foods contributing to a single food group were analysed to determine mean
nutrient content, range, and coefficient of variation (CV = SD/mean x 100) set at
<15% for the main macronutrient. Reference to existing methodologies was
required in order to assess the acceptability of expected variation. Thus, the SD
and range results were compared to those reported for the 1995 ADA Exchange
Lists for Meal Planning, the only other set of exchange lists to provide specific data
on within-list variations from mean nutrient estimates 17 .
Comparison with core food groups
In order to establish whether general nutritional adequacy might be achieved from
an intake pattern based on the reference food groups, they were compared with
core food guide classifications outlined in AGHE and Food Guide Pyramid 13, 14.
Additionally, food groups that did not meet nutrient density criteria consistent with
ADA guidelines, that is, foods with high (saturated) fat or sugar (sucrose) content,
were identified as ‘foods to limit’ and excluded from the final set of food groups for
which intake levels were set.
Determination of a recommended food group intake pattern
Construction of a food group intake pattern to meet nutrient targets
Mean amounts for the energy and macronutrient content from each of the food
groups were rounded-off to the nearest whole number, with the following
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exceptions: the protein content of one serving of milk was rounded down to 10g
instead of up to 11g due to a greater number of individual food items containing
nearer to that amount; the fat content of medium-fat meat was rounded down to 5g
rather than up to 6g in order to be consistent with the sum of available data for
individual fat types; finally, the small CHO content of soybeans and nuts was
ignored to enable a better representation of more common foods listed in these
groups, such as fish, and oils/spreads, respectively.
In this way, a simplified nutrient composition table in a 'ready reckoner' format was
produced. A total diet pattern was constructed from a defined number of servings
from selected reference food groups using corresponding ready reckoner
estimates to produce specific targets for total energy and macronutrient intakes.
Based on the average requirement for moderately active, weight stable adults, the
target for energy was around 8,000 kJ/day 338, 339. Core food recommendations
were adhered to by aligning the number of servings from the reference food groups
with minimum daily requirements from core food guide classifications 13, 14.
Nutrition principles for diabetes management

8

were also considered in order to

enable advice on portion control, CHO -counting, and identification of the type of
CHO (wholegrain, high fibre, low GI). Macronutrient goals corresponded to low fat
intakes and current diabetes recommendations 8 : approximately 30% energy as
total fat (<10% saturated (SFA) and ~10% total polyunsaturated (PUFA) fat) and
around 20% protein, leaving 50% energy as carbohydrate. Atwater Factors were
used to convert percentage of energy to grams of macronutrients 340 . Steps in the
determination of the recommended food group pattern are outlined below:
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(i)

Foods from the carbohydrate group were included in the diet first, where

50% of energy translated to around 250g carbohydrate, or 15 exchanges of foods
delivering 15g carbohydrate per exchange [allowing for some carbohydrate from
vegetables]. Ready reckoner estimates for the protein and fat content of these
foods were also calculated at this stage.
Protein targets were next addressed by referring to the recommended amount from
cooked meat or meat equivalent 13 , with an average amount from all sources
achieving, 5oz [150g]. Protein means were added to those obtained from
carbohydrate-rich foods, established in (i).
(iii)

Targets for different types of fat were lastly addressed, mainly through the

inclusion of foods that deliver PUFA, since SFA from carbohydrate and protein
foods was already found to be adequate from the inclusion of lean and low fat
groups in steps (i) and (ii).
Total kJ and grams of macronutrients from the overall intake pattern were
calculated and compared to targets.
Matching dietary advice to the recommended food group intake pattern
Using this framework, dietary advice would refer to a specific number of servings
per day from each of the reference food groups defining the recommended food
pattern. The advice would be appropriate for diabetes, allowing individualised food
choices and the type and distribution of carbohydrate-rich foods and meals
throughout the day.
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Nutritional adequacy of the food group intake pattern
Overall nutritional adequacy was assessed qualitatively by comparing the number
of servings from across the food group intake pattern with core food requirements
for adults 13, 14 . A random selection of food items to represent each of the food
groups in the recommended pattern and in the amounts specified was compared
with >75% of intakes recommended

339, 341

for energy, protein and vitamins A, C, E,

folate, and minerals, iron, calcium, magnesium and zinc. Selection of a ‘random’
food item was achieved when an individual blinded to the food database chose a
number between zero and the number of foods contained in the corresponding
food list, inclusively. When foods from that list were arranged in reverse order, the
food corresponding to the number chosen became the representative food. This
process was repeated independently for each food group.
Comparison with unrounded estimates of dietary intake
The effect of using rounded estimates for calculations of total dietary intakes
needed to be assessed. Based on the food group intake pattern developed for
8,000kJ, total estimates for energy, CHO, protein, fat, and each fat type were
calculated from ‘rounded’ ready reckoner estimates and from the original
unrounded means, and the differences compared.
Variation due to individual food choices
The variation in intakes for total energy and macronutrients that might be expected
from food choices within the restraints of the food group intake pattern was also
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assessed. This was achieved by taking the sum of variances from each food group
for CHO, protein, fat and each fat type, respectively. The square root of the sum of
variances provided a total standard deviation (SD) for each macronutrient variable
and, in turn, a SD for total energy intake. In this way, energy and macronutrient
distributions from all possible food combinations to meet the prescribed pattern of
intake were determined.
The steps undertaken to achieve the assessments of the effects of rounding and
variation due to individual food choices are outlined below:
(i)

A total mean estimate in grams for each macronutrient and fat type in the

overall food pattern was determined from the sum of the original means for each of
the included food groups
(ii)

The SD of each estimate determined in (i) was calculated using the formula:

SD[total grams] = v(x1 SD21 + x2 SD22 + x3 SD23 + … + xn SD2n)
Where,

SD = standard deviation

x1 = number of serves from food group 1
SD21 = variance for the total mean (grams) from food group 1
(iii)

The total grams ±SD determined in (i) and (ii), respectively, for each

macronutrient variable were converted to energy (kJ) using Atwater Factors.
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(iv)

The resultant energy±SD for total carbohydrate, protein and fat determined

in (iii) were summed to give total energy and SD for the overall diet.
The co-efficient of variation (CV) for each macronutrient variable and total energy
were calculated from mean total energy±SD determined in (iv). CV<15% was the
arbitrary estimate set for reasonable variation for intakes of total energy and each
macronutrient and fat type from the food group intake pattern..
5.3 Results
Development of food groups as sources of macronutrients and fat types
Identification of foods to include in the food groups
Major food groups commonly consumed by the study sample were rank ordered to
reveal 24% of protein intake came from meat, 42% of carbohydrate came from
cereal-based foods, and 18% of fat from oils and margarines. Cereal-based foods
also made major contributions to the protein (21%) and fat (11%) fractions of the
diet, while milk and yog hurt made secondary contributions to both protein (15%)
and fat (11%). Combining milk, yoghurt, meat and cheese provided most of the fat
intake - predominantly saturated fat.
Categorisation of the included foods based on macronutrient composition
Three hundred and forty eight common food items composing approximately 75%
of the total macronutrient content of the diets of the study sample were categorised
according to macronutrient composition to form nine sub-categories and 13 final
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food groups outlined in Fig.5-1. Corresponding mean estimates for energy and
macronutrient content of individual food portions are provided in Table 5-2.
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Table 5-2 Mean±SD and range for estimates of the main macronutrient content of food groups based on macronutrient composition

Macronutrient
Food List

Carbohydrate (g)
No.

Vegetables
33
½ cup cooked/1 cup raw
Starchy foods
89
1 slice/ ½ cup
Fruit
38
1 piece
Table sugar
1
1 tspn/5g
Milk (low/reduced fat)
12
1 cup
Milk (full fat)
5
1 cup
Soymilk (full fat)
1
1 ¼ cup
Meat(lean/low fat)
68
30g/1 oz
Meat (medium fat)
30
30g/1oz
Meat (high fat)
24
30g/1oz
Oily fish, soybeans
6
30g/1oz
MUFA-rich
24
1 tspn/5g
PUFA-rich
17
1 tspn/5 grams
17 a
ADA published values : 0-4.7;

b

a

Protein (g)

Mean

SD

Range

2.3

±1.1

0-4

14.9

±1.8

11-19

15.2

±1.4

5.0

a

Fat (g)
a

Mean

SD

Range

Mean

SD

Range

1.9

±0.9

1-4

0.0

±0.0

0-0

c

3.1

±1.5

1-10

0.8

±0.7

0-2

13-18

d

1.2

±0.8

0-3

0.1

±0.3

0-1

±0.0

0-0

0.0

±0.0

0-0

0.0

±0.0

0-0

14.6

±1.6

12-17

10.8

±0.9

10-12

1.9

±1.9

0-4

15.2

±0.8

14-16

11.8

±1.9

10-15

11.4

±0.6

11-12

15.0

±0.0

15-15

11.0

±0.0

11-11

12.0

±0.0

12-12

0.1

±0.4

0-2

7.2

±0.7

6-8

1.8

±1.1

0-4

0.4

±0.8

0-3

7.2

±0.8

5.7

±0.8

5-7

0.5

±1.0

0-3

7.0

±0.8

6-8

9.3

±1.3

8-12

0.5

±0.8

0-2

7.2

±0.4

7-8

3.5

±0.6

3-4

0.5

±0.6

0-2

0.4

±0.9

0-2

5.2

±0.5

5-6

0.2

±0.5

0-2

0.2

±0.4

0-1

5.1

±0.3

5-6

c

1-14; 11-23;

d

b

e

e

f

g

h

i

11-20; 11-17; 5-9; 5-11; 3-5; 3-6

f

g

6-9

h

i
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Estimation of food group variation
For each of the 13 food groups, within-list variation was low: CV<15% for primary
macronutrients (data not shown); and SD <2g, although the number of foods listed
varied from 1 to 89 (Table 5-2). The vegetables group was the exception to this
with greater variation, but with very low macronutrient content. Therefore, serving
size modification aimed at reducing the variation for energy (CV<15%) (data not
shown) as the main dietary variable for this food group rather than macronutrient
content. Standard deviation and range for individual foods within each list
compared well with those reported in the literature 17, the results demonstrating in
most cases a narrower data set. Therefore, mean estimates for each of the
reference food groups were considered representative of the energy and
macronutrient content of individual food items listed within each group.
Comparison with core food groups
Food guides 13, 14 generally refer to five core food classifications (bread/cereals,
vegetables, fruit, milk, meat and equivalents) outlined in Table 5-3. In addition, the
AGHE refers to a broad variety of extra ‘foods to limit’. In contrast, our
categorisation process derived 13 food groups, 10 of which were determined to be
appropriate for the nutritional management of diabetes. Hence, foods listed in the
reference food groups identifying table sugar/sugar -rich foods, full-fat milk and
high-fat meat/fast foods represent more specific ‘foods to limit’. Further, differences
between our food groups and the guides were: the inclusion of CHO-rich starchy
vegetables with cereal-based starches such as bread rather than with other
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vegetables with low CHO content; cheese listed as a protein-rich food with meat
rather than with milk and these groups sub-categorised to address differences in
the amount and type of fat they contain; and finally, the inclusion of high-fat foods
such as oils, spreads and nuts; again with sub-groups for proportional differences
in the type of fat. Although more discriminating between foods, our final set of food
groups were consistent with core food guide classifications in that a minimum
number of servings across the overall pattern of food group intake would ensure
adequate nutrition.
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Table 5-3 Comparison of existing food guidance systems and macronutrient-based reference food
groups used to construct a pattern of intake to guide advice for diabetes treatment
Core Food
a,b
Guide
Classification

Average
Serve size

USDA

a

Serves/day

AGHE

b

Serves/day

Reference
c
Diet Model
Serves/day

4-8

5

Macronutrient-based
Reference
Food Groups

All vegetables,
legumes

½ cup
cooked

3-5

VEGETABLES

Bread, cereals,
rice, pasta,
noodles

1 slice
½ cup

6-11

All fruit

1 medium

2-4

2-4

4

FRUIT

Milk, yogurt,
cheese

1 cup

2-3

2-4

2

MILK (low/reduced fat)

Excludes potatoes, corn, legumes

8-14

9

STARCH
Plus potatoes, corn, legumes
(not soybeans)

Excludes cheese

d

SOY MILK (full-fat)
Meat, fish,
poultry, eggs,
nuts, legumes/
dry beans

'extra foods '
including
margarine, oils,
sweets,
biscuits, snack
foods & alcohol

Cooked
meat
equivalent
a
2-3oz
b
65-100g
c
30g(1oz)
a

Limited
b
145kcal
c
1tsp fat
c
10g nuts

2-3

1-1.5

5

Excludes oily fish, nuts, legumes
Includes cheese

(medium fat)
Includes eggs and cheese

OILY FISH/SOY BEANS d
Limit

0-3

MUFA
3

14

Includes oils, spreads, nuts

PUFA
5
Limit

a

MEAT (lean/low fat)

Food Guide Pyramid
13
Australian Guide to Healthy Eating
c
Pattern of intake developed from Reference Food Groups to provide approximately 8000kJ
d
High in PUFA
e
High in MUFA
b

d

Includes oils, spreads, nuts

- sugar-rich foods
- milk/yogurt(full fat)
- meat/fast food
(high fat)

e
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Determination of a recommended food group intake pattern
Construction of a food group intake pattern to meet nutrient targets
Rounded mean estimates corresponding to each list of foods provided a “ready
reckoner” of energy and macronutrient compositions for the final set of food groups
(Table 5-4). Subsequent food group assemblage using ‘rounded’ ready reckoner
estimates achieved an intake pattern corresponding to that defined in Table 5-3.
Therefore, in theory the prescribed food group pattern achieved the nutrient
proportions targeted (provided in brackets): 8290kJ (8000kJ), 67g total fat 30%E
(30%E), 15g SFA 7%E (<10%E), 22g PUF A 10%E (10%E), 106g protein 22%E
(20%E) and 235g carbohydrate 46%E (50%E).
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Table 5-4 ‘Ready Reckoner’ format for energy and macronutrient content of food groups

FOOD CATEGORIES

Serving

CHO

PTN

FAT

MUFA

PUFA

Size

Gram

Gram

gram

kJ

gram

gram

VEGETABLES

½ cup

2

2

0

80

(20)

0

0

0

Carbohydrate
STARCH
Bread, Cereals,
Vegetables, Legumes

1 slice/
½ cup

15

3

1

335

(80)

0

0

0

FRUIT

1 piece

15

1

0

285

(70)

0

0

0

1 cup

15

10

2

500

(120)

1

1

0

1 ¼ cup

15

10

12

845

(200)

1

3

7

30g (1oz)

0

7

2

195

(45)

1

1

0

30g (1oz)

0

7

5

335

(80)

3

2

0

OILY FISH/SOYBEANS 30g (1oz)

0

7

4

260

(60)

1

1

2

Fat
MUFA
Oils/Spreads/Nuts
PUFA
Oils/Spreads/Nuts

5g (1tsp)

0

0

5

200

(50)

1

3

1

5g (1tsp)

0

0

5

200

(50)

1

1

3

MILK
Low/reduced fat
Milk, yogurt
SOY MILK (full-fat)
Protein
MEAT
Lean/low fat
Meat, Fish, Cheese
Medium fat
Meat, Cheese, Egg

Energy

SFA

(kcal) gram

Matching dietary advice to the recommended food group intake pattern
Food-based advice was constructed in terms of the required number of daily
servings from each of the reference food groups included in the recommended
intake pattern (Table 5-3). Foods of low glycaemic effect corresponded well to
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existing food groups such as fruit and milk, with more discriminating advice largely
confined to the starch group, which could be sub-categorized to identify
wholegrain, high fibre and/or low GI individual food choices. In terms of CHO
distribution, advice would refer to equivalent serving sizes from within the starch,
fruit and milk groups.
Nutritional adequacy of the food group intake pattern
The recommended intake pattern was at least equivalent to the minimum number
of servings outlined in core food guides 13, 14(Table 5-3). A random selection of food
items to represent the food groups in the recommended intake pattern provided at
least 75% of amounts recommended 339, 341 for other major nutrients outlined in the
Methods section (data not shown).
Comparison with unrounded estimates of dietary intake
Calculation of the same 8,000kJ food pattern using original mean estimates
(provided in Table 5-2) for each of the included food groups resulted in small
differences in total energy and macronutrient intakes compared to those achieved
using ready reckoner estimates (presented in 2.1 and in brackets here):
7980.9+365.5kJ (8290kJ), 65.0+4.1g (67g) total fat, (13.4+2.9g (15g) SFA,
21.6+2.6g (22g) PUFA), 102.5+5.8g (106g) protein and 239.6+7.2 (235g)
carbohydrate. The effect of rounding, therefore, was considered minimal and
justified the use of simplified estimates for ease in the development of a prescribed
dietary intake.
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Variation due to individual food choices
Estimates of variation from all possible food combinations suggest individual
choices to match the model would be reasonably close to dietary targets,
particularly for total energy intake (SD±365.5kJ/87.4kcal). The coefficient of
variation for each macronutrient variable (CHO=3.0%, protein=5.7%, fat=6.3%, and
for individual fat fat types was MUFA=10.7%, PUFA=12.0%, and total energy=5%)
was considered clinically acceptable. Greater variation was determined for SFA
(CV=21.7%).
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CONCLUSION

5.4

Summary

There are many contexts in which dietary advice needs to be formulated. In both
the clinical context and in nutrition research methods need to be clearly defined so
there is some assurance of nutritional goals. Food groups based on exchange lists
of foods support this process by enabling s elections from a range of foods to meet
both energy and nutrient requirements . Published exchange lists, however, have
demonstrated some large within-list variations 17 and may not address all the
requirements for macronutrient manipulation. For the purposes of achieving lowfat, energy-controlled diets and recommended proportions of each type of fat in the
diet, this study tested an advice strategy based on the development of a set of
macronutrient-based reference food groups and a recommended intake pattern.
The advice was subsequently shown to adequately address targets for the type of
fat consumed within a nutritionally adequate, energy-controlled diet. Further, being
a reference framework, the general principles would apply to all, but when it came
to specific foods a number of food combinations could be used, allowing increased
flexibility for individual food preferences and health and lifestyle objectives. The
structured advice approach, however, ensures consistent and accurate targeting of
nutrients regardless of these individual differences.
As the focus of dietary advice is on foods and concerns relative amounts of
macronutrient intakes, a recommended intake pattern was developed from food
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categories using one criterion at a time and reference standards to ensure total
energy requirements, macronutrient proportions and overall nutritional adequacy.
Working from foods commonly consumed by a local sample of women with GDM,
major food sources of macronutrients were determined. In this way, the
significance of secondary sources of macronutrient intake were uncovered and the
importance of attending to multiple food components underscored. This resulted in
a greater final number of food groups compared with existing core food guide
classifications outlined in current food guidance systems 13, 14. Corresponding food
lists differentiated well between foods with substantially different relative
proportions of macronutrients and the type of fat, for example, cows milk versus
soymilk and meat versus oily fish, where the distinction between SFA-rich and
PUFA-rich foods was apparent. In contrast, existing food guides do not differentiate
well between foods in which fat is the secondary macronutrient contribution, mainly
high protein foods, such as milk, meat, and nuts (in lists where nuts are included as
a high protein food even though the main macronutrient they contain is fat).
ADA exchange lists 15 now sub-categorise exchangeable edible fat sources based
on the major fat type. However, bearing in mind edible fat alone can account for
just 30% of total daily fat intake
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, the application of ADA Exchange Lists is less

likely to have an impact on individual fat proportions. For example, a weight loss
intervention based on the USDA Food Guide Pyramid and ADA exchange lists
showed reductions in total and SFA intakes, but little change to the proportion of
PUFA in the diet 22. Our greater number of food groups assured targets for the type
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of fat, meeting the challenge for achieving both nutritional adequacy and
appropriate dietary fat profile. Where not all food groups were included in the
sample pattern, a substantial number of servings from PUFA-rich food sources
were necessary, highlighting the importance of advice for the regular consumption
of some foods and not others. While goals for the relative proportions of different
types of dietary fat may also be met through judicious food choices, the present
guidance systems are too blunt to make this assumption.
5.5 Theoretical significance
One of the biggest challenges in addressing macronutrient-referenced dietary
goals is to provide valid and feasible advice on foods to consume. By confirming
the theoretical achievement of nutritional goals, this paper has outlined a
systematic approach to dietary advice referring to food groups that differentiate
between foods based on primary and secondary macronutrient content. Having
done so, the approach has demonstrated a methodology that can be used for other
plans according to requirement. Whilst all foods may not fall clearly into any one
group, the structured nature of the approach facilitates a level of capability for the
achievement of macronutrient targets. The advice system, therefore, is appropriate
not only in the diabetes context, but for the treatment of other clinical indices
associated with the Metabolic Syndrome, including CVD and overweight, as well as
general healthy eating strategies, and research to substantiate health-related
claims on nutrient/food effects.
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5.6 Limitations and areas for further research
While the categorization process has inherent limitations 268, 270, these mainly stem
from the criteria used to categorise foods. In this case, the criteria for food group
development were taken from the macronutrient parameters to be used in the
development of the overall diet. Thus, the resultant food groups were used as
building blocks for the construction of an intake pattern to meet predetermined
dietary targets, and therefore were considered appropriate.
Specificity of the study sample, the relatively small number of foods listed and the
fact that dietary estimates were based on a single food pattern may limit the
generalisation of results. However, a single dietary pattern was important to
demonstrate an ‘ideal’ template on which advice can be based for consistent
dietary outc omes. This lends itself to substantiation research in which a single
nutrient or food can tested within the overall diet plan 257. Although the number of
foods was limited, mean estimates for macronutrient content corresponded to
those reported for exchange lists using a greater number of foods 17. Further,
variation due to any combination of individual food choices from within the
recommended food pattern was low and likely narrower than existing advice
systems that demonstrate wider variation within individual food categories 13, 17.
The advice system was therefore judged as adequate for consumption of different
types of fat in the proportions defined by current recommendations, and particularly
supportive of total diet advice for controlling energy intake (SD±365.5kJ/87.4kcal).
Greater variation for saturated fat (likely due to the increased number of staple
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foods containing this type of fat) was readily overcome in the construction process
by ensuring the upper estimate for SFA variation (+2SD) was below the target level
(<10% of energy). For any system, however, encouraging consumption of a wide
variety of foods from within and across food groups reduces the risk of
consumption patterns that lie at the extreme ranges of energy and macronutrient
intakes as well as ensures nutritional adequacy 338, 339. Acceptance of the advice
system by practitioners and its utility in clinical practice and in diverse ethnic
groups or for dietary interventions other than for diabetes would be of interest and
may provide the basis for future research. The impact on weight, glycaemic control,
and blood lipid levels compared with a control group receiving general advice
would provide health-related outcomes to substantiate the benefits. Most
importantly, its application in RCTs is required to confirm the theoretical
evaluations and to assess its feasibility in diabetes groups under free-living
conditions .
5.7 Relevance to thesis and Implications for practice
A structured methodology to guide advice for the achievement of specific nutrient
targets has been developed and the importance of differentiating bet ween foods of
varying macronutrient content, particularly the type of fat, has been theoretically
confirmed. PUFA-rich foods have been identified as those requiring identification
and specific attention for regular intakes within the overall diet. A template for the
application of advice has been developed and appears conducive to simplified
advice in intervention trials.
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Where the developed system has successfully combined specific macronutrient
recommendations with existing guidelines and practices, advice would refer to daily
servings from each of the reference food groups in a recommended pattern. The
quality of CHO intake would be improved by differentiating wholegrain, high fibre,
and/or low GI choices within the starch group and including at least one of these in
each meal distributed throughout the day. Individual modifications would be
achieved in consideration of usual eating patterns, with relative amounts of
significant foods, for example, oily fish, soy foods and/or nuts for increasing PUFA
intakes, developed in proportion with individual energy needs.
In recognition of the need for evidence-based practices for the provision of advice,
this study outlines the development of a structured approach to advice for the
treatment of diabetes and overall nutritional adequacy. Application of the advice
system in RCTs would confirm the theoretical evaluations conducted here and
provide evidence for the feasibility and effectiveness of the advice system in
diabetes groups under free-living conditions. The method could also be used to
test the delivery of adequate amounts of required nutrients within the total diet
framework to substantiate the benefits.
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CHAPTER 6 TESTING THE FEASIBILITY OF FOOD PATTERN ADVICE IN AN
INTERVENTION TRIAL

A significant portion of this chapter has been published in the peer-reviewed article:
Gillen LJ, Tapsell LC. Advice that includes food sources of unsaturated fat supports future risk
management of Gestational Diabetes Mellitus. J Am Diet Assoc 2004;104(12):1863-1867
LG was responsible for the implementation of the study, organization and conduct of data
collection, dietary interventions and dietary assessment and analyses, preparation of the
manuscript and involved in critical discussions of study design and outcomes. LT was responsible
for critical discussions of study design and outcomes and preparation of the manuscript.

6.1 Introduction
The RCT is considered the gold standard by which evidence supports practice. For
this thesis, having developed an advice framework for the theoretical achievement
of nutrient targets, successful implementation in an intervention trial involving freeliving individuals would confirm its feasibility in practice and appropriateness for
substantiation research. Where food lists were representative of consumption
patterns of a local sample of GDM women, application in a similar group would
appear to be a natural extension of the research. Furthermore, diagnosis in the
third trimester of pregnancy necessitates relatively brief and intensive treatment
(over the remainder of the pregnancy) with short term clinical (delivery) outcomes.
Hence, women with GDM represent an ideal study group for dietary intervention
research and provide the study sample for the intervention described here.
GDM, or an impaired glucose tolerance first diagnosed during pregnancy 78, affects
up to 14% of the pregnant population 83, 99, 342, 343. The primary focus of GDM
management is the prevention of adverse perinatal outcomes 8, 78. Although the
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obstetric benefits of this strategy have yet to be demonstrated 241, 344 , there may be
longer term advantages for a positive diagnosis 345, 346. Women with GDM are at
high risk of the recurrence of GDM in a subsequent pregnancy 89, 347, 348 and of
T2DM in later life 90, 273-275, 306, 307 . CVD and CHD risks are also high 276, 277, with
endothelial dysfunction (an early marker of mac rovascular disease) and lipid
abnormalities observed as early as the index pregnancy 93-95. Women who develop
T2DM have a four to five-fold increase in CHD mortality rate compared with nondiabetic women 349. 30, 92, 96. Hence, the diagnosis of GDM identifies a population ‘at
risk’ and provides an important opportunity for the development of intervention
strategies aimed at delaying or preventing onset of diabetes and its long term
consequences 241, 346. Lifestyle modifications have been shown to lessen the risk of
diabetes and its complications 20, 21, 190, 350, providing good argument for the early
establishment of dietary patterns aimed at reducing risk in the GDM population.
Current GDM management practices focuses on glycaemic control 8, 78, targeting
the CHO fraction of the diet 351 . Food guidance systems support advice for
controlling the type, amount and distribution of CHO -rich foods as well as ensuring
nutritional adequacy for pregnancy 15. On the other hand, dietary fat has been
linked with the etiology of insulin resistance 74, 100, and hence with diabetes and
CVD risk. Cross-sectional observations also implicate the amount 152 and type of
dietary fat 153 in the development of GDM, in particular a lower P:S ratio, compared
to healthy pregnant women 155. Therefore, controlling both the amount and type of
dietar y fat may be an important primary prevention strategy for these women.
While guidelines for the prevention and treatment of diabetes and CVD

8 352

largely
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support this strategy, targeted advice on fat-rich foods is necessary for the
achievement of fatty acid goals. The aim of the study reported here was to
compare the usual fat intakes of women with GDM given additional advice on food
sources of unsaturated fatty acids to those advised on a general low fat dietary
approach.
6.2 Methods
6.2.1 Participants and Study Design
From May through December 2002, 32 women newly diagnosed with GDM were
recruited on request at their first attendance at the Illawarra Health, Diabetes
Service, Wollongong, New South Wales, Australia. Routine screening for GDM is
conducted in the Illawarra Region at the beginning of the third trimester of
pregnancy. Diagnos is, using an oral glucose tolerance test (OGTT), is determined
based on the recommendations of ADIPS (50). Women diagnosed with GDM are
referred to the Diabetes Service for medical management. Participants were
required to have a reasonable understanding of written and spoken English.
The study comprised a RCT conducted during GDM management from about 30
weeks gestation to delivery. The control group received general advice that
focused on low fat strategies and the amount, type and distribution of CHO-rich
foods. The intervention group received the same advice plus specific advice on the
amount and frequency of food sources of unsaturated fatty acids. At an initial group
education session all participants received education on home blood glucose
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monitoring from a Registered Nurse Diabetes Educator, and general dietary advice
from an Accredited Practicing Dietitian (APD) (standard management practices).
Participants were then randomly assigned to one of two parallel dietary advice
groups. The overall diet plan was calculated to meet specific targets for levels of
protein, fat (and fat subtype) and CHO within individual energy needs. Each
participant was required to follow the respective dietary advice for the remainder of
the pregnancy, with the number of clinic visits based on need, provided at the
discretion of the dietitian. Dietary and clinical data were collected at the time of
randomization (baseline) and prior to delivery (intervention), at least four weeks
after randomization.
All participants completed an interviewer-administered open-ended DH
questionnaire validated within a GDM population in the Illawarra region 337 and
presented in Appendix C. The same dietitian conducted each DH questionnaire at
baseline and intervention time points, asking participants to describe their ‘usual’
daily eating pattern with variations. Usual was defined as foods consumed
regularly over the previous one-month period. A short food frequency questionnaire
on common food groups was included in the interview to act as a cross-check.
Participants were also required to complete three-day weighed FR at the same two
time points , presented in Appendix D. Each participant was individually instructed
on how to measure and record all foods consumed over two typical weekdays and
one weekend day. Standard metric household measures and standardised forms
were provided for this process. Data on age, stage of gestation, gravida (number of
pregnancies), parity (number of live births), incidence of GDM in a previous
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pregnancy and family history of diabetes (known diabetes in a parent, grandparent
or sibling), country of birth and ethnic origin (Australia/UK or other country) usual
daily activity and pre-pregnancy weight were collected by self-report. Height and
baseline and intervention weights were measured and recorded. BMI was
calculated for self-reported pre-pregnancy weight, while weight gain was assessed
as the difference between the pre-pregnancy weight and the measured intervention
weight. The initiation of insulin was based on ADIPS recommendations and
recorded for individual cases where appropriate. Individual insulin requirements
during pregnancy were recorded. Pregnancy outcomes were also recorded in
terms of newborn characteristics: weight, length and head circumference; and the
nature of delivery: premature delivery (<38 weeks gestation), induced delivery and
any other intervention beyond a normal vaginal delivery.
In order to establish energy requirements and to account for the impact of physical
activity on pregnancy outcomes, reported daily activity was categorized as
sedentary or light based on subjective judgment. Due to advanced stages of
pregnancy no other activity category was required for this sample.
Control Group
Each participant was provided with an individualised portion-controlled CHO meal
plan based on the redistribution of habitual CHO intake, reported informally at the
initial group education session (standard practice at the Diabetes Service). To
support the meal plan, exchange lists of CHO-rich foods were also provided. In
addition, participants received ongoing general dietary advice based on core food
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guide recommendations for pregnancy 13, and strategies for reducing total and
saturated fat in the diet. Advice considered individual food preferences and
incorporated the GI for CHO-rich food choices 221.
Intervention Group
Each participant received information similar to the control group in all respects
plus information on additional food groups of fat-rich foods (Table6-1). Energy
requirements were established individually, based on reported (DH) baseline
intakes. Each diet was calculated to provide <10% of energy from SFA and
approximately 10% of energy from PUFA as recommended by ADA for the
treatment and prevention of diabetes and related complications 8 . To support the
meal plan, exchange lists of fat-rich foods were provided (Table 6-2).
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Table 6-1 Example of individualised advice provided to each subject in the intervention group
(8000kJ (2000kcal) per day)
Bread/Cereal
Rice/Potato/
Pasta

Vegetables

Fruit

Milk

Lean
meat

Oily
Fish

Spreads/
Oils/Nuts
MUFA

Spreads/
Oils/Nuts
PUFA

Daily
servings

8

5

4

600ml

600g
(20oz)/
week

450g
(15oz)/
week

2tsp

5tsp

Breakfast

2

1

330ml

1

30ml

Morning
Tea
Lunch

3

2

Afternoon
Tea
Dinner
Supper

30ml
1

3

3

30ml
30ml

1

150ml
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Table 6-2 Exchange lists of foods with different fat profiles provided to the intervention group to
support individualised dietary advice

Saturated fat*

Monounsaturated fat**

Amounts in brackets = 1 serve
Milk (1 cup)
Oils (1tsp)
Skim, low or reduced fat
Olive
Trim custard
Canola
Sunola
Yoghurt (7oz)
Peanut
No fat, Low fat, Lite
Macadamia nut
Diet lite
Almond nut
Ice Cream (2 scoops)
Diet, Low fat, Lite
Deli Meats (1 slice = 1oz)
Light ham,
Turkey, chicken breast
97% fat free meats
Other Meats
Trim all visible fat
Cheese (2 slices)
Free, extra lite, lite
Cottage, low fat ricotta
Egg (1 medium = 1oz
meat)
Omega-3 enriched

Polyunsaturated fat**
Oils (1tsp)
Sunflower
Safflower
Sesame
Soybean
Grapeseed
Cottonseed

Spreads (1½tsp)
Canola margarine
Olive margarine
Sterol margarine (canolabased)
Peanut Butter
Avocado (1tb)

Spreads (1½tsp)
Polyunsaturated margarine
Soy margarine
Sterol margarine (poly-based)

Dressings (1tb)
French (with olive oil)
Italian (with olive oil)

Dressings (1tb)
French (regular)
Italian (regular)

Nuts (1tb)
Almond
Cashew
Macadamia
Peanut

Nuts (1tb)
Brazil
Pine nuts
Walnut

Pecan
Pistachio
Other (15 each)
Olives
Potato snacks (in sunola oil)
French fries (in canola oil)

* Advice was to prefer these low fat food choices to meet the prescribed number of serves from Milk
and Meat groups
** Advice was to choose these foods to meet the prescribed number of serves from this fat type

Dietary data were entered into FoodWorks (Xyris software, Brisbane, Version 2.1,
2000, Xyris software, Brisbane, Australia) for nutrient analysis. This software
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incorporated the Commonwealth Department of Community Services and Health
nutrient tables for use in Australia: AUSNUT, Canberra, 2000.
Food intake data were converted to energy and macronutrient values, expressed
as kilocalories (kcal) and %E, respectively. Bland Altman plots were used to
determine the level of agreement between data taken from the DH and FR (55).
DH data were used for all group comparisons. Achievement of dietary goals was
defined as mean fatty acid intakes of <10% of energy as SFA, >7% of energy as
PUFA, and P:S ratio >1 8
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. The number of individuals in each group achieving

fatty acid goals was assessed.
To assess the quality of data, dietary data obtained from DH interviews and FR
were compared using the Bland-Altman approach for comparison, where the 95%
limits of agreement are set as two standard deviations from the mean of the
difference 286. Evidence of overall bias, indicated by observations of the mean
difference away from zero and a relationship between difference and mean, was
confirmed using the correlation coefficient (P<0.05). For each dietary variable,
limits of agreement within target ranges of consumption were considered clinically
acceptable.
In order to assess the relative contribution of different foods to total dietary fat
intakes, foods were categorized based on predominant fatty acid content. The
amount of fat provided by a single food was expressed as a percentage of the total
fat consumed from all foods.
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All statistical analyses were conducted using SPSS for Windows, Version 11.0,
2001 (SPSS Inc, Chicago, Ill.). Comparisons between control and intervention
groups for data defining previous GDM (yes/no), family history of diabetes (yes/no),
birth and ethnic origins, activity, nature of delivery, and numbers of individuals
achieving fatty acid targets were performed using Pearson’s chi -square tests.
Comparisons for data defining age, height, weight, gestation, gravida and parity,
and characteristics of the newborn were assessed using independent samples ttests. Independent samples t-tests were also used to compare energy and
macronutrient intakes at baseline, and for changes in intake as a percentage of
baseline (% change) following dietary advice. Repeated measures ANOVA was
used to assess differences in energy and macronutrient intakes over time (time
points were baseline and intervention) with dietary advice group as the betweensubjects factor. Results are expressed as mean+SD with the level of significance
reported at P<0.05 for all comparisons.
The Human Research Ethics Committee of the University of Wollongong and
Illawarra Area Health Service provided ethical approval for this research.
Information provided to participants and consent forms for this study are provided
in Appendices E and F, respectively.
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6.3 Results
Of the 96 women referred to the Diabetes Service during the recruitment period, 32
(16 control and 16 intervention) agreed to participate in the study. Exclusions were
confined to one woman with poor English language skills. Baseline DH data were
obtained from all participants. Two women, one from each group, did not complete
an intervention DH due to early delivery of the newborn. FR data were obtained
from twenty-seven participants (n=15 control, n=12 intervention) at the intervention
time point. Gestation data indicate that women were first seen at around 30 weeks
gestation for the collection of baseline data and that intervention data were
collected at around 36 weeks gestation. Delivery of the newborn occurred at
around 39 week’s gestation. BMI data based on self-reported pre-pregnancy
weight indicate that the average subject was overweight prior to the current
pregnancy. No significant differences were found between the two groups of
women in terms of age, height, self-reported or recorded weights, or corresponding
BMI, weight gain, stage of gestation, gravida or parity. The two groups were also
similar for numbers of participants reporting previous GDM, family history of
diabetes, birth and ethnic origins, and categories of activity (data not shown). One
control and two intervention participants required insulin treatment during the
pregnancy. There were also no significant differences between groups for
pregnancy outcomes defined by newborn characteristics, or nature of delivery
(data not shown). (Table 6-3)
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Table 6-3 Maternal characteristics of the control group, intervention group and the two groups
combined (mean±SD)

Characteristics
Age (baseline) (yrs)
Height (cm)
Weight (pre pregnancy) (kg)
2
BMI (pre pregnancy) (kg/m )
Weight gain (kg)
Gestation (baseline) (wks)
Gestation (intervention) (wks)
Gestation (delivery) (wks)
Gravida (no. of pregnancies)
Parity (no. of live births)
Baby’s birth weight (g)
Baby’s length (cm)
Baby’s head circumference (cm)

Control
Group
n=16
31.9±4.5
162.4±6.4
69.2±13.1
26.0±3.4
13.7±6.6
30.7±0.9
36.2±0.9
38.9±1.2
2.4±1.7
0.9±1.1
3414.1±98.8
50.4±0.6
34.8±0.9

Intervention
Group
n=16
30.6±4.7
161.9±5.8
67.0±11.5
25.6±4.5
12.7±6.5
29.0±6.0
35.6±2.1
38.4±2.0
2.3±2.1
0.8±1.2
3452.4±184.7
49.3±1.2
35.1±1.6

Combined
Groups
n=32
31.2±4.6
162.1±0.1
68.1±12.1
25.8±3.9
13.2±6.5
29.8±4.3
35.9±1.6
38.7±0.3
2.4±1.9
0.8±1.1
3431.9±99.2
49.9±0.6
35.0±0.3

No significant differences were found for energy and macronutrient intakes
reported by the two study groups at baseline (Table 6-4). In terms of dietary
recommendations, both groups reported mean SFA and PUFA intakes at baseline
above and below recommended values, respectively, with all women reporting
PUFA intakes well below the rec ommended level. As a result, calculated P:S ratio
for both groups, and for all individuals, was well below target range at the
commencement of the study.
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Table 6-4 Target versus macronutrient intakes reported at baseline by the control and intervention
groups and the two groups combined (mean+SD)

Target

Energy (kJ)
Carbo hydrate (%E)
Protein (%E)
Total fat (%E)
Saturated fat (%E)
Monounsaturated fat
(%E)
Polyunsaturated (%E)
P:S ratio

50
20
30
<10
>10

Control
Group
(n=16)
10257.2±3526.2
48.0±7.2
18.1±3.8
30.9±6.9
13.3±3.6
11.0±2.4

10
>1

3.8±1.4
0.3±0.1

Baseline Intakes
Intervention
Group
(n=16)
9140.7±2620.6
47.5±6.3
20.3±3.3
30.0±5.5
12.8±3.4
10.3±1.7
3.9±1.4
0.3±0.1

Combined
Groups
(n=32)
9698.9±3073.4
47.8±6.7
19.2±3.7
30.5±6.1
13.1±3.4
10.6±2.1
3.9±1.4
0.3±0.1

E=energy

Changes in macronutrient intakes in response to dietary advice are presented in
Fig 6-1. Significant differences between the two dietary advice groups were limited
to changes in fatty acid intakes. The control group reduced mean SFA (% energy)
consumption to 14% below that reported at baseline, compared with a 39%
reduction for the intervention group (P=0.008). The control group also reported a
30% increase from baseline for mean PUFA (% energy) intakes compared with a
134% increase for the intervention group (P=0.001).
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Figure 6-1 Changes in macronutrient intakes following treatment advice, control and intervention

Dietary intakes reported at 36 weeks gestation are presented in Table 6-5.
Although both groups reported a reduction in energy, mean energy intake for the
control group was significantly lower than that reported by the intervention group
following treatment advice. While this difference failed to reach significance as a
treatment group effect over time, the reduction in energy compared to baseline was
significant for the control group only (P<0.01). Significant effects due to dietary
treatment over time were again confined to mean fatty acid intakes. Differences in
group profiles for mean PUFA intakes and P:S ratio over time were highly
significant. The control group increased mean P:S ratio 31% above the ratio
reported at baseline compar ed with a 310% increase for the intervention group.
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Table 6-5 Target versus macronutrient intakes reported following dietary advice (36 weeks
gestation) by the control group and intervention groups (mean+SD)

Target

Energy (kJ)
Carbohydrate (%E)
Protein (%E)
Total fat (%E)
Saturated fat (%E)
Monounsaturated fat (%E)
Polyunsaturated fat (%E)
P:S ratio

50
20
30
<10
>10
10
>1

Dietary intake at
36 weeks gestation
Control
Intervention Group
Group
(n=15)
(n=15)
7488.0±987.2
8701.3±1829.8
45.5±5.7
42.8±4.7
22.7±2.6
23.3±3.7
29.4±6.4
31.8±6.3
*
11.0±4.0
7.5±1.7
**
11.0±2.3
3.6±3.0
***
4.4±1.4
8.2±2.4
***
0.4±0.2
1.1±0.2

E=energy
Significant effect due to treatment over time using repeated measures ANOVA,
*
**
***
P<0.05, P<0.01, P<0.001, control group versus intervention group

In terms of dietary targets, these differences were reflected in the achievement of
SFA and PUFA targets. Only the intervention group achieved mean SFA, PUFA
and P:S ratio within the respective recommended ranges.
No individual participant from either group achieved PUFA intakes or P:S ratio
within the target range prior to treatment (Table 6-6). Following dietary advice, the
majority of individuals from the intervention group reported values consistent with
both SFA and PUFA recommendations, with 12 out of 15 from this group achieving
a P:S ratio within the target range. In contrast, only one participant from the control
group reported adequate PUFA intake, with no individual from this group achieving
the target P:S ratio. Hence, differences between groups for numbers reporting
adequate PUFA (P=0.001) and optimal P:S ratio (P<0.001) following dietary advice
were highly significant.
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Table 6-6 Numbers of individuals achieving dietary goals at baseline and following dietary advice
(36 weeks gestation), control and intervention groups

Dietary
a
targets

Baseline

36 weeks gestation

(n=16)

(n=15)

Control
Group

Intervention
Gro up

Control
Group

Intervention
Group

SFA (<10%E)

4

3

8

13

PUFA (> 7%E)

0

0

1

10

P:S ratio (>1)

0

0

0

12

**

***

Data are numbers of individual study participants
**
***
P<0.01, P<0.001 by Pearsons Chi-square, control group versus intervention group

Patterns of consumption of food sources of dietary fat were very similar between
the control and intervention groups prior to dietary advice. SFA-rich foods such as
milk, cheese and meat groups contributed around 50% of mean total fat intakes
(41g fat per day vs. 35g fat per day) while PUFA-rich oils/spreads, fish, soymilk
and nuts contributed less than 15% (12g fat per day vs. 10g fat per day).
Following advice, the control group increased their fat intake from PUFA-rich foods
to 28% of total fat intake (17g fat per day), mainly through the increased use of oils
and spreads. And, although fat from SFA-rich food groups was reduced (27g fat
per day) the proportion of total fat consumption from these foods was still high
(45% of total fat intake). In contrast, the intervention group almost reversed the
proportions of SFA (22% of total fat intake) and unsaturated dietary fat (57% of
total fat intake) reported at baseline by substantially reducing (17g fat per day) and
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increasing (43g fat per day) consumption of fat from all food groups classified as
SFA- and PUFA-rich, respectively.
The quality of the dietary data was viewed as favourable. Using Bland Altman
plots, good agreement was demonstrated between DH and FR data for energy (kJ)
and macronutrient (g) variables (55). There was no evidence of overall bias for
data collected using either the DH or FR for any of the dietary variables tested.
Agreement between data from the two methods was considered clinically
acceptable, that is, the 95% limits of agreement were, for energy (E) 715.4−864.6Kcal, protein 6.5-−3.1%E, CHO10.5-−10.7%E, total fat 8.8-−11.6%E, SFA
5.0-−6.2%E, MUFA 5.0-−5.4%E, and PUFA 2.7-−3.7%E. DH data were therefore
considered valid estimates of usual dietary intakes for statistic al comparisons.
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CONCLUSION

6.4

Summary

Several large studies have shown that lifestyle modifications are important primary
prevention strategies for those at-risk of T2DM and CVD complications 19-21. The
diagnosis of GDM identifies ‘at risk’ women at an early stage in the possible
development of these metabolic disorders, and thus these women represent an
ideal study group for primary prevention strategies 346 . Where dietary fat has been
implicated in the development of diabetes and CVD risk, the current focus on CHO
intake may limit long-term benefit from dietary intervention. The study reported
here aimed to demonstrate how a broader focus and targeted advice that modifies
fat profile is an approapriate primary prevention strategy during GDM
management. Importantly, nutritional adequacy, glycaemic control, weight control
and perinatal outcomes were not compromised by this shift in focus.
Within the limits of the recruitment period, 32 out of 95 eligible women volunteered
for the study with only one potential participant excluded based on the limited
selection criteria. The data indicate that the average participant was 31 years of
age, had a family history of diabetes, and was overweight prior to the current
pregnancy, demonstrating multiple risk factors for future diabetes within this study
sample 275.
Dietary data were considered a valid reflection of usual intakes. At the
commencement of the study mean SFA and PUFA intakes reported by the study
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sample were consistent with data reported for the general population in Australia
353, 354

. These intakes, however, are not consistent with current recommendations

outlined by ADA and AHA 8, 352. Interestingly, all individuals reported baseline
PUFA intakes below the recommended range, indicating dietary risk and further
suggesting the need to include advice on fats, in particular PUFA, as part of GDM
management. While all women reduced SFA intakes in response to advice
(general low fat versus targeted for individual fatty acids), only the intervention
group achieved the PUFA target and, hence, optimal P:S ratio. General low fat
advice strategies, on the other hand, did little to improve the fatty acid profile of the
control group and brought about a significant reduction in mean energy intake
(more than 2700kJ) compared to the intervention group (less than 500kJ
reduction). While weight management is important for these women a reduction in
kilojoules in response to dietary advice is a phenomenon previously observed in
GDM women 303, which in the former can result in small for gestational age babies
240

, an outcome no less concerning than large for gestational age babies.

In terms of individual participants, 12 out of 15 women in the intervention group
achieved a P:S ratio >1 following dietary advice, whereas no individual from the
control group achieved this target. This may be explained by considering the
position of habitual fatty acid intakes in relation to their corresponding targets, and
the need for opposing advice strategies. General dietary advice favors total fat
reduction, relying heavily on core food guide classifications and recommendations
that do not differentiate between foods on the basis of fat type 16 . Furthermore,
Western s taples such as SFA-rich milk and meat groups attract advice for daily
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intakes to ensure nutritional adequacy particularly during pregnancy. Therefore, the
frequency of consumption of these foods can define total SFA intakes, even when
low fat products are used and may account for the increased consumption of fat
from cheese products observed for our control group following advice. Conversely,
PUFA-rich foods such as oils, spreads and nuts, by virtue of their high fat content
and, in some cases, their position outside core food groups, are considered more
worthy of restriction 13. Thus, a focus on total fat consumption may have
unfortunate consequences, resulting in low fat intakes highest in SFA, as observed
for the control group. Australian population surveys conducted between 1983 and
1995 support this argument, revealing a decline in average total fat and PUFA
intakes along with increased average saturated fat consumption

355

. While

judicious food choices from existing core food exchange lists may achieve the
desired fat profile, we consider the guidance systems too blunt to make this
assumption. Consequently, for the intervention group in this study a wider range of
food groups were used to enable fatty acids to be targeted. For example, soymilk
was listed as an alternative to milk, oily fish types were listed separately from other
protein-rich food sources, and nuts were listed with oils and spreads within welldefined MUFA-rich and PUFA-rich food groups. Hence, unsaturated fat-rich foods
were readily distinguishable from SFA-rich foods, while individual food preferences
determined actual food choices.
After advice, the control group largely limited intakes of unsaturated fatty acids to
exchangeable edible fats, mainly oils and spreads, but amounts were inadequate
for the achievement of fatty acid goals. In contrast, the intervention group reported
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multiple shifts from SFA- to PUFA-rich food sources in order to achieve the
appropriate P:S ratio, indicating targeted advic e on specific foods is more likely to
deliver the amount of unsaturated fat required.
At commencement of the study, meat and dairy staples provided over half of
dietary fat intake reported by the total study sample. After advice, the intervention
group reported over half of dietary fat intake from PUFA-rich foods. Major changes
in food choice by the intervention group were increased consumption of oils and
spreads (mainly margarines low in trans fatty acids), oily fish and nuts to
approximately 1oz each per day, lean fish to 1 ½ oz per day, and legumes (mainly
soymilk) to almost 3oz per day. Importantly, concomitant reductions in fat from
meat and dairy from 5 oz to 3 ½ oz per day and 15 oz to 13 oz per day,
respectively, were also reported, inclusive of lean and low fat choices. In contrast,
the control group reported little change to the pattern of intake from fat-rich food
sources.
6.5 Theoretical significance
In terms of dietary risk profile, this sample of women with GDM reported
undesirable habitual fatty acid intakes. The inclusion of advice on food sources of
unsaturated fatty acids demonstrated how optimal fatty acid profiles can be
achieved, not possible when advice is limited to a focus on CHO-rich foods and/or
general low fat strategies. The large increases required for foods rich in
unsaturated fat reflect the low levels of consumption at baseline and demonstrate
the need for a more dichotomous approach to dietary advice to adequately shift
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intakes from saturated to unsaturated fat sources. Interestingly, the perception of
advice for the consumption of ‘foods’ (soy, fish, nuts) rather than ‘fats’ (oils and
margarines) overcame an apparent reluctance by some participants to
preferentially consume fat. Even when oils and margarines were consumed,
participants were sparing in their use, indicating that a reliance on exchangeable
edible fats for increasing unsaturated fat in the diet may be difficult for consumers
already indoctrinated into a low fat regime.
6.6 Limitations and areas for further research
Incomplete data collection was limited to one person from each group and
therefore unlikely to affect results. While sample size was not large, the high
degree of homogeny in terms of baseline demographic and dietary profile data
supports representation of the wider population. The sample was likely to be
biased toward women who were willing to keep FR and motivated to follow dietary
instructions, however, there was no discernable difference between groups.
Randomization of participants into two dietary advice groups then ensured similar
group profiles prior to the implementation of different dietary advice strategies,
thereby improving the chances of detecting differences between groups over time.
With no differences between groups for insulin therapy or pregnancy outcomes,
there were no apparent reasons why external factors might have impinged on
achievement of dietary targets other than the intervention.
A larger prospective dietary intervention study in men and women with T2DM is
required to confirm the transfer of this dietary strategy to other diabetes groups and
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to substantiate the impact of food patterns in terms of clinical markers of diabetes
and CVD risk.
6.7 Relevance to thesis and implications for practice
It would seem from the clinical outcomes demonstrated in this study that the total
diet approach encompassed in standard practice was universally effective. The
opportunity to provide dietary advice for women with GDM, however, should be
addressed with a long-term view to their health status, particularly as they bear
known risks for T2DM and CVD. Improving the dietary fat profile of the diet
warrants consideration and this means targeting information on foods that deliver
unsaturated fatty acids at the expense of saturated fats. Dietitians should provide a
balanced emphasis on foods such as oils, margarines, nuts, legumes and fish
along with the traditional core foods such as meat, milk and cheese to ensure
optimal fatty acid intakes are actually consumed.
For this thesis, this study confirmed the feasibility of an advice system based on a
model food pattern using all foods in the diet. The theoretical achievement of
nutrient targets was confirmed by practical implementation in a clinic sample of the
treatment group. In particular, specific advice on fat sources enabled differences in
individual fatty acid proportions without impacting on other dietary variables within
the total diet. This was important in order to confirm the appropriateness of advice
for the achievement of specific nutrient changes to enable further research to
establish a clinical benefit from the intake of a specific nutrient or food.

199
CHAPTER 7 CONFIRMING THE EFFECTIVENESS OF FOOD PATTERN
ADVICE IN SUBSTANTIATION RESEARCH

A significant portion of this chapter has been published in the peer-reviewed article:
Gillen LJ, Tapsell LC, Patch CS, Owen A, Batterham M. Structured dietary advice incorporating
walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus. J Am Diet
Assoc 2005:In press (July)

Clinical results referred to in this chapter have been published in the peer –review
article:
Tapsell L, Gillen L, Patch C, Batterham M, Owen A, Bare M, Kennedy M. Including walnuts in a lowfat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2
diabetes. Diabetes Care 2004;27:2777 -2783
LG was responsible for dietary intervention, dietary advice protocols, dietary assessment and
analysis, involved in critical discussions of study design and outcomes as well as preparation of the
manuscripts. LT was responsible for study design, organization and conduct of data collection and
critical discussions of study design, analyses and outcomes and preparation of results manuscript.
CP was involved in data collection and critical discussions of study design and outcomes. AO was
involved in critical discussions of study design and outcomes. MB was responsible for statistical
analyses and involved in critical discussions of study design and outcomes.

7.1 Introduction
Having confirmed the clinical feasibility of food pattern advice under free-living
conditions, a second intervention trial was conducted to confirm the effectiveness
of the advice system in terms of health-related outcomes as a result of changes to
the macronutrient profile. If results are to be generalized to the diabetes population,
it was also important to demonstrate the clinical transfer of food pattern advice
from GDM women to the wider diabetes community, and to provide evidence for
long-term adherence to advice (six months). Additionally, the incorporation into the
overall diet of a single food source (walnuts) of a specific nutrient (PUFA) informs
substantiation research, providing a framework for nutrition intervention to confirm
health claims on individual nutrients/foods .
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Evidence-based guidelines for the management of T2DM and related CVD refer to
cardio-protective proportions of individual fat types 8 . Conversion of macr onutrient
targets into practical advice on foods, however, is one of the most challenging
aspects of nutrition management. A total diet approach, ‘where all foods can fit into
a healthful eating style’, is recommended 242, and an exchange system of food lists
supports this process 15, 335. However, general low fat advice strategies based on
current exchange list systems do not necessarily lower the proportion of SFA

22

.

Adequacy of the PUFA fraction, concomitantly lowered during low fat advice, may
also require attention 23. Conversely, advice to increase unsaturated fat intake may
result in unintended increases in total fat and energy 25. Even when food-based
advice matches nutrient targets, achieving long-term adherence to dietary advice is
problematic in free living populations
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.

Further research is required to establish evidence-based practices that ensure
recommended fatty acid proportions within low fat energy-controlled diets. For this,
new dietary advice approaches need to be tested in free living subjects. An
exchange system based on the fat composition of foods, however, has not been
established, nor has the position in the diet of individual high fat foods as
significant delivery sources of essential fatty acids. While fish is recommended for
its n-3 PUFA content based on evidence from the general population 8 , fish and
other individual food sources of n-3 fatty acids require further investigation in
diabetes populations. The cardio-protective benefits of nuts and their unsaturated
fat content have been reviewed 357. Despite being energy dense, strong dietary
compensation and little change in energy balance have been reported during
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chronic consumption of nuts 171. Hence, the incorporation of nuts into low fat
energy-controlled diets may be an appropriate strategy for the adequate
achievement of unsaturated fatty acid targets. Walnuts in particular, with high n-3
PUFA content, may provide an additional source of these fatty acids 184. The
feasibility of advice for the regular consumption of a high fat food has not been
previously assessed in free living diabetes subjects. The study reported here
aimed to assess the achievement of dietary fat targets in a sample of patients with
T2DM randomly assigned to one of three dietary advice interventions over six
months: a control group given general low -fat advice and two intervention groups
given total diet advice using a recommended food intake pattern for the
achievement of the recommended fat profile, with one group incorporating walnuts
into the PUFA fraction of the diet.
7.2 Methods
7.2.1 Participants and Study Design
The study was conducted in Wollongong, Australia. Subjects with established
T2DM were recruited by advertising through local media, at the Illawarra Health
Diabetes Centre in Wollongong and among University of Wollongong (UOW) staff.
The content of the recruitment advertisement is provided as Appendix G. Inclusion
criteria were assessed during a telephone screening survey (Appendix H): aged
35-75 years, diagnosed with T2DM for at least one year and generally well.
Exclusion criteria were: on insulin therapy (or with HbA1c >9%), BMI>35kg/m2 , with
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major debilitating illness, known food allergies or food habits inhibiting the study,
illiteracy and inadequate conversational English.
The study was conducted under controlled trial conditions where subjects were
randomly assigned to one of three parallel dietary advice groups each targeting
30% energy from total fat: low fat (LF) (control), modified low fat (MF) and modified
low fat with specific advice to include 30g walnuts per day (Walnut). To avoid
contact between participants receiving and not receiving walnuts, the LF and MF
groups were seen at the Wollongong Diabetes Centre, while those in the Walnut
group were seen in clinic rooms at the UOW. An experienced Accredited Practising
Dietitian counseled all individuals. Each participant was required to follow the
respective dietary advice for six months following randomization.
Dietary advice provided to each group is outlined in Figure 7-1. All participants
were provided with an individualised portion-controlled CHO meal plan based on
the redistribution of habitual CHO intake 333 . To support the meal plan, exchange
lists of CHO-rich foods incorporating the GI
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were also provided. In each group,

participants were referred to core food guide recommendations outlined in the
Australian Guide to Healthy Eating (AGHE) 13, and individual food preferences
were considered.
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Figure 7-1 Outline of dietary advice provided to each group

Food category

LF (control)

MF

Walnut

Carbohydrate-rich

No. portions
Distribution
CHO type

No. portions
Distribution
CHO type

No. portions
Distribution
CHO type

Protein-rich

Serving size

No. portions
Fish portions

No. portions
Fish portions

Milk a llowance

Type of milk

Total (ml)
Type milk (LF/PUFA)

Total (ml)
Type milk (LF/PUFA)

Spreads/oils/nuts

Type of spread/oil

Total (g)
Total (g)
Type fat (MUFA/PUFA) Type fat (MUFA/PUFA)

Walnuts

-

-

30g/day

In addition to the above, the LF group received standardised general dietary advice
that corresponded to usual practice methods used at the Wollongong Diabetes
Centre for reducing total and saturated fat in the diet. Distinctions between staple
foods containing mainly saturated or unsaturated fat were emphasized in a ‘good
fat’ versus ‘bad fat’ approach. The number of clinic visits was based on individual
need provided at the discretion of the dietitian, as per usual clinical practice at the
Centre.
Participants in the MF group received more structured advice in the form of a meal
plan based on energy requirements, established individually from reported baseline
intakes (Table 7-1). Development of the meal plan has been described in
CHAPTER 5, and was based on a reference model calculated from mean
estimates representing the macronutrient and fat composition of exchange lists of
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staple foods to provide 50% of energy from CHO, 20% of energy from protein and
30% of energy from total dietary fat in the proportions of <10% of energy from SFA
and approximately 10% of energy from PUFA. In order to differentiate fat type,
each meal plan referred to nine categories of foods that corresponded to the
macronutrient exchange lists, a greater number than core food groups 13. The extra
groups provided specific advice for the amount and frequency of individual PUFArich foods such as soymilk and oily fish, and for high-fat foods highest in
unsaturated fat, such as oils, margarines and nuts. Exchange lists of ‘MUFA-rich
and PUFA-rich’ foods were also provided, presented in Chapter 4 Methods 4.2.
Monthly clinic visits were supported by one telephone contact between each visit to
check compliance, assessed by ‘cross-checking’ reported daily intakes from all
food groups against the meal plan provided.

Table 7-1 Example of individualised advice provided to each subject in the Walnut group (8000kJ
(2000kcal) per day)
Bread/Cereal
Rice/Potato/
Pasta

Vegetables

Fruit

Milk

Lean
meat

Oily
Fish

Spreads/
Oils

Walnuts

Daily
servings

9

5

4

600ml

600g
(20oz)/
week

450g
(15oz)/
week

2tsp

30g

Breakfast

3

1

330ml

1

30ml

Morning
Tea
Lunch

3

2

Afternoon
Tea
Dinner
Supper

30ml
1

3

3

30ml
30ml

1

150ml
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Individuals in the Walnut group received a meal plan as described for the MF group
but with the inclusion of 1oz (30g) walnuts per day as part of the PUFA content of
the diet. To facilitate intake, one month’s supply of individually wrapped daily
portion packs of walnuts were provided to each person at eac h clinic visit. Contact
and assessment of compliance was consistent with those methods outlined for the
MF group.
At baseline, three, and six months all participants completed an intervieweradministered open-ended DH questionnaire, previously validated within a diabetes
population in the Illawarra region 279, 337 and modified for this study, and three-day
weighed FR as outlined in Appendices I and J, respectively. Two experienced
dietitians, not involved in dietary counseling, conducted DH questionnaires, asking
each participant to describe his/her ‘usual’ daily eating pattern with variations.
Usual was defined as foods consumed regularly over the previous three months. A
short food frequency questionnaire on common food groups was included in the
interview to act as a cross-check. Each participant was individually instructed on
how to measure and record all foods consumed over two typical weekdays and
one weekend day. Standard metric household measures and standardised forms
were provided for this process.
Data on age, family history of diabetes, country of birth, and usual daily activity
were collected by self-report. Height was measured at baseline. Weight and
percentage body fat were measured at 0, 3, and 6 months using scales and a
bioelectrical impedance component (Tanita TBF-622 foot to foot analysers). These
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scales are applicable to standard clinical practice and in this context compare
reasonably well with dual x-ray absorptiometry as a reference technique
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. BMI

was calculated for each measured weight. Reported daily activity was categorized
as sedentary, light, moderate, or active based on subjective judgment using Food
Authority Organization (FAO) definitions 359 . Clinical data on blood glucose and
lipid levels were also obtained.
Dietary data were entered into FoodWorks nutrient analysis software program
(Xyris, Version 3.2, Brisbane, Australia, 2002) using the Australian nutrient
database AusNut Rev.14 360 and the fatty acid database of Australian fatty acids
(Rev.6 RMIT, Melbourne, 2002).
Food intake data were converted to energy and macronutrient values, expressed
as kilojoules (kJ) and %E, respectively. Primary outcomes were the proportions of
individuals from each group achieving fatty acid targets, defined as mean intakes
of <10% of energy as SFA (1), >7% of energy as PUFA (PUFA:SFA (P:S) ratio >1)
8

, minimum intakes for n-3 fatty acids 11: 2.22g ALA, and 0.65g EPA+DHA and n-

6:n-3 ratio <10 361.
To assess the quality of the DH data, comparisons were made with FR data
collected at the corresponding time point. An estimation of the potential bias in
reported energy intakes was undertaken, where reported estimated intakes (EIrep)
were compared with EEest, calculated using the Schofield Equation 298 with
reference to estimated activity levels (16). Finally, erythrocyte fatty acid
composition was assessed as a biomarker for reported intakes 362.
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Trained professionals drew blood samples that were sent to a quality assured
pathology laboratory (Southern IML Pathology) for analysis of HbA1c, total-C, LDLC, HDL-C and triglyceride levels in keeping with standard clinical practice.
Biomarkers were assessed in the UOW laboratory using standard techniques.
Erythrocyte fatty acid composition was determined by gas chromatography.
Erythrocyte membrane lipids were isolated by ultracentrifugation
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and the fatty

acids derivatized using a direct trans-esterification method 364 . The resulting fatty
acid methyl esters were analysed by gas chromatography using a Shimadzu GC17A equipped with a 30m x 0.25mm capillary column (FAMEWAX, Restek GMbH)
with hydrogen as a carrier gas. Fatty acid identification was based on the retention
time of authentic fatty acid methyl ester standards (Sigma-Aldrich, Australia).
Foods were categorized based on the predominant content of each fat type: SFA-,
MUFA- or PUFA-rich. The contribution of these foods to total dietary fat intake by
each intervention group at 0, 3 and 6 months was calculated as a percentage of
the total fat consumed from all foods by that group. Similarly, major sources of n-3
PUFA were determined by calculating the n-3 fatty acid intakes from individual
foods as a percentage of total n-3 consumed. Mean amounts (grams) of significant
foods were also reported.
All statistical analyses were conducted using SPSS for Windows (Version 11.0,
2001, SPSS Inc., Chicago, IL. USA and STAT (Version 7.0, 2002, STATA Corp,
College Station, TX. USA). For baseline subject characteristics non-Gaussion data
were log transformed prior to analysis. Data were presented as mean±SD prior to
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transformation to assist interpretation. The level of significance was reported at
p<0.05. A one-way ANOVA was used for comparisons between groups, with post
hoc analysis performed using Tukey’s test. Non-parametric analysis was
conducted using the Kruskall-Wallis test.
For comparison of dietary data assumptions of normality were made. A one-way
ANOVA was used for comparisons of dietary data at 0, 3 and 6 months. Repeated
measures ANOVA on data from those completing the trial assessed differences in
macronutrient intakes over time (0, 3 and 6 months) with treatment group as the
between-subjects factor. Results were expressed as mean+SD with the level of
significance reported at p<0.05. Differences in proportions achieving targets were
assessed by chi square analysis. Changes in clinical outcomes were analysed with
an intention to treat model using repeated measures ANOVA.
Data from the DH and the FR were compared using Bland-Altman plots, where the
95% limits of agreement are set as two standard deviations from the mean of the
difference between the two data sets 286. A mean difference close to zero indicates
minimum bias. A significant correlation between the difference (DH-FR) and mean
(DH-FR/2) provides evidence of systematic bias. For each dietary variable, the
range of consumption reported for the two data sets were considered clinically
acceptable when limits of agreement were no greater than 200kcal for energy, 2%
of energy for macronutrients and 1g for n-3 PUFA. Differences in the extent of
under-reporting (EEest-EIrep) between and within the method (DH and FR) over time
were investigated using repeated measures ANOVA. Spearman’s correlation co-
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efficient was determined to assess the relationship between reported changes in
dietary PUFA and erythrocyte levels in subjects.
The Human Research Ethics Committee of the University of Wollongong and
Illawarra Area Health Service provided ethical approval for this research.
Information provided to participants and consent forms for this study are provided
in Appendices K and L, respectively.
7.3 Results
Of 101 volunteers, 58 men and women (21 LF group, 20 MF group and 17 Walnut
group) met the selection criteria. With 34 males and 24 females, there was no
significant difference in the proportion of males and females randomised to each
group. One participant from each group withdrew during the six-month intervention
period. Thus, 55 subjects (20 LF, 19 MF, 16 Walnut) provided complete data sets
for all three time points (0, 3 and 6 months) assessed during the trial.
There were no significant differences between groups for age, height, weight, or
BMI, with the average participant bordering on obese at commencement of the
study (Table 7 -2). The three groups were also similar for numbers of participants
reporting a family history of diabetes, ethnic origins, and categories of reported
activity (data not shown). There was no significant difference in the proportion of
males and females randomised to each group. Mean HbA1c results for the total
study sample at baseline indicated good glycaemic control for a diabetes
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population. There were no significant differences between groups for clinical
characteristics except for total cholesterol.
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Table 7-2 Baseline characteristics of subjects from each group and for the total sample

Parameter

Total
sample
59.3±8.1
30.0±3.7
84.5±12.8
33.6±9.1
6.75±1.0
4.52±0.9

Control
(n=21)
60.1±8.2
29.2±2.6
81.9±11.2
31.2±8.1
6.56±0.8
4.79±0.8

Mod Fat
(n=20)
59.8±7.4
30.2±4.6
84.6±14.3
35.1±10.2
6.82±0.9
4.58±0.9

Walnut
(n=17)
57.7±9.0
30.7±3.9
87.6±12.8
34.5±9.1
6.94±1.2
4.11±0.8

P#

Age (yrs)
0.634
2
BMI (kg/m )
0.453
Weight (kg)
0.397
Body fat (%)
0.352
HbA1c (%)
0.475
Cholesterol
0.041
(mmol/l)*#
LDL (mmol/l)*
0.118
2.53±0.8
2.70±0.8
2.66±1.0
2.17±0.7
HDL (mmol/l)*
0.860
1.10±0.2
1.11±0.2
1.11±0.2
1.08±0.3
TG (mmol/l)*
0.255
1.95±0.81
2.18±0.82
1.76±0.84
1.90±0.74
*data were loge transformed prior to analysis
#P value presented is for one-way ANOVA, control and walnut groups were significantly different
using Tukey’s test. Transformation did not correct non-normality, using Kruskal-Wallis P=0.035.

At baseline, there were no significant differences between groups for total energy,
macronutrient and proportional fat intakes (mean+SD) (Table 7-3). In terms of
dietary recommendations, mean SFA intake for each group was within the
recommended range (<10% of energy), with over half of all individuals already
achieving this target for this fat type. Mean PUFA intakes, however, were below
target with only six out of 58 individuals from the total study sample consuming
adequate dietary PUFA (>7%E). Hence, P:S ratio and n-3 PUFA intakes were
below target for all groups at commencement of the study.
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Table 7-3 Energy and macronutrient intakes of all groups at 0,3,6 months intervention: amount consumed (mean±SD) and number (percent) of
subjects achievi ng dietary targets
Variable
Time
Energy (kcal)
CHO (% E)
PTN (%E)
Fat (%E)
SFA (%E)
[n (%)]
PUFA(%E)
[n (%)]
P:S ratio
ALA (g)
[n (%)]
EPA+DHA(g)
[n (%)]
N6:n-3 Ratio
[n (%)]
a

Target

2000
50
20
30
<10%
=7
1
2.22
0.65
<10

a

0
(n=21)
2053.8+568.1
46.4+6.6
20.8+2.8
28.5+6.4
8.9+2.5
14(67)
5.3+1.3
1(5)
0.6+0.2
1.3+0.7
2(10)
0.5+0.3
5(24)
6.6+2.9

Control
3
(n=20)
2128.2+604.8
45.2+7.2
21.0+2.0
29.4+6.9
8.6+2.8
15(75)
c
5.9+1.3
g
4(20)
0.7+0.3
c
1.5+1.1
g
5(25)
c
0.4+0.2
h
3(15)
d
8.2+5.7

6
(n=20)
2146.0+431.8
43.1+8.1
20.7+2.7
32.6+8.5
b
10.2+4.1
h
11(55)
c
5.8+1.8
g
5(25)
0.6+0.3
c
1.4+0.7
g
3(15)
b
0.4+0.2
g
1(5)
7.5+3.6

0
(n=20)
2090.5+504.1
44.1+7.7
20.6+4.5
31.2+7.1
9.7+3.1
10(50)
6.3+2.8
4(20)
0.8+0.6
1.4+1.0
4(20)
0.6+0.5
5(25)
8.2+8.3

Modified fat
3
(n=19)
2015.6+541.7
42.2+6.4
22.5+3.1
31.7+5.9
7.8+2.1
17(90)
c
8.0+2.0
g
12(63)
1.1+0.5
c
2.0+1.1
g
7(37)
c
1.2+0.8
h
14(74)
d
5.3+2.4

6
(n=19)
1977.8+500.1
41.4+6.0
22.6+3.6
32.7+6.1
b
7.7+2.3
h
15(79)
c
9.4+2.8
g
15(79)
1.3+0.5
c
1.7+1.4
g
5(26)
b
1.2+1.1
g
14(74)
8.3+5.0

0
(n=17)
2024.7+664.6
46.9+6.5
21.9+3.4
27.7+7.2
9.0+2.8
8(47)
5.4+1.5
1(6)
0.7+0.4
1.4+1.0
2(12)
0.4+0.4
3(18)
8.6+8.4

Walnut
3
(n=17)
2139.9+574.5
43.9+5.7
20.9+3.3
32.2+5.2
7.8+ 2.4
15(88)
c,e
11.7+1.6
g
17(100)
e
1.7+0.8
c
3.7+1.7
g
16(94)
c
0.7+0.4
h
8(47)
d
5.7+1.4

6
(n=16)
2006.6+376.2
43.5+3.8
21.5+2.5
31.8+4.1
b, f
6.9+1.6
h
16(100)
c,e
11.7+1.8
g
16(100)
e
1.8+0.5
c
3.4+1.9
g
15(94)
b
0.8+0.6
g
9(56)
5.7+1.4

19(91)

15(75)h

15(75)i

17(85)

19(100)h

12(63)i

12(71)

17(100)h

16(100)i

Recommendations from ADA, AHA, ISSFAL and the literature (Hu, 2001).
Significantly different between groups at the given time point (one way ANOVA, p<0.01)
c
Significantly different between groups at the given time point (one way ANOVA, p<0.001)
d
Significantly different between groups at the given time point (one way ANOVA, p<0.05)
e
Significant effect due to treatment over time (repeated measures ANOVA, control versus walnut group, p<0.001)
f
Significant effect due to treatment over time (repeated measures ANOVA, control versus walnut group, p<0.01)
g
Significant difference between groups in proportions achieving target at the given time point (chi square, p<0.001)
h
Significant difference between groups in proportions achieving target at the given time point (chi square, p<0.01)
i
Significant difference between groups in proportions achieving target at the given time point (chi square, p<0.05)
b
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After six months, energy intakes remained similar between groups with no
significant changes from baseline. Significant differences between groups were
confined to the fat profile, emerging as early as the 3-month time point and
maintained at six months. The Walnut group was the only group to achieve all fat
targets by the 3-month tim e point. These values were maintained at six months,
with 100% of individuals achieving desired intakes for total SFA (P<0.01), total
PUFA (P<0.001), and n6:n-3 ratio (P<0.05), with the majority of subjects achieving
minimum n-3 fatty acid intakes. The MF group achieved all fat targets but the
minimum intake for ALA fatty acids, with only 26% of subjects achieving this target
at six months. Additionally, this group was unable to maintain the reduction in n-6:
n-3 ratio seen at three months, whilst the Walnut group achieved the lowest n-6:n-3
ratio. In contrast, the LF group reported little change to mean PUFA intakes, with
few individuals achieving target proportions for individual fat types.
After adjustments for sex, there were no significant changes in body weight
throughout the trial for all study groups (Table 7-4). BMI also remained constant.
There was a trend toward a significant interaction in body fat percentage
(p=0.057). Post hoc follow-up indicated a significant increase in body fat in the
control group only, but there were no other significant changes over time. At the
three month measurement point, there was no significant overall change in body
fat over time, but the change in body fat in the walnut group was significantly
different compared to the control group (p<0.04).
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Table 7-4 Change in weight, body fat, HbA1c and lipids over time

Variable

Control
0
3
N(F/M)
(8/13)
Age
60.48
±8.16
Weight*
81.87
82.07
±11.19 ±11.46
BMI
29.22
29.34
±2.60
±2.72
% body fat* 31.23
32.11
±8.05
±8.41
HbA1c
6.56
6.40
±0.80
±0.85
TC
4.79
4.71
±0.82† ±1.06
LDL
2.70
2.68
(1.56)
(1.76)
HDL
1.11
1.19
±0.22
±0.24
TG
2.18
1.85
±0.82
±0.80
*Baseline and repeated measures
†significantly different at baseline

Modified fat
0
3
(10/10)
59.30
±7.11
82.27
84.55
84.70
±11.67 ±14.31 ±14.00
29.42
30.16
30.12
±2.80
±4.51
±4.33
32.39
35.13
35.54
±8.21
±10.16 ±10.09
6.75
6.82
6.77
±0.88
±0.88
±0.86
4.90
4.58
4.58
±1.08
±0.88
±0.81
2.69
2.58
2.59
(1.49)
(1.30)
(1.29)
1.25
1.11
1.24
±0.27
±0.24
±0.20
2.13
1.76
1.65
±0.71
±0.82
±0.80
analysis adjusted for sex.
6

6

84.36
±14.07
30.05
±4.23
35.51
±9.95
7.03
±0.95
4.83
±0.99
2.73
(1.20)
1.34
±0.21
1.55
±0.73

Walnut
0
(6/11)
57.71
±8.97
87.61
±12.83
30.72
±3.85
34.48
.±9.12
6.94
±1.22
4.11
±0.81†
2.17
(1.31)
1.10
±0.24
1.90
±0.74

3

6

87.05
±13.06
30.51
±4.33
33.72
±8.56
6.58
±0.92
3.94
±0.70
2.01
(1.06)
1.16
±0.24
1.72
±0.60

86.33
±13.07
30.26
±3.84
34.00
±8.97
6.89
±0.82
4.02
±0.77
1.95
(0.75)
1.30
±0.62
1.70
±0.68

P value
time
group

Txg

0.570

0.493

0.248

0.264

0.599

0.229

0.374

0.379

0.057

0.000

0.489

0.380

0.037

0.021

0.434

0.634

0.032

0.316

0.000

0.766

0.046

0.006

0.208

0.174

215

HbA1c levels decreased at three months then increased, leaving a time effect for
overall increase in HbA1c (p<0.001). The level, however, remained at or below 7%
for each group. The total cholesterol levels of the Walnut group remained lower
than the other two groups at each time point (p=0.021). There was also a
significant time effect for changes in this variable (p=0.037), but univariate analysis
failed to show a significant increase in any individual group. In contrast, while LDLC levels of the walnut group were not significantly lower than the other two groups
at baseline (Table 7-2), the continued lower levels produced a significant group
effect in the trial (p=0.032), and in univariate analysis the Walnut group LDL-C
levels decreased significantly over time (p=0.036) with no change observed in the
other two groups (Table 7-4).
HDL c holesterol levels increased significantly in all three groups, producing a time
effect (p<0.001). Post hoc analysis indicated a significant increase in each arm
(p<0.001 for all groups), but the walnut group appeared to increase at a greater
rate in the second six months, noting the significant time by group effect (p=0.046).
Mean triglyceride levels dropped in the first three months, a trend which continued
for all but the control group where they rose again in the second three months. This
produced a significant time effect (p=0.006), but the degree of variation in the data
meant that no significant differences were found between groups in these changes.
Again, the levels were not high, with mean values ranging from 1.55 to
2.18mmol/L.

216
DH data compared well with FR data. The mean difference was close to zero for
each dietary variable, and the range for the limits of agreement lay within defined
and clinically acceptable values (data not shown). Significant correlations were
found between mean and difference values for reported protein intakes at six
months (r=-0.311, P<0.05), SFA at three months (r=-0.319,P<0.05), EPA+DHA at
baseline (r=0.353, P<0.05) and ALA at baseline (r=-0.295, P<0.05) and three
months (r=0.379, P<0.01). On observation of the plots for reported protein, one
extreme value at lower and higher intakes, respectively, appeared to create the
regression line. An outlier in the SFA plot appeared to have a similar effect. The
plots for ALA and EPA+DHA, however, appeared to show a general trend for
greater differences at higher intakes.
Reported energy intakes from the DH were within approximately 10% of estimated
requirements at all time points but the value was substantially higher for FR and
this increased in magnitude with time (Table 7-5).

Table 7-5 Group mean differences between reported energy intakes (EIrep) and estimated ene rgy
(EEest ) as an indicator of under or over reporting in the DH and FR
DH
FR
DH
FR
DH
FR
Group
mean
-12.7(±33.2)
-17.6(±28.2)
-9.3(±25.2)*
-20.2(±30.9)* -10.8(±24.0)* -22.5(±31.0)*
difference
(±SD)
* significantly different at P<0.05 between the groups at each time point; using repeated measures
ANOVA

Dietary intake of very long chain n-3 PUFA (EPA+DHA) was strongly related to the
levels seen in erythrocyte membranes at baseline, three months and six months
(P<0.01) (data not shown). At six months, significant correlations were also seen
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for the n-6:n-3 ratio (P<0.05) and total n-3 fatty acids (P<0.02) (data not shown). A
significant change in the n-6 PUFA content of erythrocyte membranes over the
duration of the study was determined due to treatment over time (P<0.01), with the
greatest increases occurring in the Walnut group (Table 7-6).
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Table 7-6 Erythrocyte fatty acid composition for all groups at 0,3,6 months intervention

Variable
Time
16:0
18:0
18:1n-9
18:2n-6
20:3n-6
20:4n-6
20:5n-3
22:6n-3

0
(n = 21)
20.43±0.77
14.79±0.75
11.70±1.11
8.20±1.11
1.82±0.48
13.91±1.59
1.35±0.44
5.67±0.88

Control
3
(n = 20)
20.36±0.91
14.70±0.69
11.60±1.00
8.39±1.27
1.72±0.48
13.66±1.43
1.21±0.35
5.74 ±1.00

6
(n = 20)
20.70±0.99
15.32±0.50
12.45±1.17
8.60±1.21
1.86±0.53
14.19±1.34
1.32±0.44
5.28±0.90

0
(n = 20)
19.92±1.43
14.98±0.83
11.42±0.64
8.48±1.42
1.80±0.31
13.53±0.89
1.23±0.25
5.87±1.20

Modified fat
3
(n = 19)
20.03±0.93
14.96±0.93
11.32±0.66
8.60±1.43
1.75±0.32
13.14±1.02
1.36±0.40
6.19±1.04

6
(n = 19)
20.34±0.83
15.41±0.49
12.00±0.70
8.68±1.35
1.72±0.34
13.47±1.66
1.75±1.14
6.10±1.24

Erythrocyte membrane fatty acid composition is expressed as % of total fatty acids.
Values are Mean ± SD.
*interaction term significant 0-3 months P=0.003 for contrast

0
(n =17)
19.80±1.07
15.45±0.94
11.93±0.85
7.79±1.21
1.60±0.31
13.38±1.36
1.24±0.55
5.60±1.37

Walnut
3
(n = 17)
19.56±1.42
15.07±1.18
11.47±0.97
8.84±1.60
1.58±0.39
13.06±1.32
1.32±0.70
5.61±1.30

6
(n = 16)
20.49±1.14
15.58±0.88
12.36±0.89
8.92±0.96
1.75±0.38
13.86±1.41
1.84±0.68
5.31±1.38

RMANOVA (P value)
time
treatment interaction
0.000
0.000
0.000
0.000
0.038
0.000
0.155
0.060

0.134
0.348
0.301
0.878
0.437
0.344
0.415
0.232

0.328
0.986
0.488
0.006*
0.168
0.6 52
0.289
0.255
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Analysis of food patterns revealed some interesting data, with specific shifts in
intakes by intervention groups between three and six months, but not the control
group. At baseline, foods rich in SFA contributed the greatest proportion of fat
intake for all groups (38% of mean daily fat intake), with meat providing the main
source of dietary fat (about 22%), and nuts rich in PUFA providing about 10% of
total fat consumption. After six months, this profile remained much the same for the
control group, with SFA-rich staple foods (meat, cheese, milk and butter) the main
source of dietary fat intake (39%). If anything, a small shift in fat sources from
PUFA-rich to MUFA-rich foods was observed for this group. In contrast, the MF
group reported a shift from SFA-rich to both MUFA-rich and PUFA-rich foods (29%
and 32% of total fat intake, respectively). For the Walnut group, however, there
was a big shift to PUFA-rich foods (45% of total fat), substantively walnuts
(individuals reporting 100% compliance for consuming 30g walnuts/day throughout
the length of the study). PUFA-rich nuts (almost exclusively walnuts) now
contributed 31% of total fat intake for this group, with oily fish providing a further
6%.
The major sources of n-3 PUFA for the walnut group were walnuts, where 30g/day
provided 50% of the total daily intake, and oily fish (350g/week) provided a further
17%. The major sources of n-3 fatty acids for the MF group were oily fish, where
500g/week oily fish provided 42% n-3 intake, and a combination of soy products,
legumes and ‘n-3 enriched’ products provided another 22%.
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CONCLUSION

7.4

Summary

Several large studies have demonstrated lifestyle modifications as important
intervention strategies for the prevention and treatment of T2DM and CVD
complications 19-21, 365. The approaches used in these studies provide evidence for
nutrition intervention practices. The RCT, represents the highest level of research
evidence 258 and was the model used for this study to assess the efficacy of three
dietary advice approaches. Structured advice referring to two alternative intake
patterns based on a set of food groups identifying sources of unsaturated fats were
more likely to achieve essential fatty acid targets than general low fat advice
approaches. Importantly, none of the approaches adversely affected energy
balance or blood glucose control in these T2DM patients.
Men and women with established T2DM were randomised into three dietary
intervention groups. There were no significant differences between groups for
dietary intakes at baseline. Mean total fat and SFA intakes were considered
reasonable and low. PUFA intakes, however, were also low across all groups and
below the levels recommended. Taking into account previous exposure to advice,
these results suggest that current dietary advice practices for diabetes, whilst
supportive of total fat reduction, do not enable adequate intakes of dietary PUFA.
These practices appear fairly universal in Western cultures, so the findings would
have reasonable relevance to those outside Australia.
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In an attempt to increase the amount of PUFA, subjects in the MF and Walnut
groups received structured advice for all food groups in the diet including specific
advice on food sources of PUFA, with those in the Walnut group given advice for
the regular consumption of walnuts. After six months, with no significant changes
to mean energy or major macronutrient intakes, dietary fat profiles diverged
significantly from the control group. The MF and Walnut groups achieved desirable
increases in the proportion of total PUFA as well as further reductions in mean
SFA, while the LF group reported little change to individual fat proportions.
Shifts in the fat profile could be explained by changes in food choice patterns,
where fat from SFA-rich staple foods (milk, cheese, meat and butter) was
substituted with regular intakes from significant food sources of PUFA. For the
walnut group these foods were walnuts and oily fish, whereas the MF group
reported oily fish, legumes (mainly calcium enriched soymilk), nuts and n-3
enriched foods. In contrast, the lack of change in sources of fat for the LF group
concur with data from previous intervention trials 22, 23 and from Australian
population surveys 353, 354 that suggest saturated fat remains the main type of
dietary fat in the diet despite lowered total fat intakes.
7.5 Theoretical significance
At commencement of the study, subjects reported sub-optimal habitual PUFA
intakes. A total diet approach incorporating walnuts and oily fish successfully
modified the fat profile in line with current recommendations, without increasing
energy intake in patients with T2DM. The greater success for individuals in the
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Walnut group demonstrated the utility of incorporating a ‘functional food’ source
into the total diet pattern for the achievement of adequate intakes of a required
nutrient 366. Furthermore, greater success by both intervention groups compared
with the control group suggests the need for more structured advice practices in
the clinical context. Judicious food choices from existing core food groups could
also achieve desired fat proportions, but the guidance systems are too blunt to
make this assumption.
While this study has demonstrated the impact of targeted advice on individual
foods, it was important that this knowledge be set in the context of the whole diet.
In order to address the relatively high n-6: n-3 ratio of walnuts advice for the
concomitant inclusion of n-3-rich fish was also required. Thus, 30g walnuts/day and
350g oily fish/week provided 50% (mostly ALA) and 17%, respectively, of total n-3
fatty acid intake. This enabled achievement of the most desirable (lowest) n6: n-3
ratio by the walnut group. The MF group relied more heavily on fish, 500g oily
fish/week providing 42% of n-3 PUFA, with the remaining n-3 intakes coming
largely from a range of food choices including soymilk. This latter pattern of intake
did not enable adequate achievement of the ALA fatty acid target by the MF group,
with a lower n-6: n-3 ratio not maintained at six months. Moreover, the earlier
achievement (at three months) of target PUFA and SFA proportions by 100% of
individuals in the Walnut group indicate that the combination of walnuts and oily
fish were more effective and more sustainable than the larger intake of fish alone.
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Thus, the feasibility of total diet advice incorporating significant individual food
sources of PUFA to individuals with T2DM under free-living conditions has been
demonstrated. The effectiveness of the advice system being tested was confirmed
by relevant health-related clinical outcomes. For example, c hanges in blood lipid
levels confirmed the benefits of changes to the dietary fat profile for improvements
in metabolic control 262. The Walnut group in this study started and continued with
lower total-C than the other two groups and lowered compared to raised levels at
six months, but the changes were not statistically significant over time. However,
LDL-C levels decreased significantly in the Walnut group with no change in the
other two groups , providing a significant group effect. These results may be
explained by the concomitant significant rise in HDL levels, by all groups, with the
Walnut group increasing at a greater rate in the second six months. There were no
detectable differences between groups for changes in triglycerides with the
lowered levels seen in all groups significant over time. Previous evidence of
decreased total-C and LDL-C in the diets of at-risk subjects has been from twothree servings of walnuts per day 367. The significance of this study, therefore, is
that improvements in blood lipids were achieved from a practical single serving per
day.
7.6 Limitations and areas for further research
Of the 101 men and women who volunteered, only about half 50% were eligible for
the study due to the strict selection criteria used. While this may limit generalisation
of results, it ensured an homogenous intervention group, thereby strengthening the
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ability to detect differences over time. The number of participants who did not
complete the study (one from each group) was considered s mall and unlikely to
affect results.
When explaining the results, differences in dietary advice protocols needed also to
be considered. While the control group reflected general dietary advice and
‘flexible’ counseling practices, the two intervention groups were matched for the
‘programmed’ delivery of structured advice for all food groups in the overall diet,
including exchange lists of MUFA-rich and PUFA-rich foods highlighting the
significance of identifying these food sources for achievement of fat targets. Hence,
results from alternative patterns of food intake could emerge.
Where primary outcomes were dietary variables and achievement of dietary goals,
dietary compliance was an important aspect of study design. Regular contact and
monthly provision of portion-controlled packs of walnut supplies enabled regular
monitoring. The previous exposure to dietary advice would indicate the potential for
high compliance by all groups. However, the Walnut group was the only group to
achieve all fatty acid targets , reflecting the high adherence to the consumption of
walnuts. Notably, after six months, the LF group had fewer individuals achieving
the SFA target than at the beginning of the study (from 67% to 55%) , with mean
SFA intake increasing to a level above the recommended range.
The lack of change in body weight and BMI across all groups also confirmed the
effectiveness of each intervention protocol with no reduction in energy intake, often
seen in controlled dietary studies, and no weight gain effect often seen in
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supplemental food studies. This suggests optimal dietary compliance and
consistency across treatments. While differences in physical activity were not
noted, and weight remained constant, the trend toward a difference in changes in
body fat between the control and Walnut group was novel. Differences in fatty acid
metabolism may have had a role, where diets lower in saturated fats and higher in
unsaturated fat can impact on body fat distribution and fat mass 368-371. Anecdotal
evidence from subjects in the Walnut group suggests increased s atiety from the
consumption of walnuts, also reported in other nut studies 171, 372, but requiring
further investigation. Regulatory mechanisms at the level of the hypothalamus 373
may be involved and is another area requiring further research.
Energy balance is an important aspect of T2DM and needed to be controlled. The
impact of the regular consumption of high-fat foods on energy intake, therefore,
required further assessment. At commencement of the study, reported energy
intakes for the study sample were reasonable, within around 10% of estimated
requirements. The lack of change in energy intakes, despite marked increases in
oily fish and nut consumption by the two intervention groups, demonstrated the
utility of structured total diet advice for the incorporation of high-fat foods.
Another important aspect of T2DM management is measures of blood glucose
control. Results for the study sample were considered representative of good
diabetic control at the beginning of the study. While some deterioration in
glycaemic control might be expected over six months, mean HbA1c remained at or
below 7% for each study group with no significant differences between groups,
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indicating reasonable control of the diabetic state. Such results demonstrate the
worthiness of all intervention protocols and help allay concerns that increased
PUFA consumption (more than doubled in the W alnut group) might have adverse
effects on glycaemic control.
The quality of dietary data was also assessed and found to be favorable for this
type of analysis. The DH provided more accurate estimates of energy intake, while
FR showed negative signs of subject burden 279, 288. Bias was unlikely or
explainable for most variables. For example, while differences between the two
methods for ALA and EPA+DHA intakes at baseline were plausible, this was likely
due to infrequent intakes of foods such as fish and not consumed during the three
days of FR. In contrast, the DH covers all variation in intake and is more likely to
capture irregular consumption patterns. More regular intakes of foods high in ALA
and EPA+DHA at six months resulted in greater agreement and justified the use of
the DH as the reference method for studying dietary change. In particular, changes
in reported n-6 and n-3 fatty acids were confirmed over time through biomarker
analyses, including the regular consumption of walnuts and fish, respectively. The
strongest correlation with dietary intake was for reported EPA+DHA at all time
points (P<0.01), although significant correlations for n-6: n-3 ratio and for total n-3
PUFA at the completion of the study also confirmed reported intakes.
7.7 Relevance to thesis and implications for practice
This trial has confirmed the feasibility of a structured ad vice system to bring about
pre-determined changes in nutrient intakes and improvements in clinical outcomes
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under free living conditions. For the treatment of diabetes, the theory on nutrients
was successfully implemented through the identification of significant food sources
of unsaturated fatty acids for recommended changes to the dietary fat profile. For
the purposes of this thesis, RCT conditions substantiated the effectiveness of the
advice system in terms of improvements in health outcomes such as blood lipid
levels and percent body fat, clinical associations for diabetes and the Metabolic
Syndrome. Furthermore, the successful inclusion of walnuts for the delivery of
adequate PUFA and by extension n-3 fatty acid intakes without changes to other
dietary variables demonstrated the utility of the system for assessments of
individual food/nutrient effects.
Dietary assessment for individuals with diabetes should, therefore, consider the
type of fat in the overall diet. Advice will require attention to both lowering SFA and
ensuring adequate amounts of unsaturated fat, particularly challenging in terms of
PUFA intakes. This study has demonstrated the value of using a food group
approach to total diet advice in which separating out foods based on their fat
composition is useful for achieving proportional intakes of different types of fat. In
addition, incorporating walnuts within this framework is likely to assure adequate
intakes of PUFAs, including substantial amounts of n-3 fatty acids.
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CHAPTER 8 THE EFFECTIVENESS OF STRUCTURED FOOD PATTERN
AD VICE FOR NUTRITION INTERVENTION

8.1 Summary
The effectiveness of MNT is dependent on the conversion of theoretical positions
on nutrient intakes to practical advice on foods. This thesis has demonstrated that
structured advice linking theoretical macronutrient targets to food sources will
result in better achievement of nutritional guidelines and subsequent clinical benefit
than general dietary advice. Using diabetes treatment as the example, an advice
system based on specific food sources of macronutrients and individual types of fat
was developed and applied in the clinical context. Achievement of targets for
energy and individual fat proportions by subjects under free-living conditions
confirmed the feasibility of the advice system, whilst improvements in clinical
outcomes substantiated the benefit. In this way, evidence has been provided for
MNT and the methodology for establishing this evidence has been exposed.
Diabetes is one of a cluster of clinical abnormalities known as the Metabolic
Syndrome, linked to insulin resistance and CVD risk 6, 374. The traditional focus for
dietary management has been on CHO intake for direct effects on blood glucose
control3. However, the weight of current research evidence supports consumption
of specific proportions of different types of fat to benefit the broader concept of
metabolic control and, hence, a range of related outcomes 10 . Nutrition guidelines
for diabetes and related complications largely reflect the research evidence by
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providing recommendations for specific proportions of saturated and unsaturated
fats in the diet 8. Current food guidance systems are not specific enough to ensure
individual fat targets 16 . In fact, adjunct dietary advice that refers to exchangeable
edible fat portions has the potential to increase total fat and energy 25 and the
proportion of n-6 rather than n-3 fatty acids 24, which may compromise potential
benefits. Consequently, this thesis considered that, in the case of diabetes
treatment, the challenge was to develop a food-based system to concurrently guide
advice for the provision of adequate nutrition as well as controlling energy intake,
and the amount and type of CHO and fat in the diet.
In order to develop a food-based advice framework, the research focus was on
food patterns for delivery of the required nutrient mix. Examination of the usual
food intakes of a sample of glucose intolerant women in Study 1 of this thesis
provided insight into the possible link between dietary change, food factors and
patterns of intake, and abnormal glucose metabolism. In turn, da ta from this first
study sample contributed to the identification of food groups as sources of
macronutrient variables and the development of a model intake pattern to address
the macronutrient content of the total diet, outlined in Study 2 of the thesis . In this
way, a food guidance system for the achievement of individual fat targets and
adequate nutrition was established using all foods in the diet. The theoretical basis
of the system was confirmed via the practical application in women with GDM in
Study 3, and also demonstrated in men and women with T2DM in Study 4. The
latter study also confirmed the clinical effectiveness of the food group approach
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and demonstrated the incorporation of an individual food source of a specific
nutrient and subsequent improvements in health-related outcomes.
8.2 Limitations in study design
Generalisations that could be made from the combined studies are outlined in the
following discussion. As acknowledged throughout this research, study design was
important in order to effectively assess the relationship between specific food
patterns and differences in nutrient intakes and subsequent clinical values 258. In
each of the trials conducted, differences in fat profile alone were achieved using
parallel treatment groups in which advice was similar for all aspects of the diet
except for specific information on certain foods as sources of individual fat types.
Thus, it could be argued that the changes observed in clinical outcomes, for
example significant differences for improvements in blood lipid profiles, were due to
differences in the proportions of individual fat types, in particular increases in the
amount of dietary PUFA, with shifts in food patterns guiding their achievement.
While the RCT is at the pinnacle of research evidence for diet-disease
relationships, limitations applicable to all intervention trials apply 258. In reality,
proving ‘cause and effect’ relationships between a dietary treatment and clinical
outcomes such as insul in resistance is inherently difficult. First of all, evidence from
dietary studies in humans relies on less direct affects using known clinical markers
of disease. Secondly, multiple food components and variation between individuals
make it hard to identify a single dietary variable that impacts on these outcomes.
Where the aim of research is to provide evidence to inform practice, this is largely
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dependent on the careful and successful transfer of the theory on nutrient effects
into appropriate advice on f oods. Constructing a food pattern that identifies specific
sources of required nutrients is a useful approach for aligning nutrient intakes with
individual foods. While food pattern analyses may be biased due to prior
knowledge on nutrient/food factor effects 267, the descriptive nature of results
informs practice and enhances dietary advice in a way that nutrient analyses
cannot.
Greater numbers of individuals in the intervention groups achieved dietary targets,
clearly indicating a better transfer of nutrient intake theory to clinical practice.
Advice to each individual, however, exposed the variation inherent in exchange list
systems based on representative nutrient estimates, and highlights the need to
emphasize variety in the delivery of advice to free-living individuals 17. This thesis
demonstrated that reference to a structured food intake pattern encompassing the
macronutrient content of the total diet supports variety in food intake as well as low
variation in nutrient intake. While additional food groups and sub-categories of
foods reduced the variation between individual foods and allowed an emphasis on
foods as secondary nutrient sources, too many lists, however, may prove
cumbersome and impractical for the delivery of simplified food-based advice.
If nutrition research is to provide evidence for practice via reliable and valid results,
compliance to dietary advice is an important issue that requires substantial
support. The structured nature of clinic support and of the advice system itself was
effective for the achievement of dietary targets in two trials involving individuals
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with GDM and T2DM, respectively. The supply of walnuts in Study 4 to individuals
with T2DM in standard portion amounts assured minimum PUFA targets and took
the guesswork out of advice and subsequent measures of compliance. The lack of
significant differences in weight between groups in both trials supported dietary
compliance across treatments, while differences in lipid profile in T2DM subjects
reflected differences in adherence to nutrient targets. Lower cholesterol levels for
the Walnut group throughout this study were the result of a randomization
phenomenon. This bias meant that a significant improvement in that group was
more difficult to achieve, and only served to strengthen the particular outcome for a
further reduction by this group.
Having achieved dietary differences, it was also important to provide evidence for
the acceptability and practicability of the dietary protocol by individuals in the study
samples. Up to six months adherence to advice by free-living T2DM individuals
was a good indication of the feasibility of the developed system. However, advice
to intervention groups was individualised and followed an intensive treatment
format. These aspects of dietary counseling have previously been found to be
effective 19, 20, 189, 191, but not always provided as standard clinical practice. The
provision to subjects of a convenient daily portion amount of walnuts may have
aided the 100% dietary adherence reported. However, the consumption of walnuts
in a realistic amount also had an impact, suggesting ready transfer to the free-living
context. This was confirmed in the form of positive feedback from subjects in this
group.
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The transfer of results to other groups is contingent on similar qualities between
those in the study sample and those to whom results are to be generalized 258.
Results from any one cohort may demonstrate bias related to the characteristics of
the group as well as the known bias association with greater motivation to comply
in study volunteers. However, high motivation and exposure to previous advice are
qualities associated with people with diabetes, and therefore may be characteristic
of the wider diabetes community. In the trials reported as part of this thesis, a
narrow range of selection criteria limited the numbers recruited but resulted in
similar dietary and clinical characteristics at baseline, strengthening the ability to
detect a difference due to treatment over time. Similarly, differences in the
experience and skills of the practitioner must not unduly bias results. For this, the
structured nature of the model food intake pattern evaluated in this thesis provided
a template for practitioner and patient alike, allowing more standardised tailoring of
individualised advice and systematic monitoring of dietary compliance.
The ‘validity’ of dietary data as primary outcome variables has implications for the
interpretation of results and acceptance as evidence for nutrition intervention
practices 294. The lack of a reference measure or ‘gold standard’ against which to
assess dietary intake data is considered problematic 285 .Therefore, comparisons
between methods is dependent on estimates of potential bias to provide an
understanding of the relationship between the test measure and the truth.
Compared with FR data, the quality of data from the DH method was considered
favorable. Bias was either unlikely or explainable, with the FR showing negative
signs of subject burden over time. The DH was useful in these analyses in that it
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covered all variations in meal and intake patterns and therefore was a more
accurate measure of habitual intake than the FR. In particular the DH captured
irregular consumption patterns of individual foods such as fish. Where ‘underreporting’ of energy intake is possibly the greatest source of bias in dietary studies
294

, again the DH was assessed as less susceptible and confirmed as the most

appropriate method for dietary analyses in this research. Biomarker analyses
confirmed reported n-6 and n-3 intakes and changes in intakes over time,
substantiating intakes of walnuts and fish as major sources, and adding support to
the relationships between nutrients, foods and changes in clinical values, in this
case, consistent with existing knowledge on dietary fat and its influence on
metabolic markers of insulin resistance 74, 77.
8.3 Significance of the research to this thesis
Where this thesis sought to provide evidence for nutrition and dietetics practice, the
establishment of a dietary advice system required an understanding of the
relationships between food patterns and clinical outcomes. Although the focus was
on changes in fat intake, established clinical practices needed to be taken into
account. In the case of diabetes treatment, these target the CHO fraction of the
diet. In support of this, the findings from observations of the dietary intakes of GDM
women in Study 1 illustrated the complex nature of dietary change and its impact
on food patterns within the overall diet. Whilst the results justified attention to CHO
intakes, they demonstrated the variation in food factors relating to this nutrient and
possible implications for blood glucose control. The results suggest that both the
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type and distribution of CHO intake are important and that reference should be
made to specific food groups, portion sizes and the overall pattern of foods within
the total diet.
The process for developing an appropriate set of food groups and construction of a
model dietary intake pattern demonstrated how individual food sources of required
nutrients could be incorporated into the total diet to achieve targeted nutrient
proportions. Whilst applicable to all nutrients, achievement of individual fat targets
highlighted the inadequacies of core food groups for this purpose and the need to
identify a greater number of food groups to address a broader range of nutrients
and specific nutritional requirements beyond those required to provide adequate
nutrition 266 . The substantial contribution of fat from secondary food sources, such
as milk and meat as sources of SFA, and fish and soy as sources of PUFA,
demonstrated the need to effectively identify these foods in advice seeking to
enable an effective exchange of nutrient intakes and thus modify dietary fat profile.
Whilst core food groups within the model readily achieved the saturated fat limit,
achievement of optimal overall fat profile was dependent on the adequate inclusion
of PUFA-rich food groups.
Using the RCT as the gold standard to confirm the feasibility and relevance of
structured advice to diabetes groups, its practical application was tested in the
free-living context. Importantly, the shift in focus from CHO intake and glycaemic
control to the application of the theory on fat for overall metabolic control had no
negative effects for controlling energy intakes, weight and glucose homeostasis
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compared with control groups receiving conventional advice. Thus, the
effectiveness of each of the dietary protocols for short-term clinical benefit was
confirmed. Longer-term risk management in terms of clinical markers of IR and
CVD risk, however, was only addressed in the intervention groups in which
recommendations for different fat types were achieved.
Assessment of habitual intakes at baseline determined the consumption of dietary
PUFA as inadequate across all groups in which habitual intakes were assessed.
This was the case regardless of previous exposure to dietary advice as part of
diabetes management in both GDM and T2DM and/or already lowered SFA
intakes, as was the case in T2DM individuals. Thus, the focus of advice was
largel y on the adequate achievement of recommended PUFA intakes. In GDM
women, the better achievement of the recommended fat profile in the intervention
group, in terms of group and individual data, reflected increased intakes of PUFArich foods, mainly through shifts in fat intake from meat and dairy (using leaner cuts
and low fat products) to oily fish, soy and nuts.
The successful transfer of advice from GDM women to the wider T2DM community
was an important step in the validation process. Further, incorporation of an
individual food (walnuts) as delivery agent for increasing PUFA intakes was
simultaneously assessed and the benefits substantiated through relevant clinical
outcomes. Hence, two intervention groups in this study demonstrated alternative
food choic es from within the same framework for achievement at six months of
specific targets for individual fat proportions, including those set for n-3 PUFA
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intake. On the one hand, an average 500g oily fish per week provided the main
source of PUFA/n-3 PUFA in the diet. Alternatively, the incorporation of walnuts
into the overall diet resulted in an even better achievement of PUFA targets (the
recommendation for alpha-linolenic acid (n-3 PUFA) was only achieved by the
Walnut group). Providing the substantial portion of PUFA intakes and 50% of n-3
PUFA intakes, 30g (1oz) walnuts per day reduced the dependence on fish to 350g
per week. Importantly, the high n-6:n-3 ratio of walnuts was not reflected in the
overall ratio for the total diet, verifying the value of total diet advice and
underscoring the significance of complementary food combinations such as
walnuts and fish. Furthermore, the early achievement of dietary targets by the
Walnut group (in three months rather than six) indicated an important role for key
food sources of essential nutrients in getting results, and by extension benefits,
faster.
In contrast, the lack of impact on fat proportions in control groups (both GDM and
T2DM) highlighted the inadequacies of existing advice systems to address targets
for fat types. In GDM this may be attributed to the low priority given to advice on fat
for these women. However, in T2DM general advice on fat and fat type, including
the recommended ‘two servings of fish per week’ 8, 375, was provided to the control
group in that study. Of concern was that SFA intakes for the control group actually
deteriorated over the study period. This supports the argument that general low fat
advice focuses attention on excluding visible edible fats, mainly unsaturated fats,
whilst a large proportion of SFA intake is from core food staples.
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For those incorporating walnuts into the total diet over six months, the weight gain
often reported in ‘supplemental’ food studies did not occur 357. Further, in view of
the lack of differences between groups for weight change and physical activity
levels, the trend toward body fat loss in the Walnut group was an interesting
phenomenon and may reflect suggestions that diets lower in saturated fat and
higher in unsaturated fats have a beneficial effect on body fat distribution and fat
mass 368, 370, 371, 376 . Whether this was due to differences in fat metabolism and/or
regulatory mechanisms at the level of the hypothalamus 377 , however, requires
further research. Anecdotal evidence suggests increased satiety may have been a
factor.
Beneficial changes to the blood lipid profile provided further evidence of the
effectiveness of the advice system for exchanging saturated for unsaturated fat in
the diet, a phenomenon reported by previous studies in which the balance of fat
intake has been shifted rather than reductions in total fat intake alone 262. While
improvements in blood lipid levels have been previously shown in response to
walnuts, these studies used much larger ‘supplemental’ amounts 357, where longterm adherence may be an issue. This research has demonstrated the way in
which a realistic amount of an individual food can be incorporated into the total diet
to increase consumption of a required nutrient to adequate levels to obtain health
benefits.
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8.4 Applications to research methodology and clinical practice
In this thesis, the development of an appropriate advice framework for the
treatment of diabetes required reference to the theory on nutrients and previous
research on food patterns as well as evidence from previous dietary intervention
trials. In this way, a set of reference food groups and overall pattern of intake was
established in which all foods are addressed and the recommended diet is
described in a way that supports advice. Theoretical evaluation and successful
transfer to practice in RCTs provided a methodology for nutrition intervention.
RCTs provide the highest level of research evidence to support the theory on
nutrients, demonstrating the practical application of advice methodologies and
substantiating benefits in free-living individuals and. The results provide evidence
for nutrition intervention and a methodological framework in which manipulation of
specific nutrients and foods within the overall diet can be achieved and consistent
health-related outcomes attained. The studies conducted as part of this thesis have
shown how researchers/clinicians may use knowledge on food group composition
to tailor advice to individuals for achievement of dietary targets (nutrients under
study) and consistent clinical outcomes. Prior development of food groups and the
construction of a dietary model with specific targets in mind ensured an appropriate
food intake pattern on which to base advice for individuals. Whilst theoretical
evaluations acknowledged the variation inherent in free-living intakes, the lack of
differences between intervention groups for major macronutrient variables,
including total fat intake, was an important result. Thus, the practical application of
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the advice system demonstrated how total diet advice could effect a change in
target variables without impacting on other dietary variables. More specifically, it
confirmed the successful manipulation of individual fat types without unwanted
increases in total fat and energy intakes that may dilute diet-disease associations
and/or counter anticipated benefits 25. This is an important premise in
substantiation research methodology so that individual food/nutrient contributions
to the diet can be identified in relation to specific health outcomes. In this way, the
inclusion of walnuts to increase intakes of n-3 PUFA demonstrated the
effectiveness of a structured advice framework for testing a single food as the only
change to the diets of free-living individuals and the way in which assessments in
substantiation research apply. While the treatment was for diabetes and individual
fats were the nutrients targeted, in theory the principles would apply to other
nutrients and food sources. Future research application would involve the
substantiation of health claims on individual nutrients/foods. In terms of evidence
for practice, future research might involve the application of the advice system in
other treatment groups. Of particular interest would be adaptations for specific
ethnic groups using culturally appropriate foods. Alternatively, the novel finding
relating to body fat loss in response to the food pattern inclusive of walnuts (Study
4) suggests application of the system in overweight/obese subjects for the
establishment of evidence on the correct macronutrient balance for the
management of overweight 378.
MNT requires evidence-based support for the specific application of research
knowledge. In the case of evidence-based practices for diabetes and related
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complications, dietary approaches for long- and short-term risk management need
to be confirmed. In terms of direct effects on glycaemic control, established
practices attending to the amount and type of CHO in the diet appears justified,
with equivalent amounts of CHO per serve to allow portion control. Where the
glycaemic effect of individual foods largely match established core food groups, for
example milk and fruit as low GI foods, an emphasis on these foods is considered
reasonable. Further discrimination within the starch group (bread and cereals plus
starchy vegetables) based on whole grains, high fibre and/or gycaemic index can
be readily implemented. In the RCTs conducted as part of this thesis, this attention
to the CHO fraction was incorporated into the advice system and was consistent
across advice groups resulting in good glycaemic control for all groups. However,
in terms of longer-term risk management for people with diabetes, the
establishment of proven methods for addressing the fat profile was required to
support the change in focus to overall metabolic control and recommendations for
proportional intakes within the fat fraction of the diet.
Appropriate advice referred to a greater number of food groups than used to
assure nutritional adequacy. The additional food groups distinguished between
SFA-rich (meat and dairy) and PUFA-rich foods (soy, fish, oils and nuts) and
enabled a model food intake pattern for the achievement of targets for individual fat
types whilst controlling energy and other nutrients. Significantly, while differences
in food choices were achieved, food groups developed to identify specific sources
of PUFA were essential to the achievement of targets within the fat profile.
Furthermore, overall nutrition was not compromised by modifications to core food
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groups and staple foods. The incorporation of walnuts demonstrated the way in
which an individual food can be included in a ‘healthy diet’ pattern for the
convenient and swift delivery of adequate or substantial amounts of a required
nutrient.
In summary, in MNT the application of advice requires evidence to support
practice. This thesis has provided evidence from theoretical and practical research
perspectives for a structured approach to advice. Hence, an advice system linking
nutrients to food patterns and individual foods was developed to assure targets in
nutrition intervention. Using the advice system for diabetes treatment, current
recommendations on macronutrients and the type of fat in the diet were
theoretically established in a model food pattern. Implementation of the advice
system in diabetes groups under free living conditions was shown to be feasible
and effective in practice affording evidence to support nutrition intervention
research and MNT in the treatment of diabetes.
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APPENDIX A: FOOD SUBSTITUTIONS USED FOR GI ANALYSIS IN STUDY 1

Food Item
Cereal/grains
Bread
Breadcrumbs, commercial
Bread, lebanese, white
Bread, mixed grain
Raisin toast, commercial
Breakfast Cereal
Muesli slice, home prep
Muesli bar, choc-coated
Muesli, swiss-style
Bakery Goods
Cake, carrot/chocolate/plain
Cake, fruit
Cake, rock
McMuffin, bacon & egg
Meat pie/pasty
Muffin, banana/bran/chocolate
Pie, apple, high, family
Pie, cottage
Pudding, sponge, steamed
Sausage roll
Scone, plain, commercial
Vol au vent
Biscuits
Biscuit, plain sweet, unspecified
Cruskits, crispbread
Tiny Teddy biscuits
Pasta
Lasagna/cannelloni
Rice
Rice, creamed, canned
Rice, fried, Chinese restaurant
Rice, white, boiled, unspecified

Substitution

GI

Bread, white (wheat flour), mean
Pita bread
Multi-grain, Tip Top
Bread, white+sultanas+sucrose, mean

70
57
43
46

Muesli, b/fast cereal, toasted
Muesli bar + chocolate, milk, mean
Muesli, b/fast cereal, non-toasted

43
55
56

Cake, pound
Cake, pound + sultanas, mean
Cake, pound
English Muffin bread
Pastry, flaky
Mean of all muffins
Pastry + apple, mean
Pastry, flaky + potato, mashed
Cake, sponge
Pastry, flaky + sausage, mean
Bread, white (wheat flour), mean
Pastry, flaky

54
55
54
77
59
60
49
75
46
44
70
59

Arrowroot + Morning Coffee, mean
Mean of all crackers
Arrowroot + Morning Coffee, mean

70
71
70

Ravioli, meat -filled, cooked

39

Rice, Calrose, white+milk, whole, fluid +
sucrose, mean
Mean of all white rice
Rice, Calrose, white, cooked

60
83
87
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Food Item
Fruit
Salad, fruit, fresh
Apple, canned, sweetened
Apple, stewed
Fruit drink, apple
Fruit drink, orange
Jam, 100% fruit or unspecified
Jam, stone fruit
Mandarin
Nectarine
Vegetables
Nachos, home prep
Potato, chips, commercial
Potato, mashed, dried
Potato, new, peeled, boiled
Potato, pale skin, baked
Potato, pale skin, mashed
Potato, pale, skin, peeled, boiled
Taco shell, El Paso
Milk Products
Flavoured milk
Frozen Yoghurt
Smoothie, banana
Sundae, McDonalds
Thickshake, McDonalds

Substitution

GI

Fruit cocktail, canned in natural juice
Apple + sucrose, mean
Apple
Apple juice + sucrose, mean
Orange juice + sucrose, mean
Mean of all jam
Jam, Glen Ewin, apricot spread
Orange
Peach

55
52
38
53
55
53
55
44
42

Corn chips, Doritos
French fries, fine cut
Instant potato, prepared
Potato, new, canned, drained
Potato, Pontiac, baked in oven, mean

42
75
83
65
93

Potato, Pontiac, mashed, mean
Potato, Sebago, peeled, boiled, mean
Corn chips, Doritos

91
87
42

Milk, whole, fluid + sucrose, mean
Mean of all yoghurt
Milk, whole, fluid + banana
Ice cream, full fat + sucrose, mean
Milk, whole, fluid + ice cream + sucrose, mean

46
25
41
63
51

Sugar-rich products
Sugar-rich beverages
Mineral water, flavoured
Soft drink, all flavours
Sugar-rich foods
Chocolate, candy -coated
Chocolate, dark/milk
Chocolate, milk, with nuts
Golden syrup
Gums
Ice confection
Licorice
Picnic Bar
Sugar confectionary, jelly type
Miscellaneous foods
Beer nut, salted
Beans, mixed, canned
Dumpling
Falafel/hummus
Soup, bean, home prep
Sauce, black bean
Soup, chicken noodle, dry mix

Soft drink, Fanta
Soft drink, Fanta

68
68

Chocolate, milk + sucrose, mean
Chocolate, milk
Chocolate, milk + peanuts, mean
Sucrose, mean
Sucrose, mean
Sucrose, mean
Sucrose, mean
Snickers Bar
Jelly beans

57
49
32
65
65
65
65
41
80

Peanuts, roasted, salted, mean
Mean of all beans
Bread, white (wheat flour), mean
Chick peas, boiled, mean
Mean of all beans
Black beans, boiled
Noodles, 2-minute

14
37
70
33
37
30
46
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APPENDIX B: CARBOHYDRATE -RICH FOODS OF UNKNOW N GI EXCLUDED FROM GI
ANALYSIS IN

STUDY 1

Cereal/grains

Fruit

Sugar-rich products

Biscuit, choc-coated
Biscuit, chocolate chip
Biscuit, cream-filled
Biscuit, cream-filled, choc
Bun, fruit, iced
Cake, iced
Chocolate Bavarian
Cornflour
Ice cream cone
Lamington
Mint slice, biscuit
Nut Feast, Uncle Toby’s
Pancake
Pastry, shortcrust
Rice cracker, plain, Sakata
Rice pudding
Spring roll, deep fried
Spring roll, Thai, restaurant
Tabbouleh
Tim Tam, Arnotts

Apricot nectar
Fruit bar
Prune

Cherry Ripe
Chocolate topping
Crunch, chocolate
Kit Kat
Violet crumble

Vegetables
Coleslaw
Potato gems
Potato salad
Potato scallop, deep fried
Rhubarb, stewed, sugar added
Milk products
Beverage, chocolate, Cadbury
Buttermilk, cultured
Fruche
Malted milk powder
Paddle pop

Miscellaneous foods
Cheesecake
Devon/fritz
Ice cream cone
Moussaka
Pie, fruit
Pie, lemon
Pudding, self-saucing
Quiche
Slice, vanilla
Soup, minestrone
Soup, pea & ham
Tart, custard
Twisties, chips
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APPENDIX C: I NTERVIEWER -ADMINISTERED DIET HISTORY Q UESTIONNAIRE I N S TUDY 3

Illawarra Health & Smart Foods Centre
Interviewer-administered Diet History

Client code: _________________

Age: _________

Interviewer: _________________

Interview number: ____________

DOB: _______________ Height: ____________ cm

Current Weight: _____________

BMI: ___________

Date: _____________

Pre pregnancy Weight: ______________

Parity: ____________

Est. Date of Delivery: ______________

Previous GDM pregnancies: _______________

Family History of Diabetes: _________________________________________

Country of birth: ________________________

Ethnicity: _________________________

Medications: _______________________________________________________________________________________________

History of health conditions: ____________________________________________________________________________________
Supplements: _________________________________________________________________________________________________
Physical activity:_______________________________________________________________________________________________
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Part 1: Breakfast How many days in the week do you eat breakfast? __________
Prompts
CARBOHYDRATE
Bread/toast/fruit loaf
Muffin/crumpet
Cereal–cold/hot
Potato/corn
Baked beans
Fruit/juice
Milk/Soymilk
Yoghurt
PROTEIN
Meat/bacon/sausages
Cheese
Eggs (regular/n-3)
Fish/fresh/canned/paste
VEGETABLES
Tomato
Mushroom
Canned
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
honey/jam/vegemite/sauce
Cordial/soft drink

Type

Serving Size

Frequency
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Part 2: Morning Tea How many days in the week do you eat morning tea/snacks? ______________
Prompts
CARBOHYDRATE
Bread/toast/fruit loaf
Muffin/crumpet
Biscuit/crackers/cake
Cereal bar
Baked beans
Fruit/juice
Milk/Soymilk
Yoghurt
PROTEIN
Cold meat/chicken
Cheese
Eggs (regular/n-3)
Salmon/tuna/sardines
VEGETABLES
Salad
Cooked
Canned
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
jam/honey/vegemite/sauce
Cordial/soft drink

Type

Serving Size

Frequency
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Part 3: Light Meal How many days in the week do you eat a light meal at home? __________ Away from home?___________
Prompts
CARBOHYDRATE
Bread/toast/roll/flat bread
Muffin/crumpet/croissant
Biscuit/crackers/cake
Potato/corn
Baked beans
Fruit/juice
Milk/Soymilk
Yoghurt
PROTEIN
Cold meat/chicken
Cheese
Eggs (regular/n-3)
Salmon/tuna/sardines
VEGETABLES
Salad
Cooked
Canned
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
jam/honey/vegemite/sauce
Cordial/soft drink

Type

Serving Size

Frequency
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Part 4: Afternoon Tea How many days in the week do you eat afternoon tea/snacks? ____________________
Prompts
CARBOHYDRATE
Bread/toast/fruit loaf
Muffin/crumpet
Biscuit/crackers/cake
Cereal bar
Baked beans
Fruit/juice
Milk/Soymilk
Yoghurt
PROTEIN
Cold meat/chicken
Cheese
Eggs (regular/n-3)
Salmon/tuna
VEGETABLES
Salad
Cooked
Canned
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
jam/honey/vegemite/sauce
Cordial/soft drink

Type

Serving Size

Frequency
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Part 5: Main Meal How many days in the week do you eat the main meal at home? _________ Away from home?_________
Prompts
CARBOHYDRATE
Potato/pumpkin/mashed
Sweet potato/corn
Pasta/rice/couscous
Lasagna
Chips/wedges
Bread/toast
Beans/lentils
Fruit-canned/fresh/Juice
Milk/soymilk
Custard/ice cream/yoghurt
PROTEIN
Meat/steak/chop/sausages
Chicken
Cheese
Quiche
Eggs (regular/n-3)
Fish-fresh/frozen/canned
Soy products/tofu
VEGETABLES
Carrot
Peas/beans
Broccoli/zucchini
Cabbage/cauliflower
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
COMPOSITE MEALS: (frozen dinners)

Type

Cooking method

Serving size

Frequency
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Part 5: Main Meal (Continued)
Prompts
CARBOHYDRATE
Potato/pumpkin/mashed
Sweet potato/corn
Pasta/rice/couscous
Lasagna
Chips/wedges
Bread/toast
Beans/lentils
Fruit-canned/fresh/Juice
Milk/soymilk
Custard/ice cream/yoghurt
PROTEIN
Meat/steak/chop/sausages
Chicken
Cheese
Quiche
Eggs (regular/n-3)
Fish-fresh/frozen/canned
Soy products/tofu
VEGETABLES
Carrot
Peas/beans
Broccoli/zucchini
Cabbage/cauliflower
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
COMPOSITE MEALS: (frozen dinners)

Type

Cooking method

Serving size

Frequency
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Part 5: Main Meal (Desserts/Drinks)
Prompts
CARBOHYDRATE
Rice
Bread/toast
Fruit pie/pastries
Pudding/cake/cheesecake
Sago
Beans/lentils
Fruit-canned/fresh/Juice
Milk/soymilk
Custard/ice cream/yoghurt
PROTEIN
Cheese
Eggs (regular/n-3)
Soy products/tofu
VEGETABLES
Rhubarb

FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
Cordial/soft drink

Type

Cooking method

Serving size

Frequency

312

Part 6: Takeaway/Restaurant Meals
Prompts
McDonald’s
• Quarter pounder
• Burger
• Fries
• shake/sundae
Kentucky Fried Chicken
• fried chicken
• roast chicken
• nuggets
• fries
Pizza
• pan
• thin-based
• toppings
• soft drink
Asian food
• Chinese
• Japanese
• Thai
• Vietnamese
Fish and chips
• battered and fried
• grilled
• potato scallops
• fries
Other
• soft drink
• Indian food
• Italian food
• Mexican food

Type

Serving size

Frequency
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Part 7: Evening Snack Foods
Prompts
CARBOHYDRATE
Bread/toast/fruit loaf
Muffin/crumpet
Biscuit/crackers/cake
Fruit/juice
Milk/Soymilk
Custard/ice cream/yoghurt
PROTEIN
Cold meat/chicken
Cheese
Eggs (regular/n-3)
Salmon/tuna
VEGETABLES
Salad
Cooked
Canned
FAT
Margarine/oil/dressing
Peanut butter/nuts
Avocado/olives
Butter/cream
Other Foods
Tea/coffee
Sugar/milo
jam/honey/vegemite
Cordial/soft drink

Type

Serving Size

Frequency
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Part 8: Food Frequency Checklist (only tick required if accounted for)
Type of food
Bread
Biscuits/cake
Crisps
Fruit/dried fruit
Fruit juice
Beans/legumes
Milk/yoghurt
Ice Cream
Soft drink/cordial
Jam/honey/spreads
Lollies/chocolate
Cheese 20g = 1 slice, 1party cube, 2tbsp grated
Eggs (regular/n-3 enriched)
Avocado
Fish (white/oily)
Nuts
Alcohol

Serving size

Frequency
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Part 9: Food Preparation Practices
6.1 Butter/Margarine
What type do you usually use?
a) Butter
b) Dairy Blend
c) Margarine - polyunsaturated, regular
6.2 Oil/Fat in Cooking
What type of oil/fat do you use in cooking?
a) Butter
b) Dairy blend
c) Margarine - polyunsaturated, regular
d) Margarine - polyunsaturated, reduced fat
e) Margarine - monounsaturated, regular
f) Margarine - monounsaturated, reduced fat
g) Lard or dripping

e) Margarine - monounsaturated, regular
f) Margarine - monounsaturated, reduced fat
g) Margarine - polyunsaturated, reduced fat

h) Olive oil
i) Canola oil
j) Soybean oil
k) Gold’n Canola
l) Other vegetable oil

6.3 Fat on Meats/Chicken
How much fat is trimmed from meat before cooking/eating?
a) None
b) 25%
c) 50%
d) 75%
e) All
6.4 Salt
a) All the time during cooking
b) All the time at the table
c) Some of the time during cooking
d) Some of the time at the table

h) Canola margarine
i) Gold’n Canola
j) Soy margarine

____________________________________________

How much skin do you eat on chicken?
a) None
b) 25%
c) 50%
d) 75%
e) All
f) Other, please specify: ______________________________
e) Never during cooking
f) Never at the table
g) I don’t use salt at all

What do you consider to be a serve of salt? __________________
1
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APPENDIX D: 3 DAY FOOD RECORD IN STUDY 3

THE UNIVERSITY OF WOLLONGONG
METABOLIC RESEARCH CENTRE
ILLAWARRA DIETARY INTERVENTION STUDIES
3 DAY FOOD RECORD/DIARY
We need as much detail as possible so these diaries can be of use to estimate your usual consumption. Please
help by checking that you have supplied the following information as you record each meal.
Measuring cups, spoons and small kitchen scales are supplied to you, so please use them to record amounts.
A sample record is enclosed as an example of one volunteer’s diary.
Breakfasts
Cereal – type, brand, amount. Measure amount milk, sugar added. Also type of milk.
Toast/Bread – which type, brand is useful.
Spreads – measure your usual spread by the teaspoon as it goes on – this can be your reference each day. This
amount may vary for crumpets/toast, compared to bread as hot toast/crumpets soak up more butter/margarine.
Toppings – did you have jam, honey, etc., amount/teaspoons if possible.
Tea/Coffee – how do you have it? Measure your usual dash of milk once to see how much you add. Tell us type
of milk and amount of sugar added, if any.
Fruit/Fruit Juices – amounts. Please specify brand of juice and whether 100%, or if it is a fruit drink (not juice).
Morning/Afternoon Teas – record how many cups of tea, coffee, and amount and type of milk. Biscuits, etc. –
how many, type.
Lunches
Sandwiches – type of bread, spread used (may need to ask if you are using canteen). Was spread usual amount
you would use? What type of fillings – estimate number of slices of meat, cheese. If it is a salad sandwich, what
is actually in there – beetroot, meat, etc. as well?
Take-aways – try to estimate quantities as best you can. Include type of cooking oil.
Evening Meals
Raw-weight of cooked meat. If it is a meal for 4, estimate how much of the meal you ate (i.e. 1/3, ¼).
• How was meat cooked?
• How much, and what type of oil/margarine was used?
• Did you eat fat on meat?
• Did you eat skin on chicken?
• What vegetables, salad, rice, pasta was served with meat and how much?
• What salad dressings, butter, cream was added?
Desserts
• Brand of ice-cream. How many scoops or tablespoons?
• Fruit/tinned fruit – quantities?
• Yoghurt – brand, amount?
• Cheeses – what types, how much?
• Commercial products – brands?
• Home-cooked goods – i.e. apple crumbles, etc. Recipe would be helpful.
Drinks - Remember to record wine, soft drinks, juices, etc.
Also remember that we are not judging you by what you eat. The records are needed because this is a scientific
project. To make it a valid study we need the truth, so don’t be afraid to write down everything you eat and
drink.
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THE UNIVERSITY OF WOLLONGONG
METABOLIC RESEARCH CENTRE
ILLAWARRA DIETARY INTERVENTION STUDIES

SAMPLE FOOD RECORD
PLEASE RECORD EVERYTHING THAT YOU EAT AND DRINK FOR 3 DAYS

DAY:
DATE:
TIME
OF
DAY

B
R
E
A
K
F
A
S
T

THURSDAY
29/4/99
TIME

8a.m.

DESCRIPTION OF AMOUNT OF
FOOD OR DRINK

HOW
PREPARED/
COOKED

¾ cup Special K
1 cup Lite-White Milk
1 Buttercup Wonder White toast

spread with 1 teaspoon
Canola marg

1/2 teaspoon Vegemite

M
O
R
N
I
N
G
10a.m.
T
E
A
/
S
N
A
C
K
S

EXAMPLE ONLY

4 Cruskit Biscuits

spread with 4 teaspoons
peanut butter
with 2 tablespoons Lite White
Milk

Cup of tea
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SAMPLE FOOD RECORD
PLEASE RECORD EVERYTHING THAT YOU EAT AND DRINK FOR 3 DAYS

DAY:
DATE:
TIME
OF
DAY

THURSDAY
29/4/99
TIME

12.30

A
F
T
E
R
N
O
O
N
T
E
A
/
S
N
A
C
K
S

DESCRIPTION OF AMOUNT OF
FOOD OR DRINK

2p.m.

3p.m.

HOW
PREPARED/
COOKED

2 sandwiches – 4 slices wholemeal bread spread with total of 3
filled with 2 slices Soccerball ham
teaspoons Canola marg
½ avocado
1 small tomato
½ lettuce leaf
5 slices cucumber

L
U
N
C
H

EXAMPLE ONLY

1 banana

40g dry roasted peanuts
glass of cordial (diet)
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SAMPLE FOOD RECORD
PLEASE RECORD EVERYTHING THAT YOU EAT AND DRINK FOR 3 DAYS

DAY:
DATE:
TIME
OF
DAY

THURSDAY
29/4/99
TIME

6.30pm

EXAMPLE ONLY

DESCRIPTION OF AMOUNT OF
FOOD OR DRINK

1 x cod fillet (120g cooked)
2 medium potatoes (200g cooked)

D
I
N
N
E
R

S
U
P
P
E
R
/
S
N
A
C
K
S

8.30pm

HOW
PREPARED/
COOKED

fried in 1 tablespoon Canola
oil
boiled

¾ cup broccoli
½ cup carrot

steamed

1 slice white bread

spread with ¾ teaspoon
Canola marg

Tinned peaches in natural juice
(3 halves)
1 banana
2 scoops Dairy Bell ice-cream

9.15pm

Cup of coffee
1 granita biscuit

with 2 tablespoons whole
milk

1

320
APPENDIX E: PARTICIPANT INFORMATION IN STUDY 3

[date]
Dear Diabetes Service Client
You are offered a position in the University of Wollongong/Illawarra Area Health Service research
project to provide “dietary intervention in the treatment of Gestational Diabetes Mellitus”. The
project aims to assess the benefits and achievability of an individualised dietary plan that is based
on current research knowledge. The results of the project will contribute to improvements in the
dietary management processes for women with Gestational Diabetes to benefit pregnancy
outcomes and reduce risks to both mother and child.
If you agree to take part you will be randomly assigned to one of two dietary advice groups. All
members of both groups will be provided with an indivi dualised diet plan (negotiated with you and
based on your usual food intake), but for each group, the information will be packaged in different
ways. You will be required to follow the diet plan for the duration of your pregnancy. You will
supply and consume your own food at home.
This will require close contact with an Accredited Practicing Dietitian (APD), who will regularly
monitor your progress and provide you with support. Diet methods and research procedures that
will be used during the study are set out below, along with possible risks and burdens:
At your first appointment and at 4-weekly appointments at the Diabetes Centre
*

A dietary interview to report and discuss your food intake (approximately 2 hours) at a time
convenient to you.

*

Your height and your weight will be recorded at the initial appointment and your weight at
each appointment thereafter.

At your second appointment at the Diabetes Centre (within a week of your first appointment)
*

A dietary plan will be provided with instructions and food lists for you to follow. The plan will
be based on your regular diet. Advice regarding appropriate food choices, cooking and
recipe formulation will also be given as well as answers to any questions you may have.

Between each 4-weekly appointment (at home)
*

Measure and record your food intake over 4 consecutive days including one weekend day.
You will be provided with a food diary, kitchen scales and measuring cups and instructed in
their use.

Support meetings will be arranged by agreement at times convenient to you (at least bi-weekly)

Potential Benefits
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You will receive an individualised dietary plan from a dietitian, aimed at controlling your weight,
blood glucose, cholesterol and triglyceride levels as well as reducing your risks of detrimental
pregnancy outcomes, such as having a large-for-age baby, premature delivery, caesarian section
and special care requirements for the newborn.
A summary of your dietary analyses will be kept in your Wollongong Hospital patient notes for
reference by other health professionals.
All other information collected will be stored on computer or in locked files under number codes to
ensure your confidentiality. Reporting of this information at conferences and in scientific journals
will be in general terms and will not identify individuals.
If you agree to take part you have the right to discontinue the project at any time. Non-participation
or withdrawal will not affect your treatment or the duty of care provided to you at the Diabetes
Centre.
The people involved in the research are located at either the University of Wollongong or the
Wollongong Diabetes Centre and include:
Dietitian and PhD student at the University of Wollongong
Manager of the Smart Foods Centre at the
University of Wollongong
APDSenior Dietitian at the Wollongong Diabetes Centre
Manager of the Wollongong Diabetes Centre
Area Manager of the Illawarra Diabetes Service
If you have any questions about this research please contact at the
Smart Foods Centre, University of Wollongong, or at the Wollongong Diabetes Centre.
If you have any concerns about the research being conducted please contact the Human Research
Ethics Committee on
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APPENDIX F: CONSENT FORM IN STUDY 3

Project: Dietary Intervention in the Treatment of Gestational Diabetes Mellitus
Researchers:

I have received and read the information sheets for the research project “Dietary intervention in the
treatment of Gestational Diabetes Mellitus ”. is conducting the research at the
Wollongong Diabet es Centre as part of her PhD research with the University of Wollongong.
explained the project to me and answered my questions.
I understand that participation in the project will require me to:
a)

describe my food intake in detail to a dietitian

b)

measure and record my food intake for short periods at home

c)

follow a prescribed dietary meal plan

I have been advised of the potential burdens associated with these diet methods and research
procedures.
I have been informed that no individual data will be identifiable in the publication of results from this
study in the form of a PhD thesis, scientific journal article or conference seminar.
I understand that my participation in this research is entirely voluntary and that I am free to withdraw
my consent at any time. My decisions will not affect my treatment or my relationship with the
Wollongong Diabetes Centre in any way.
If I would like to discuss this research further I can contact at the
Wollongong Diabetes Centre or at the Smart Foods Centre, University of Wollongong. If
I have any concerns about the way the research is being conducted I can contact the Human
Research Ethics Committee on.
Dietary Intervention as Treatment of Gestational Diabetes Mellitus
I consent to participate in the research being conducted by and co-workers as it has
been described to me in the information sheets. I understand the data collected will be used for a
PhD thesis, scientific journal articles and conferences, and I consent for the data to be used in this
manner.
………………………………………………………………
Signed
………………………………………………………………
Name (please print)

……..../……..../……....
Date
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APPENDIX G: RECRUITMENT ADVERTISEMENT IN STUDY 4

Do you have type 2 Diabetes and would like to participate in a study of how it is managed by diet?

The Smart Foods Centre at the University of Wollongong is seeking volunteers for a study on the
dietary management of type 2 Diabetes Mellitus.

If you fit all these criteria, we would like you to contact us:
•

Aged 35-70years

•

Diagnosed and treated for at least 2 years

•

Generally well

•

Not on insulin therapy

•

No food allergies

The study involves working closely with research dietitians at the University and the Illawarra
Diabetes Service in testing the how well and why certain approaches to dietary management might
work best for people with type 2 diabetes. Using guidelines for dietary management based on the
best available scientific evidence, we will be concentrating on developing your usual eat ing patterns
over a 6-month period, starting in January 2003. If you would like to register your interest and find
out more, please contact Marian Bare at the Smart Foods Centre on .
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APPENDIX H: SCREENING SURVEY IN STUDY 4

Dietary Management of Type 2 Diabetes Mellitus
The Eatwell Study
In this questionnaire general questions are asked about yourself, your health and the food you eat. The
information that you provide is confidential. If you have any concerns or have difficulty in answering
any of the questions please do not hesitate to contact any of the researchers named in the information
package.
1. Title:

Dr

Mrs

Mr

Miss

Ms

2. Full Name: _____________________________________________
3. Address: ________________________________________________

______________________________________
4. Phone No.: Home: ________________________
Work: _________________________
Mobile: ________________________
5. Date of birth: _________day ___________month __________ year
6. Country of birth___________________ Language spoken at home______________________
7. Highest level of education_______________________________________________________
8. Occupation___________________________________________________________________
9. Height _________Ft ___________Inches OR ________cm
10. Weight _________St ___________lbs OR __________kg
11. Has your weight changed more than 3 kgs (7lbs) in the last 6 months?
(Please tick (ü) one box)
Don’t know
No
Yes - it has gone up by _____ lb. or ______kg
Yes - it has gone down by ______ lb. or _______kg
12. Do you smoke cigarettes? (Please tick (ü) one box)
No
Yes, 1-10 per day
Yes, 11-20 per day
yes, more than 20 per day

13. On average, how many alcoholic drinks (eg. number of middies of beer, glasses of wine, sherry,
port, nips of spirits) would you have each day during a typical week?
(Please tick (ü) a box)
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Dietary Management of Type 2 Diabetes Mellitus
The Eatwell Study
In this questionnaire general questions are asked about yourself, your health and the food you eat. The
information that you provide is confidential. If you have any concerns or have difficulty in answering
any of the questions please do not hesitate to contact any of the researchers named in the information
package.
1. Title:

Dr

Mrs

Mr

Miss

Ms

2. Full Name: _____________________________________________
3. Address: ________________________________________________

______________________________________
4. Phone No.: Home: ________________________
Work: _________________________
Mobile: ________________________
5. Date of birth: _________day ___________month __________ year
6. Country of birth___________________ Language spoken at home______________________
7. Highest level of education_______________________________________________________
8. Occupation___________________________________________________________________
9. Height _________Ft ___________Inches OR ________cm
10. Weight _________St ___________lbs OR __________kg
11. Has your weight changed more than 3 kgs (7lbs) in the last 6 months?
(Please tick (ü) one box)
Don’t know
No
Yes - it has gone up by _____ lb. or ______kg
Yes - it has gone down by ______ lb. or _______kg
12. Do you smoke cigarettes? (Please tick (ü) one box)
No
Yes, 1-10 per day
Yes, 11-20 per day
yes, more than 20 per day

13. On average, how many alcoholic drinks (eg. number of middies of beer, glasses of wine, sherry,
port, nips of spirits) would you have each day during a typical week?
(Please tick (ü) a box)
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13. On average, how many alcoholic drinks (eg. number of middies of beer, glasses of wine, sherry,
port, nips of spirits) would you have each day during a typical week?
(Please tick (ü) a box)
None

1

2

3

4

5 or more

Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday

14. Have you ever been advised that you have a high HbA1c reading (a measure of blood glucose or
‘sugar’)?
YES

NO

NOT SURE

15. Have you ever been advised that you have a high cholesterol or triglyceride reading ( a measure of
blood fat)?
YES

NO

NOT SURE

16. Have you ever been advised that you have a high blood pressure reading?
YES

NO

NOT SURE

17. Please indicate any recent measurements of these items below (if known):
Test
HbA1c
Cholesterol
Triglycerides
Blood
pressure

Date

Result

Treatment (Medications, diet, no treatment etc)
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18. Do you take any medications for your blood sugar, cholesterol, triglycerides or blood pressure?
YES

NO

NOT SURE

If YES, Please specify_________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

19. List any medications taken occasionally (eg. For headache, arthritis, hay fever, indigestion )
Medications

Dose

How often

____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
20. List any medications not already listed that you are taking regularly
Medication

Dose

How often

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________________

21. Which of the following health/medical conditions have been diagnosed by a doctor?
(Please tick (ü) one or more boxes)
High blood pressure

Migraine

Angina

Asthma

Heart disease

Menopause

Stroke

NONE

Diabetes
Arthritis

other… please specify _________________________

Gout

_____________________________________________

22. Do you currently follow a special or modified diet?
YES

NO

NOT SURE

If yes, do you follow a prescribed carbohydrate meal plan?
YES

NO

NOT SURE
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If you do follow a prescribed carbohydrate plan, please indicate the number of serves of carbohydrate
you consume each meal
Breakfast:

Morning Tea :

Afternoon Tea :

Dinner :

Lunch :

Supper :

23. If you are following another form of special diet, please specify what this is:
_____________________________________________________________________________

_____________________________________________________________
24. Who advised this diet? (e.g. doctor, self, dietitian)
___________________________________________________________________________

25. Do you have any known food allergies, intolerances or aversions to certain foods?
YES

NO

NOT SURE

Food type: _________________________________________________________________

26. Do you eat any of the following foods? (Please tick & list amount)
Amount

How Often

¨ white fish

___________

___________

¨ oily fish (salmon, tuna, sardine, mackerel)

___________

___________

¨ soy beans

___________

___________

¨ soy milk

___________

___________

¨ soy yogurt

___________

___________

¨ soy cheese

___________

___________

¨ Soy drinks

___________

___________

¨ soy & linseed bread

___________

___________

¨ soy & linseed breakfast cereals

___________

___________

¨ peanuts

___________

___________

¨ walnuts

___________

___________

¨ other types of nuts

___________

___________

please specify type: ________________________________________________________
¨ oils

___________

___________

please specify type/brand: ___________________________________________________
¨ margarine/butter

___________

___________

please specify type/brand: ___________________________________________________
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Are there any of the above foods you will NOT eat
YES , all of them

YES, some of them

NO, I will eat most foods

Please specify individual food items you prefer not to/will not eat:
_______________________________________________________________

27. On average, how many times a week would you eat meals away from home?
(i.e.: Visit a restaurant, take-away food or have meals prepared by friends? )
(Please tick (ü) one box)
6-7 times per week (most days)
3-5 times per week
1-2 times per week
1-2 times a fortnight
1-2 times a month
4-6 times a year
rarely (<6 times a year)
Never
28. Do you supplement your diet with any of the following? (Please tick (ü))
Vitamins &/or minerals
Vitamin E capsules

Dose per day ________________________________

Fish oil capsules

Dose per day ________________________________

Cod liver oil

Dose per day ________________________________

Evening primrose oil

Dose per day ________________________________

Others (please specify) _____________________________________________________
I do not supplement my diet

29. Do you eat fish? (Fresh fish - including shellfish, or canned fish)
YES
NO
If so, how frequently? (Please tick (ü))
Daily
Weekly
Fortnightly
Monthly
Never
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I understand that the information provided will be used only for the purpose of determining my
suitability to participate in the Eatwell Study. Completion of this questionnaire does NOT ensure that I
will meet all the requirements for the study.
I understand that the Smart Foods Centre regularly conducts studies such as this one which ask for
volunteers. I would like the information in this questionnaire:
to be kept in a confidential file at the Smart Foods Centre for consideration in future research
projects.
OR
to be destroyed immediately.

Signed ______________________________ Date ____________________

Thank you for your participation!
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APPENDIX I: DIET HISTORY QUESTIONNAIRE IN STUDY 4

Code:
Date:
Site:

diet history
questionnaire

Return to:
Smart Foods Centre
University of Wollongong
Northfields Av, Wollongong NSW 2522. Australia
Phone:
Fax:

ARC Key Centre of Teaching and Research
University of Wollongong

© dhq 2002. Tapsell LC, Patch CS.
diet history (Base) 2042
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Interviewer: _________________
DOB:

Ht:

_________________

____________cm

BMI: ___________ _

Age: ____________

Weight: ______________
BMR:

_______________

Medications: ___________________________________________________________

History of health conditions: _________________________________________________
Supplements: _____________________________________________________________
Physical activity level: _______________________________________________________

Core Food Choices: Please indicate the type of foods you select in these
categories
Food group
Milk (full fat,
skim)

Type

Food group
Spread (margarine
etc)
Oils (olive, canola)

Bread (white,
grain)
Drinks (sweetening)

Type
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Part 1: Breakfast
How often do you eat this meal?_____________________Home_______________Away_________

Breakfast Cereals/Porridge
Type

Amount

Frequency

Amount

Frequency

Amount

Frequency

Amount

Frequency

Milk with cereal
Sugar with cereal

Toast/Bread/Muffins etc (including toppings)
Type

Spread with toast
Topping on toast

Eggs and other cooked dishes
Type

Oil/fat

Other Foods (including drinks, fruit, yoghurt)
Type
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Part 2: Light Meal.

Lunch or Dinner (Circle)

How often do you eat this meal?_____________________Home_______________Away_________

Sandwiches/Rolls
Description (include all components)

Amount

Frequency

Amount

Frequency

Amount

Frequency

Other foods (including drinks, fruit, takeaway meals, cakes)
Description
Amount

Frequency

Spreads
Added salt
Salads
Description (include all components)

Dressings
Soups
Description (include all components)

Soup mix
Added salt
Bread
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Part 3: Main Meal.

Lunch or Dinner (Circle)

How often do you eat this meal?_________________________Home_______Away___________

Main dishes (include all components)

Oils/spreads
Dressings
Sauces

Amount

Frequency

336

Other foods (include drinks, bread, side dishes, desserts, fruit)
Type
Amount

Frequency

Part 4: Foods consumed outside meals
How often do you eat snacks?_____________________Home_______________Away_________

Type

Amount

Frequency
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Part 5: Food Frequency Checklist
Food category
Bread/crumpet
Biscuits
Crispbreads/crackers
Cakes/scones/muffins/pastries
Pancakes
Beans/legumes
Fruit
Fruit juice
Soft drinks/cordials
Chocolate/lollies
Chips
Alcohol
Milk
Yoghurt
Ice cream
Cheese
Dip/cream cheese/cheese spread
Soy milk
Soy yoghurt
Eggs/omega eggs
Salmon/tuna (fresh/canned)
Sardines/Mackerel
White fish varieties
Oysters
Walnuts
Pecans
Other nuts
Seeds

Amount

Frequency
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Part 6: Food Preparation Practices
6.1 Butter/Margarine _
What type do you usually use?
Butter
Dairy blend
Margarine - polyunsaturated, regular
Margarine - polyunsaturated, reduced fat
Margarine - monounsaturated, regular
Other_____________________________
6.2 Oil/Fat in cooking
What type of oil/fat do you use in cooking?
Butter
Dairy blend
Margarine - polyunsaturated, regular
Margarine - polyunsaturated, reduced fat
Margarine - monounsaturated, regular

Olive oil
Canola oil
Soybean oil
Gold’n Canola
Other _________________________

6.3 Fat on Meats/Chicken________________________________
How much fat is trimmed from meat before cooking/eating?
a) None
b) 25%
c) 50%
d) 75%
e) All
How much of the skin on chicken to you remove before cooking/eating?
a) None
b) 25%
c) 50%
d) 75%
e) All
Other, please specify: ___________
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APPENDIX J: FOOD RECORD IN STUDY 4

Code:
Date:
Site:

3-day food record

Return to:
Smart Foods Centre
University of Wollongong
Northfields Av, Wollongong NSW 2522. Australia
Phone:
Fax:

ARC Key Centre of Teaching and Research
University of Wollongong
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Breakfast and Morning Tea
Food

Date:___________________
Amount
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Lunch and Afternoon Tea
Food

Date:___________________
Amount

342

Dinner and Supper

Date:___________________
Food

Amount
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APPENDIX K: PARTICIPANT INFORMATION IN STUDY 4

Dietary Management of Type 2 Diabetes Mellitus
The Eatwell Study

You are kindly invited to participate in the Eatwell Study conducted by the Smart Foods Centre,
Department of Biomedical Science, University of Wollongong and the Illawarra Diabetes Service,
Illawarra Health. The project aims to assess the benefits and achievability of different dietary
approaches in the management of type 2 diabetes mellitus. The results of this research will
contribute to better understanding of the processes behind the dietary management of type 2
diabetes and thereby more effective treatment.
If you consent to participate you will be asked to:
Complete a screening questionnaire to assess your suitability for the study
For this you will be required to provide details of your medical history and dietary habits to the
researchers at the University.
Attend an information evening at the University of Wollongong at the start and completion of
the six month study period
On these occasions you will be given further information about the study and will have the
opportunity to meet and ask questions of those members of the team conducting the research.
Attend the University clinic at the start of the study, after 3 months and 6 months
* On each of these occasions you will be required to provide a fasted blood sample of
approximately 40ml (about 1.5 tablespoons). A qualified practitioner will collect the blood from your
arm and you may experience some discomfort and possible bruising.
* Your weight, height, waist circumference and blood pressure will be measured.
Attend either the Illawarra Diabetes Service in Wollongong or the University clinic
(depending on your group allocation) at monthly intervals
* On each of these occasions a dietitian will conduct a dietary interview. This will require you to
give a detailed report of your usual food intake - approximately 1 hour.
* You will be required to keep a 3 day food record prior to these interviews
* You will receive dietary advice supporting the management of diabetes
Receive telephone calls at 2 weekly intervals to see how you are going on the diet
Try to follow the dietary instructions as best you can and to advise the researchers of any
problems you may encounter in doing so
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If we are able to offer you a place in the study and you accept, you will be randomly allocated to
one of three dietary advice groups. All members of each group will be provided with an
individualised meal plan that meets current dietary recommendations and fits with your usual food
preferences as best as possible. You will be required to follow this advice as best you can for the 6
months duration of the study. As the advice is based on your normal routines, and we are testing its
feasibility, you will still be purchasing and preparing your own food as before.
Following the meal plan will require close contact with an Accredited Practicing Dietitian (APD), who
will regularly monitor your progress and provide you with advice and support. This programmed,
individualised attention over a 6-month period is one of the major benefits you will receive
throughout the study. When the study is complete we will ensure you have continued support
through the Diabetes Service. A summary of your dietary analyses, measurements of height,
weight, blood pressure and blood pathology results will be kept in your patient notes at the Illawarra
Diabetes Service for reference by health professionals in your continued care.
All other information collected will be stored on computer or in locked files under number codes to
ensure confidentiality. Reporting and publication of this information as a PhD thesis, scientific
reports, in journals and at scientific conferences will not identify any individual.
If you agree to take part you have the right to discontinue the project at any time. Non-participation
or withdrawal will not affect in any way your association with the University of Wollongong or the
Illawarra Diabetes Service.
The people involved in the research are located at either the University of Wollongong or the
Illawarra Diabetes Service in Wollongong and include:
Assoc. Prof.

Manager of the Smart Foods Centre at the
University of Wollongong
Research Fellow at the Smart Foods Centre
Dietitian and PhD student
Senior Dietitian, Illawarra Diabetes Service

If you have any questions about this research please contact A/Prof
or at the Smart Foods Centre on or at the
Illawarra Diabetes Service on If you have any concerns about the research being
conducted please contact the Human Research Ethics Committee on .
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APPENDIX L: CONSENT FORM IN STUDY 4

Dietary management of Type 2 Diabetes Mellitus:
The Eatwell Study
Associate Professor

Smart Foods Centre, Department of Biomedical Science,
University of Wollongong

Illawarra Diabetes Service, Illawarra Health
I have been given information about the Eatwell Study and discussed the research project with one
of the above nam ed researchers. I understand that is involved in this research as part of
a PhD program supervised by Associate Professor in the Smart Foods Centre, Department
of Biomedical Science at the University of Wollongong.
I understand that, if I consent to participate in this project I will be asked to:
• complete a screening questionnaire with details of my medical history and dietary habits
• attend an information evening at the University and the start and completion of the study
•attend the University clinic at the start of the study, and after 3 months and 6 months to:
provide a fasted blood sample of approximately 40ml (1.5 tablespoons), and
have my weight, height, waist circumference and blood pressure measured
Depending on my allocation, attend either the Illawarra Diabetes Service in Wollongong or the
ESRC clinic at the University at the allocated time, at monthly intervals to:
Undergo a diet history interview and keep a 3 day food record prior to these interviews.
Receive dietary advice on the management of diabetes
Receive phone calls at 2 weekly intervals to see how I am going on the diet
Try to follow the dietary instructions as best I can and to advise the researchers of nay
problems I may be encountering in doing so.
I have been advised of the potential risks and burdens associated with this research, which include
some potential bruising with the collection of blood and the need to keep to a dietary pattern as best
I can. I have had an opportunity to ask any of the above named researchers any questions I may
have about the research and my participation.
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I understand that my participation in this research is voluntary, I am free to refuse to participate and
I am free to withdraw from the research at any time. My refusal to participate or withdrawal of
consent will not affect my treatment in any way with the University of Wollongong or the Illawarra
Diabetes Service.
If I have any enquiries about the research, I can contact
at the Smar t Foods Centre on or at the Illawarra Diabetes Service on
, or if I have any concerns or complaints regarding the way the research is or has been
conducted, I can contact the Complaints Officer, Human Research Ethics Committee, University of
Wollongong on .
By signing below I am indicating my consent to participate in the research entitled the Eatwell
Study, conducted by and colleagues as it has been described to me in the
information sheet. I understand that the data collected from my participation will not identify me. It
will be used for the purposes of research that will be published in reports, scientific journals and
conferences and I consent for it to be used in that manner.

Signed

Date

.......................................................................

......./....../......

Name (please print)
.......................................................................

